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ABSTRACT 
There were two aims in this thesis. Firstly, to investigate cholinesterase 
and its isoenzymes in the fetal mouse brain, and secondly to study drug-
induced fetal damage with the following objectives in mind: (i) to 
examine new markers for the evaluation and prediction of the teratogenic 
potential of drugs, and (ii) to try and throw more light on pathogenic 
mechanisms of drug injury with particular reference to the developing 
fetal central nervous systeo. 
Acetylcholinesterase activity in brain homogenates was determined colori-
metrically and the isoenzymes were separated by polyacrylamide gel electro-
phoresis. A cyanmethaemoglobin method was used to measure the contribution 
of acetylcholinesterase activity in blood to total brain esterase activity. 
Cholinesterase activity was estimated colorimetrically, and with the aid of 
enzyme inhibitors and polyacrylamide gel electrophoresis. 
The effects of three central nervous system teratogens, vitamin A, cyclo-
phosphamide and sodium valproate when administered during embryonic develop-
ment, on gross fetal parameters in C3H mice including embryolethality, gross 
morphological abnormalities, fetal weight, brain weight, brain acetylcholi-
nesterase and its isoenzymes, and in some instances brain total protein con-
tent and choline acetyltransferase activitY,were assessed. Preliminary 
studies were also performed with a view to future areas of research on (i) 
the effects of vitamin A when administered during the pre-implantation period 
on 1iability/esterase enzyme activity, cell number, mitotic index and 
chromosome structure in the 81h blastocyst; (ii) the influence of vitamin 
C3B fetal mouse brain proteins using high resolution two-dimensional 
electrophoresisi and (iii) the effects of cyclophosphamide and vitamin A 
on cephalic DNA damage utilising a DNA unwinding assay to detect DNA strand 
breaks. 
Substantial acetylcholinesterase activity of~ 3nmol/min/mg was present in 
17-day to 19-day fetal mouse brains and 5 isoenzymes were present on 
electrophoresis. The contribution of acetylcholinesterase activity in 
blood was low at approximately 3%. Similarly, fetal mouse brain cholines-
terase activity was found to be very low and the effect of teratogens on 
this enzyme was not assessed. 
A rise in the incidence of malformations and embryolethality with increase 
in dose, and after administration earlier in gestation occurred with all 
three teratogens. A growth-inhibitory effect was another feature although 
this was most pronounced after cyclophosphamide administration. Acetyl-
cholinesterase activity was affected by the teratogen used and its time of 
administration as well as other factors such as growth inhibition, haemorr-
hage and repair processes. Vitamin A administration on day 10 of gestation 
was associated with a greater acetylcholinesterase activity compared with 
controls, which was not accompanied by a change in brain total protein 
content or choline actyltransferase activity. Cyclophosphamide and sodium 
valproate administration during the embryonic period were associated with a 
lower acetylcholinesterase activity in near-term fetuses. However, in 
fetuses examined two days after cyclophosphamide administration there was 
a greater acetyl cholinesterase activity associated with an increase in 
haemoglobin and a decrease in choline acetyltransferase. A higher acetyl-
cholinesterase ac~ivity was also observed in exencephalic brains. Vitamin 
A administration was associated with a higher activity of isoenzyme 5 
whereas cyclophosphamide and sodium valproate administration resulted in 
a lower peak height for band 4. 
When vitamin A was administered during the pre-implantation period 60h 
(xi} 
after copulation no effect on viability/esterase enzyme activity, cell num-
ber, mitotic index or chromosome structure was observed in 81h embryos. 
However, a striking incidence of abnormalities was noted in fetuses examined 
near term. 
This study suggested that teratogenic doses of vitamin A modified the 
brain protein pattern of the fetal mouse with a possible broad spectrum 
deletion of protein spots and the appearance of a limited number of 
new spots. 
There was no evidence of DNA strand breaks induced by vitamin A, which 
contrasted with obvious cephalic DNA damage after cyclophosphamide ad-
ministration. 
The potential of these techniques in the prediction of the embryotoxicity 
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C H A P T E R I 
TERATOLOGY AND THE EFFEcrS OF VITAMIN A, CYCLOPHOSPHAMIDE AND SODIUM 
VALPROATE ON THE FETUS 
1.1. Il'l'TRODUCTION TO TERATOLOGY 
Currently, a teratogen is considered to be an agent that induces struc-
tural malformations, metabolic or physiological dysfunction, or psycho-
logical or behavioural alterations or deficits in the offspring (Schar-
dien, 1985). Chemicals capable of inducing malformations also have the 
potential for inducing other deviations of development, which are referred 
to as embryotoxic effects and fit under the umbrella of the term "develop-
mental toxicity". In addition to malformation other manifestations of 
toxicity are growth retardation, death and functional alteration. 
Whether or not a given chemical has the potential to induce congenital 
abnormalities is governed by established fundamental principles of tera-
togenesis, largely formulated by Wilson (Wilson 1965, 1973): susceptibi-
lity depends on the species, the developmental stage at the time of expo-
sure, the dosage of the agent, the nature of the agent used and the physio-
logical or pathological state of the mother. 
Not all species are equally susceptible to teratogenic influence of a 
given chemical (Schardien, 1976 
netic differences (Wilson, 1977 
20). This is p~tly explicable on ge-
49). The reaction to a specifice tera-
togen may be due to differences in a species rate of metabolism, as well 
as to qualitative differences in metabolic pathways (Burns and Conney, 
1964). Accessibility of a drug to the embryo, dependent on placental 
differences, may also account for some differences in species susceptibi-
lity. As noted by Kalter (1968), inter- and intra-species variability 
, . 
may be manifested in several ways: (i) An agent that is teratogenic in 
some species may have little or no effect in others. For example, man and 
higher primates are extremely sensitive to thalidomide, whereas most other 
mammals are quite resistent. (ii) A teratogen may produce similar defects 
in various species, but these vary in frequency. (iii) A teratogen may 
induce certain abnormalities in one species that are entirely different 
from those induced in other species. 
The developmental stage at the time of exposure is crucial. During the 
pre-differentiation period in early gestation the embryo is remarkably 
resistant to teratogenesis (Austin, 1973; Spielman et al., 1977). It has 
been generally accepted by many teratologists that exposure during this 
period results in either death of the embryo before implantation or 
survival to term without any abnormality - the all-or-none phenomenon 
(Wilson, 1977 : 51; Tuchmann du Plessis, 1975 40). Austin (1973) has 
suggested that the reason for this resistance to teratogenesis is that the 
undifferentiated cells of the early embryo are totipotent and possess the 
capacity to form any part of the future individual, so that losses of cells 
can to some extent be accounted for. The effect on the cleavage embryo 
depends on the number of cells killed or inhibited; above a certain propor-
tion the embryo dies, below that figure the remaining cells multiply to 
replace those lost and subsequent development is essentially normal. 
The response to a teratogenic agent, however, is more complex than an 
all-or-none phenomenon. Spielman et al., (1977) showed that whilst cy-
clophosphamide administered before implantation had no effect on implan-
tation of rat embryos and did not cause malformations, the drug caused a 
decrease in cell number of blastocysts, subsequent fetal growth retarda-
tion and a dose dependant increase in resorption rate with the majority of 
fetuses dying during the organogenesis period. Kola (1985) has also shown 
that viable cyclophosphamide treated embryos have dose related structural 
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and functional deficits. Iannaccone (1984) demonstrated histological and 
chromosomal abnormalities in the absence of structural malformations at 
term after exposure of blastocysts to methylnitrosurea, and there are also 
some reports of malformations resulting from exposure to teratogens during 
the preimplantation period (Rugh and Grupp, 1959; Gottschewski, 1964; 
Moriss, 1972; Takeuchi, 1984). Klein and Pierro (1983) have suggested 
that exposure of preimplantation embryos to noxious agents may manifest 
as behavioural abnormalities. 
During the embryonic stage embryological differentiation and organogenesis 
occur. During the "critical period of organogenesis" there is particular 
vulnerability for induction of structural defects to organs and systems. 
As the more basic organisational patterns of organ formation are completed, 
the likelihood of major structural deviation naturally diminishes (Schar-
dien, 1976 : 17; Wilson, 1977 : 52). The embryonic stage is followed by 
fetogenesis which is characterised by growth and histological differentia-
tion and continues for a variable period after birth. Because the central 
nervous system is continuing its complex development during this stage 
abnormalities can be produced, typically histological or functional 
alterations. 
Teratogenicity is governed by dose-effect relationships. The dosage of a 
given teratogen lies within a narrow zone between that which will have 
no discernible effect and that which causes malformations or death. 
Typically the dose response curve has a steep slope, sometimes going 
from minimal to maximal effect levels with doubling the dose (Wilson, 1973). 
An exception, however, is thalidomide which is teratogenic at low doses 
but can be tolerated without embryolethality at several multiples of 
this dose . Functional defect, malformation and embryolethality are 









defect to the left and that for embryolethality to the right of the 
malformation curve (Snell, 1982a, Fig. 1.1.). A fourth curve represen-
ting offspring growth was thought by Snell to intervene probably 
between the functional and malformation curves, although he stated that 
it was not entirely clear whether for some agents it would prove to 
be isomorphic with or even to the left of the functional defects curve. 
The current concept concerning dosage is ~hat teratogenic chemicals 
are hazardous only when they disrupt development of the conceptus at 
dosages not toxic to the adult (Johnson, 1980, 1981). The implication 
is that a chemical producing terata is not necessarily a teratogen~c 
hazard because the chemical would be in essence regulated solely by the 
toxicity to the adult animal. It is well known that,due to particular 
vulnerability of certain embryonic cells (Neubert et al.,1971), the 
embryo usually has a greater susceptibility to chemicals than does the 
adult. 
Fig. 1.1. 
THEORETICAL SET OF DOSE-RESPONSE CURVES SHOWING THE RELATIONSHIP BETWEEN 












The duration of chemical treatment is another variable. In 
general acute dosage schedules are of greater teratogenic insult to the 
developing embryo than chronic dosage schedules (Schardien, 1985:10). 
Similarly, differences may exist in teratogenic response when a chemical 
is given by different routes of administration or in different dosage 
forms. With vitamin A,oily solutions must be used orally to produce 
teratogenic effects, whereas parenterally only aqueous 
effective (Kalter, 1968b). 
solutions are 
The nature of the agent determines its access to the embryo (Wilson~ 1977: 
59). Placental transfer is moderated by the drug's lipid solubility, 
molecular weight, degree of ionisation and protein binding and by placental 
properties such as maternal and fetal blood flow, drug metabolism and 
placental age. 
Finally, it is the interaction of fetal.maternal and environmental 
factors that determine the outcome of a particular teratogenic insult. 
Maternal age, parity, weight, basal metabolic rate, size and constitution 
of placenta and hormone states are all variables in strain susceptibility 
(Tuchmann du Plessis, 1975:45). These are subject to modification by 
environmental factors such as diet, temperature and circadian and seasonal 
effects (Kalter, 1965; Woollam and Millen, 1960; Sauerbier, 1981). 
The final manifestations of abnormal development may be malformations, 
death, growth retardation or functional disorder. The specific types of 
malformations occurring in different species are variable. While most 
are observed in nearly all species, the individual malformations and their 
frequency are somewhat species-dependent. Thus eye defects, exencephaly, 
polydactyly and cleft palate are seen quite coI!lIIlonly in mice (Flynn, 1968; 
Kalter, 1968a). It is important to recognise that spontaneous malfor-
mations may occur, and this varies among different species. For C3H mice 
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the rate is 3,3% (Heinecke, 1972). 
As an indicator of developmental toxicity fetal size is an important 
parameter in the assessment of potential teratogens. As a rule any potent 
teratogen will produce growth retardation in addition to malformation and 
resorption (Brent and Jensh, 1967). Indeed, overall growth retardation 
is thought by some investigators to constitute a state of increased 
susceptibility to congenital malformations (Spiers, 1982). 
Intra-uterine death, like other developmental toxicity is distributed 
along a dose-response curve. When there is undue toxicity early in 
pregnancy the embryo dies and is resorbed. If death occurs later in 
pregnancy the fetus cannot be wholly resorbed and a stillborn or dead 
and often macerated fetus is the result. Mortality may be due primarily 
to the direct action of chemicals on the conceptus regardless of whether 
or not it is malformed, or it may be secondary to maternal effects 
(Kalter, 1980). Although intrauterine death is easy to quantitate,its 
relationship to other toxicity varies (Wilson, 1980). 
Functional impairment resulting in lower intelligence or impared behaviour 
may be the result of more subtle, non structural alterations produced by 
teratogens. Agents that are teratogens of the central nervous system are 
also behavioural teratogens when given at dosages below which major mal-
formations are produced (Vorhees et al.,1979, Mooney et al.,1981). It has 
been suggested that such alterations in behaviour arise as a result of 
drug-induced modification ~f development of specific neuro-transmitter 
systems (Leonard, 1981). Apart from behavioural studies it has been 
proposed that evaluation of perinatal enzymology represents an approach 
6 
for improved testing of postnatal functional development because quantifiabl e 
deviations in enzyme activity may be sensitive indicators for deleterious 
effects (Andrew and Lytz, 1981) 
At present there are no firm or unequivocal explanations of the mechanisms 
of action of any teratogenic agent. The best overview of the mechanisms 
by which teratogens induce abnormal development is probably still that 
given by Wilson (1977). The possible mechanisms include mutation, 
chromosomal aberration, mitotic interference, altered nucleic acid or 
energy sources, enzyme inhibition, osmolar imbalance or altered membrane 
characteristics. These are ultimately manifested as one or more types 
of abnormal embryogenesis, such as cell death, reduced biosynthesis, 
impaired morphogenetic movement, failed tissue interaction, or mechanical 
disruption. The embryo is particularly vulnerable to alteration of normal 
biosynthesis (including DNA, RNA and protein biosynthesis) because it 
must maintain critical developmental schedules and because the cells 
are undergoing rapid proliferation (Ritter, 1977). This vulnerability 
may lead to decreased cellular proliferation or cell death. Whatever 
the basic mechanism many teratogens cause cell death and a reduced 
proliferative rate. The lowered cell number which results from these 
effects appears to play an important role in the genesis of malformations 
(Scott, 1977). The primary result of cell death is thought to be 
aberrant differentiation. Many complex processes are essential for 
normal differentiation, and ma,,.y of these occur in parallel. These 
include cell-cell interaction, cytodifferentiation, morphogenesis, growth, 
and expressivity of the embryonic genome. The cell surface plays a 
central role in these events (Skalko, 1981). Aberrant differentiation 
ultimately leads to malformation (Schreiner and Holden, 1983). 
However, embryonic tissue has a tremendous capacity for repair following 
injury. If the regeneration is adequate and "in time", no malformations 
will be seen (Ritter, 1977). 
I have depicted the current status of teratogenic mechanisms and the 

































































































































































































































































































































































In seeking new markers of teratogenic potential of drugs the brain is 
a useful target organ to study because its complex development continues 
throughout gestation and CNS anomalies are the most common and most im-
portant of the congenital defects. The high frequency of occurrence of 
CNS anomalies is a result of the complexity of its development (Ornoy 
and Yanai, 1980). Most anomalies are minute and morphological changes 
may be difficult to elucidate by present conventional techniques. More 
sensitive methods, such as detecting neuro-chemical changes, are there-
fore needed. 
1.2. VITAMIN A AS A TERATOGEN 
The teratogenic potential of large doses of vitamin A (retinal) in animals 
has been recognised for over 30 years. Cohlan, (1953; 1954) induced a 
variety of malformations in Wistar rats such as exencephaly, hydrocephalus, 
spina bifida, cleft palate and eye defects, using a daily dose of 75 000 IU, 
equivalent, weight for weight, to more than 25 million IU for an adult 
human. Hundreds of animal studies have since confirmed the teratogenicity 
of vitamin A, well reviewed by Geelan (1979). Of particular importance 
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is the recent focus of interest on the vitamin and its analogues in man 
because of a number of reports of birth defects (Rosa et al., 1984; Lancet 
editorial, 1985). There are at least 18 reports of suspected vitamin A 
induced human birth defects, which include abnormalities of the nervous sys-
tem, cranio-facial, cardio-aortic and genitourinary malformations (Gal et al., 
1972; Bernhardt and Dorsey, 1974; Mounoud et al., 1975; Stange et al., 
1978, Rosa, Wilk and Kelsey, 1986). Of note is that doses of vitamin A as 
low as 15 000 to 60 000 IU daily, which are comparable to teratogenic doses 
in animals, have resulted in abnormalities. 
Of further relevance is the fact that there have been at least 44 birth 
defect case reports associated with the maternal use of vitamin A analogues 
or the retinoic acid derivitives, isotretinoin and etretinate. Typically, 
absent or small low external ears or canals, central nervous system ab-
normalities and/or cardioaortic defects were present (Rosa, 1984; Rosa 
et al., 1984; Rosa, Wilk and Kelsey, 1986). 
Whilst the relevance to humans stimulated my interest in this teratogen, 
of particular pertinance to my studies was the fact that vitamin A is a 
well established central nervous system (CNS) teratogen. Exencephaly, 
described in the first studies with vitamin A in the rat (Cohlan, 1953; 
1954) is a common abnormality which also occurs, albeit with a lower inci-
dence, in the mouse (Giraud and Martinet, 1959; Kalter and Warkany, 1961-
Murakami and Kameyama, 1965; Theodosis and Fraser, 1973), and is due to 
nonclosure of the rostral neural plate. Minor closure defects of the 
neural tube may result in meningocele or meningoencephalocele (Giraud, 
Martinet and Solere, 1958; Geelan, 1979), while abnormal closure of the 
spinal cord which occurs less commonly, results in spina bifida. 
Other abnormalities include hydrocephalus, which does not occur frequently 
with vitamin A treatment (Murakami and Kamayama, 1965), microcephaly 
(Kocher, 1967) and "crowded brain", where the brain appears too large for 
the cranium with no sign of hydrocephalus (Kalter and Warkany, 1961). 
In the mouse most abnormalities of the CNS have been produced by dosing 
on one or more days between 8 and 10 days post conception. However, 
the brain continues to undergo differentiation and proliferation during 
pregnancy. Abnormal neuroblasts wera noted :;.n the cerebral cortex of 
Swiss-Webster mice treated in the second half of pregnancy on days 15, 16 
and 17 (Langman and Welch, 1967). Other histological evidence of an em-
bryotoxic effect on the CNS has been provided during the embryonic phase. 
Geelen, Langman and Lowden (1980) found swelling and degeneration of neuro-
epithelial cells with large intercellular spaces in mouse embryos treated 
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with the vitamin just before brain vesicle closure. Similar changes in 
the mouse neuro-epithelium were noted by Theodosis and Fraser (1978). 
A feature of these studies was the rapid onset of action of vitamin A 
where histological changes were apparent within 2 - 4 hours of treatment. 
Further evidence that vitamin A is a CNS teratogen is provided by the 
observations that it can produce behavioural abnormalities (Butcher 
et al., 1972; Vorhees et al., 1978; Vorhees et al., 1979; Mooney 
et al., 1981) . Of relevance is that these behavioural effects can be 
produced at doses just below the teratogenic threshold for the induction 
of morphological abnormalities. Also, behavioural abnormalities in 
offspring can be produced with prenatal exposure to larger doses after the 
period of organogenesis (Hutchings et al., 1973, 1974). 
As with any teratogen the types and incidence of malformations depend on 
the stage of pregnancy during which vitamin A is administered, on the dose, 
and to a lesser extent on the species and strain. Many investigators 
have used multiple treatments of vitamin A, although a single administra-
tion is just as effective if time and dose are chosen carefully (Shenefelt, 
1972). The effects of single doses of 10 000 IU vitamin A administered on 
different days after conception in female mice of the A/J, DBA/iJ and 
CJH/J inbred strains were studied by Kalter and Warkany (1961). 
Treatment of females between 7 and 8 days post conception caused all but 
one of the young conceived to be resorbed, whereas a single administration 
of vitamin A between 8 and 9 days after conception resulted in a 58% resorp-
tion rate, and a widespread and complex syndrome of malformations in the 
fetuses. Ten thousand IU vitamin A between 9 and 10 days post conception 
resulted in a 30% resorption rate, with only a part of the above syndrome 
in the fetuses. Both groups had defects of the head, face and mouth, but 
those treated between 9 and 10 days after conception had more severe abnor-
11 
malities of these parts than those treated earlier. A frequent defect 
of the head was exophthalmos of various degrees, often with absence of 
the eyelids. 
An agent can have an embryotoxic effect by affecting the maternal orga-
nism, the placenta or the embryo itself. In vitro studies, where emb=yos 
are cultured in the presence of excess vitamin A, have demonstrated 
that the teratogenic effects of vitamin A are due to a direct effect on 
the fetus (Geelan, 1979; Morriss, 1972; Morriss and Steele, 1974; 
Morriss and Steele, 1977; Kochar, 1975; Steele et al., 1982. In vivo 
studies have shown that the vitamin reaches the embryo. 3 . . a-vitamin A 
acid administered to pregnant mice demonstrated radioactivity in the em-
bryo one hour after dosing (Kochar and Kwasigroch, 1975; Kochar, 1976). 
Furthermore, a teratogenic dose produced a value in the embryo which was 
26-fold the value measured after administration of a non-teratogenic dose. 
Since very low concentrations of vitamin A are teratogenic in vitro, it 
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appears that only very small amounts of vitamin A reach the embryo in vivo. 
This may be related to factors involved in maternal vitamin A storage, trans-
port and metabolism (Morriss and Steele, 1974). The liver has an enormous 
storage capacity for vitamin A and the vitamin is transported in plasma bound 
to retinal-binding protein which renders it inactive (Morriss and Thomson, 
1974; Dingle, Fell and Goodman, 1972). 
The mechanisms by which the teratogenic effec~s of vitamin A are produced 
remain unclear despite numerous studies. 
Vitamin A has a toxic effect on cell membranes. Lipoprotein membranes 
have been shown to exhibit increased permeability and decreased stability 
in the presence of excessive vitamin A (Lucy et al., 1963). Because of 
its amphipathic molecular structure retinal is highly surface active. 
It is able to penetrate rapidly into lipid monolayers and hence into cell 
membranes (Bangham et al.,1964). The damaging action of large doses of 
vitamin A may then result when, following interaction between membrane 
phospholipids and retinal molecules, oxidation of the double bonds of re-
tinal and co-oxidation of membrane phospholipids occur (Dingle and Lucy, 
1965). Vitamin A has also been reported to have an enzyme mediated effect 
on membrane microviscosity (Meeks et al., 1981). 
It has been shown to haemolyse erythrocytes and is able to disintegrate 
cell and nuclear membranes of fibroblasts and cause mitochondria to swell 
(Lucy et al., 1963). The increased volume of fetal mouse neuroblasts 
after maternal exposure to large doses of vitamin A was ·speculated to be 
due to increased permeability of lipoprotein membranes within the neuro-
blasts and to swelling of mitochondria (Nawar et al., 1979). Chepenik 
and Waldman (1983) suggest that an agent such as vitamin A, which alters 
membrane lipid metabolism, can result in abnormal differentiation, which 
ultimately accounts for birth defects. (It has been postulated that most 
fetal malformations are attributable to aberrant differentiation (Schrei-
ner and Holden, 1983)). 
Vitamin A has been shown to interefere with mitosis in epithelial tissues 
in vitro (Aydelotte, 1963a, b) and in neuroepithelial cells of fetal mouse 
cerebral cortex after maternal treatment (Langman and Welch, 1967). In 
the latter experiment vitamin A had an inhibitory effect both on mitosis 
and DNA synthesis, prolonging the cell cycle by approximately 40% of its 
normal value, and affected the differentiation of neuroblasts. The vitamin 
has also been found to markedly inhibit cell proliferation (assumed from a 
decreased rate of thymidine uptake) (Kochar, 1968), and causes growth retar-
dation and inhibition of differentiation in rat embryos in vitro (Morriss 
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and Steele, 1974), and inhibits chondrogenic differentiation of embryonic 
mouse mesenchymal cells in vitro (Zimmerman and Tsambaos, 1985). Other 
workers have noted that vitamin A decreases DNA synthesis (Dingle, Lucy 
and Fell, 1961; Nanda, 1971; Morriss, 1972; Kochar, 1975). 
The hypothesis can therefore be made that excess vitamin A interferes 
with DNA synthesis, and either secondarily or independently, inhibits mi-
tosis, cell multiplication, growth and differentiation, which leads to 
abnormal morphological development. It appears unlikely, however, that 
reduction in DNA synthesis is the primary mechanism. Kochar (1975) noted 
that concentrations of vitamin A ten times that which cause malformations 
in culture did not alter DNA synthesis, and Eckhert and Hurley (1979) were 
unable to show an effect on DNA synthesis in rat fetuses exposed to doses 
of vitamin A which had induced a 61% incidence of malformations. It is 
more likely that vitamin A inhibits cell proliferation, mitosis or differen-
tiation by a different mechanism, and this leads to abnormal development. 
Maternal administration of large doses of vitamin A in rats and mice has 
been shown to produce changes in the acid-mucopolysaccharide metabolism 
of embryonic tissues, associated with morphological changes (Kochar and 
Johnson, 1965; Kochar et al., 1968). This has been suggested as a clue 
to the mechanism of origin of some malformations such as cleft palate 
(Kochar and Johnson, 1965). 
Vitamin A has been found to increase prostaglandin synthesis (Levine and 
Ohuchi, 1978). Mouse embryo palate mesenchyme cells (Chepenik and Greene, 
1981) and chick embryo limb bud mesenchyme cells are able to synthesise 
prostaglandins and Chepenik and Waldman (1983) speculate that an effect on 
prostaglandin synthesis may be a mechanism by which vitamin A could alter 
differentiation. 
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It is apparent from the literature as outlined above that a number of 
different teratogenic mechanisms have been postulated for vitamin A. It 
is not known which of these, if any, are most important. To what extent 
these are primary mechanisms or are secondary to a more fundamental em-
bryotoxic effect is not clear. It has recently been postulated that some 
fundamental molecular step in the process of differentiation provides a 
target for the action of retinoic acid, a vitamin A analogue (Kochar, 1985). 
Sporn and Roberts (1983) have suggested that to be compatible with the wide 
ranging effects of retinoids documented so far, any hypothesis put forward 
for their molecular mechanism of action must include a role in gene ex-
pression. 
Vitamin A was chosen as a suitable teratogen firstly, because it is a well 
established central nervous system teratogen and therefore likely to be an 
appropriate probe for investigating the effects on brain biochemical markers 
such as acetylcholinesterase; secondly, because of its relevance to human 
birth defects, which are similar to those produced in animals; and thirdly, 
to try and throw more light on the mechanisms of its teratogenic action, 
since it is apparent that these have yet to be adequately elucidated. 
1.3. CYCLOPHOSPHAMIDE AS A TERATOGEN 
Cyclophosphamide, an alkylating agent, has a growth inhibitory action, 
produces chromosomal aberrations, is mutagenic and has embryotoxic and 
teratogenic effects in several animal species (Tuchmann du Plessis, 1975 
89). It is one of the best studied teratogens, which has been recently 
reviewed by Mirkes (1985), and produces anomalies primarily of the central 
nervous system and skeleton in the . mouse. Four reports have appeared in 
the literature suggesting a correlation between maternal exposure to 
cyclophosphamide and appearance of birth defects in humans (Greenberg and 
Tanaka, 1964; Toledo et al., 1971; Sweet and Kinzie, 1976). 
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In mice, administration of the teratogen is associated with a dose-
dependent decrease in fetal growth, as evidenced by a decrease in fetal 
weight and crown-rump length, and a dose dependent increase in embryo-
lethality (Gibson and Becker, 1968; ujh'azy et al., 1979). Malformations 
caused by cyclophosphamide include exencephaly, hydrocephalus, encephalo-
coeles, microcephaly, exophthalmos, stunted or crooked tails, skeletal 
defects, cleft palate and aphakia (Ujh'azy et al., 1979; Gebhardt, 1970; 
Gibson and Becker, 1967; 1968). Extensive haemorrhage and necrosis are 
regularly associa~ed with the embryotoxic effects of cyclophosphamide 
(Padmannabhan and Singh, 1983). Single administrations of cyclophosphamide 
are effective and malformations depend on the day of exposure to the tera-
togen. The most sensitive period of exposure for producing murine malfor-
mations is from day 10 through day 12 of pregnancy (Gibson and Becker, 1968). 
The dose that is embryotoxic appears to vary with different strains of mice. 
For example, in Swiss-Webster mice a dosage range of 5-lOmg/kg cyclophospha-
mide resulted in weight reduction or increased in-utero mortality, and 
20mg/kg was associated with developmental abnormalities (Gibson and Becker, 
1968). In contrast, with the DM/MK strain, 25mg/kg was ineffective, and 
higher doses of 50-lOOmg/kg were needed to produce teratogenic effects 
(Shoji and Ohzu, 1965). Both subcutaneous and intra-peritoneal administra-
tion have been found to be suitable for producing embryotoxic effects. 
Histological evidence of the central nervous system effects of cyclophos-
phamide has been published by von Kreybig and Schmidt (1967i and Wendler 
(1979), who demonstrated dose dependent massive cell necrosis and degenera-
tion with oedema and haemorrhage. This involved the whole brain during 
embryogenesis, but in the early fetal stage the neuroepithelial and mantle 
layer were particularly involved. In the chick embryo cerebellum, degeneration 
of Purkinje cells, retarded development and disorganisation of morphogenetic 
events have been documented (Singh et al., 1973). 
The onset of necrosis induced by cyclophosphamide appears to be a rapid 
process. Wendler (1979) noted massive cell destruction in the fetal rat 
brain 24h after administration. In embryonic limb buds evidence of 
excess necrosis was apparent Sh after exposure and by 24h massive necrosis 
was observed (Manson et al., 1982). Repair has been recorded in the 
course of the second 24h after administration in the fetal rat brain by 
von Kreybig and Schmidt (1967}, but if an embryolethal dose of cyclophos-
phamide was used, resulting in fetal death after 2-3 days, repair did not 
occur. Wendler (1979) also noted evidence of repair and regeneration in 
fetal rat brains 72h after application of cyclophosphamide. In experiments 
with 5-fluorodeoxyuridine, a compound ~hich blocks DNA replication leading 
to degeneration and necrosis of neuroepithelial cells in the neocortex, 
evidence of repair was striking as early as 24h after application, and at 
72h the neocortoex appeared normal (Langman et al., 1980). 
Behavioural studies have provided further evidence of the central nervous 
system toxicity of cyclophosphamide. Rodier et al., (1974) showed 
that prenatal drug treatment resulted in learning defects and abnormal 
behaviour. Clyclophosphamide, administrered to newborn mice also produced 
functional impairment, and some of these defects were independent cf gross 
body malformations (Preache and Gibson, 1976). 
Cyclophosphamide is a proteragen and must be activated in vivo by hepatic 
cytochrome P-450 oxidation to cytotoxic alkylating metabolites (~antel 
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et al., 1979; Kitchin et al., 1981; Greenaway et al., 1982; Hales, 1983). 
Numerous studies have been performed to determine which of the metabolites 
produced act as the ultimate teratogens. Phosphoramide mustard has been 
shown to be an important teratogenic metabolite (Mirkes et al., 1981; 
Spielmann and Jacob-Muller, 1981; Nau et al., 1982). Although some studies 
failed to demonstrate that a second metabolite, acrolein was teratogenic 
(Mirkes et al., 1981; Schmid et al., 1981), Hales (1982) demonstrated 
by intra-amniotic injection that acrolein was teratogenic over a narrow 
dosage range. These results were confirmed by Mirkes et al., 1984. 
Although the mechanism of cyclophosphamide teratogenicity is unknown, 
available evidence supports the hypothesis that DNA is the primary target 
(Mirkes, 1985). The critical target in terms of the antineoplastic, 
carcinogenic and mutagenic properties of cyclophosphamide is also DNA. 
Although cyclophosphamide metabolites alkylate embryonic DNA, RNA and 
proteins, Murthy et al. (1973) found that the extent of drug binding to 
embryonic DNA correlated with overall frequencies of malformations, whereas 
binding to RNA and protein did not. Short et al. (1972} noted that cyclo-
phosphamide inhibits DNA and protein synthesis, but not RNA synthesis, in 
mouse embryos. They suggested the effects on DNA synthesis, rather than on 
protein synthesis, were responsible for malformations because cyclophos-
phamide-induced inhibition of DNA synthesis preceded the inhibition of 
protein synthesis. Teratogenic concentrations of phosphoramide mustard 
were found to induce DNA crosslinking whereas monofunctional phosphoramide 
mustard induced strand breaks (Mirkes et al., 1984). Despite the different 
primary lesions in DNA,both produced similar embryotoxic effects, suggesting 
that two separate DNA lesions can lead by unknown pathways to a common 
teratogenic outcome. It is thought that DNA lesions lead to cell death or 
mutations (Mirkes, 1985), which, as depicted in Fig. 1.2., lead to the final 
defect. 
Although most studies favour DNA as the critical target of cyclophosphamide-
induced teratogenicity, there is limited evidence to suggest alternative 
mechanisms. Kohler and Merker (1973) have published data that they suggest 
indicates cyclophosphamide exerts its teratogenic effects by alkylating 
mR..~ directly. There is also some evidence that alkylation of proteins 
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constitutes the primary target of cyclophosphamide teratogenecity (Gurtoo 
et al., 1978). The induction of chromosomal aberrations is another 
possible mechanism. A dose dependent increase in cyclophosamide-induced 
chromosomal abnormalities has been demonstrated in 12-day mouse fetuses 
(Mayne and Legator, 1983). Similarly, Kola (1985) found an increased 
number of chromosomal aberrations in mouse blastocysts exposed to the 
teratogen. 
Cyclophosphamide was chosen as a suitable teratogen for the studies in 
this thesis firstly, because it is a well established central nervous 
system teratogen; secondly, because of its relevance to human birth 
defects; thirdly, to compare the effects with those of vitamin A; and 
finally, to try and throw more light on the mechanisms of its action. 
1.4. SODIUM VALPROATE AS A TERATOGEN 
Valproic acid, or dipropylacetic acid, and its salt, sodium valproate, 
have recently gained prominence as anticonvulsants (Simon and Penry, 
1975; Browne, 1980). It is known that these drugs cross the human 
placenta (Dickinson et al., 1979; Nau et al., 1981a), and there have 
been numerous case reports associating a variety of birth defects with 
their use during pregnancy, including craniofacial abnormalities, hydro-
cephalus, low birth weight and genitourinary abnormalities (Dalens et al., 
1980; Clay et al., 1981; Gomez, 1981; Thomas and Buchanan, 1981; Bailey 
et al., 1983; DiLiberti, 1983; Hanson et al., 1984). There appears to 
be a substantial association between maternal valproate use and neural 
tube defects (Bjerkedal et al., 1982; Robert and Guibaud, 1982; Robert 
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and Rosa, 1983; Robert et al., 1984; Lindhout, 1984) and a distinct fetal 
valproate syndrome has been described with characteristic facial abnorma-
lities (DiLiberti et al., 19~4). The teratogenic potential of valproate in 
humans has been recently reviewed (Pillans and Kola, 1985; Jager-Roman, 1986). 
Valproate is known to be teratogenic in rabbits, rats and mice (Whittle, 
1976; Brown et al., 1980; Nau et al., 1981b). Teratogenic doses of the 
drug for mice are about tenfold higher than human therapeutic doses (Schar-
dien, 1976 : 113; Whittle, 1976). In vitro studies have demonstrated a 
direct embryotoxic effect on the murine embryo (Kao et al., 1981; Bruck-
ner et al., 1983). Maternal valproate treatment during early organogene-
sis (days 8-10) in the CD-1 mouse, produced a dose-related increase in con-
genital abnormalities and a decrease in fetal weight, whereas greater 
embryo mortality was apparent during late organogenis (days 11-13, Kao 
et al., 1981). With daily administration of sodium valproate between days 
7 and 15 in NMRI mice, Nau et al., (1981b) also found a dose-related 
increase in growth retardation, embryolethality and exencephaly. Similar 
findings were noted in mouse embryos in culture (Bruckner, et al., 1983). 
Valproate-induced murine abnormalities include exencephaly, irregular 
fusion of brain folds, microcephaly, stunted forebrain development, cleft 
palate, and rib and vertebral defects (Whittle, 1976; Sucheston et al., 
1979; Brown et al., 1980; Nau et al., 1981b; Kao et al., 1981; Bruckner 
et al., 19831. 
Histological changes in the neuroepithelium of exencephalic embryos in 
culture, such as alterations in the morphology of mitochondria and the 
occurrence of large protrusions in the lumen of the neuroepithelium, pro-
vide further evidence for a CNS teratogenic effect of valproate (Bruckner 
et al., 1983). As far as I can ascertain nothing is known of the tera-
togenic mechanisms of valproate. 
From the foregoing, it would appear that sodium valproate is a central 
nervous system teratogen with obvious relevance to human birth defects. 
It was therefore chosen as a further suitable dysmorphogenic agent in this 
thesis to compare the effects on acetylcholinesterase and its isoenzymes 
with vitamin A and cyclophosphamide. 
20 
C H A P T E R 2 
ANIMAL MODEL 
2.1. CHOICE OF ANIMAL MODEL 
The mouse is a natural choice because of its high fertility and 
availability in substantial numbers, as well as its known sensiti-
vity to teratogens, including vitamin A, cyclophosphamide and 
sodium valproate (see Chapter 1). Also, the malformations can 
mimic human malformations, for example those produced by hyper-
vitaminosis A (Shenefelt, 1972; Bernhardt and Dorsey, 1974; 
Stange et al., 1978). 
An aspect of experimental teratology is the variability in the 
effects of teratogens on prenatal development. Apart from en-
vironmental factors genetic factors play an important part in 
this variability. To obtain homogeneity of genetic make-up 
inbred strains must be used, and the only inbred strains easily 
obtainable are strains of mice. Genetically determined respon-
ses of an inbred strain to an experimental manipulation will 
usually be less variable than the responses of a heterogeneous 
population (Kalter and Warkany, 1961). 
The inbred strain I have chosen is the C3H mouse strain. The 
full designation is C3H/HeAfHa UCR). 
A potential disadvantage in using mice is the high sponteneous 
abnormality rate which in C3H mice is 3.3% (Schardien, 1976 : 23; 
Heinecke, 1972). However, by comparing sufficient numbers of control 
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and test animals this should not affect statistical analysis. 
2.2. MOTIVATION FOR USING AN ANIMAL MODEL 
To study the effect of teratogens on the nervous system, as for 
example in determining potential changes in a biochemical marker 
such as acetylcholinesterase, requires an animal model from which 
brain tissue can be obtained. Such information cannot be obtained 
from human studies. The problems of predicting teratogenicity of 
an agent in man on the basis of animal studies are well known and 
I will not elaborate on these. Suffice it to say that I am aware 
the extrapolation of these findings to man is difficult, but never-
theless might serve as a useful pointer. A further aim of this 
study was to help elucidate some of the mechanisms of teratogeni-
city, and such knowledge could be of value in understanding the 
mechanisms of teratogenic agents in man. 
2.3. EXPERIMENTAL CONDITIONS 
The mice were housed in a large artificially lit room, the lighting 
timed for a 12 hour cycle from 6 a.m. to 6 p.m. Air temperature 
0 was thermostatically controlled at a mean of 21 C, and maximum and 
minimum temperatures were checked daily and recorded. Twe·lve to 15 
air changes were provided per hour. 
The female animals were housed in communal cages in groups of 
15-20 per cage until 2 days prior to mating when they were placed 
6 animals per cage of approximately 450 cms
2
. Tli_e males were kept 
one animal per cage of approximately 450 cms 2 . Cages were lined 
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with autoclaved wood shavings. All animals were fed Epol mouse 
cubes ad libitum, and were allowed water ad libitum. Table 2.1. 
shows the constituents of Epol mouse cubes. Water bottles were 
washed daily and water provided as necessary. Cages were cleaned 
two times a week and autoclaved approximately every two weeks. 
Young healthy virgin female mice aged 8-12 weeks and weighing 
20-23g were used for all experiments. (Puberty in the mouse 
starts at 4-6 weeks of age and females usually start breeding at 
6-8 weeks (Williams, 1976). Mature males weighing 24.0-27.5g 
were used and the stock was changed approximately every 8-16 
weeks according to mating performance. 
2.4. MATING PROGRAM 
The animals were mated monogamously once weekly. In an attempt to 
achieve an optimal pregnancy rate the following format was used. 
Between matings females were confined together in groups of 15-20 
in the absence of males to induce anoestrus (Whitten, W.K., 1959). 
Forty-eight hours prior to mating the females were placed 5-7 
animals per cage, male urine sprinkled on the bedding and the cages 
placed between male cages. Male urine was placed on the bedding 
morning and afternoon until mating. (Females tend to come into 
heat after approximately 48 hours of exposure to olfactory stimuli 
(pheromones) from the male's urine (Whitten, W.K., 1956; Whitten, 
W.K. ~. 1968). Females should therefore be in oestrus at the 
time of mating. 
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TABLE 2.1. 
EPOL MICE CUBES AND PELLETS 














Vitamin A 13 793 
Vitamin D3 1 332 
Vitamin E 16 535 
Vitamin B6 3,257 
Thiamine 2,2 
Riboflavine 4,274 
Calcium Pantothenate 19,75 
Niacin 23,034 











Yellow Maize Meal, Bran (wheat), Molasses. 
Plant Protein 
Groundnut, Lucerne, Sunflower. 






p .p .m. 











p .p .m. 
Timed matings were performed and were restricted to a 2h period from 
5 a.m. to 7 a.m . Mice are nocturnal breeders and oestrus begins in 
75 % of mice 4-6h after dark (i.e. between 10 p.m. and midnight in the 
mice used). The mean duration of oestrus is 14h. The usual time of 
ovulation is 8 - llh after the onset of heat (Hafez, 1970). An early 
morning mating therefore ensured a maximum chance of pregnancy. 
The females were r l~oved after 2h and examined for the presence of 
a copulation plug (a yellowish-white mucus plug. The vagina after 
copulation also appears erythematous and swollen). The following 24h 
period was designated as day O of pregnancy. The day after was 
therefore day 1 post conception (p.c.). Apart from copulation plugs 
two other parameters were used as indicators of pregnancy in mice 
more than 8 days p.c., namely abdominal swelling or a significant weight 
gain by the time of dosing. Approximately 50 females were mated per 
week. The pregnancy rate varied between approximately 10 and 30%. 
2 • 5 • DOS ING PROGRAM 
on the first day of dosing with a teratogen the female .mice suspected 
of being pregnant were randomly and equally divided into test and 
control groups. Animals were weighed, numbered by means of ear-
punching and kept 3 per cage thereafter. All mice used were healthy. 
Vitamin A palmitate ("Arovit", 300 000 IU/ml Roche products; Isando, 
South Africa)rwas diluted with Arachis oil and administered by gastric 
intubation to the test animals. Controls received an equal quantity 
of Arachis oil (purified peanut oil). 
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Sodium valproate (Reckitt and Colman, United Kingdom) was dissolved 
in sterile water and administered by subcutaneous injection. Con-
trols were injected with an equal quantity of sterile water. 
Cyclophosphamide (Noristan, Pretoria, South Africa) was dissolved in 
sterile water and administered by subcutaneous injection and con-
trols were injected with an equal amount of sterile water. 
Details regarding dosage and preparation of the above agents are 
described under the respective experiments (see Chapters 6, 7 and 8). 
2.6. SACRIFICE, REMOVAL OF FETUSES AND BRAIN REMOVAL 
To evaluate teratogenic effects of drugs, termination of pregnancy 
before parturition is necessary, because female mice are likely to 
cannibalise malformed and dead offspring (Palmer, 1978; Wilson, 
1973) . Pregnant females were usually sacrificed 1 to 2 days prior 
to term, i.e. on day 18 or 19 p.c. Sacrifice on day 15 p.c. or 
earlier meant working with extremely small and friable brains which 
were technically difficult to remove. Whole heads were therefore 
used in these experiments. 
The weight of each mouse was recorded and sacrifice was by cervical 
dislocation. All mice were killed within 2h in any particular experi-
ment to obviate any difference in age. The abdominal cavity was 
opened and uterine horns externalised. The number of implantation 
sites and resorptions was noted, membranes removed and fetuses 
examined by gross inspection for obvious external abnormalities. 
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The number of live and dead fetuses was recorded and fetal abnorma-
lities noted. All live fetuses were weighed. GenerallY, litters of 
approximately equal number were compared in the test and control 
groups. 
Brain removal 
Fetuses were decapitated to enable maximal drainage of blood. De-
capitation was effected by a single swift cut at the first cervical 
vertebra. Brains were then removed within 30 - 60 seconds and 
weighed. All brains appeared macroscopically normal, even in cases 
with external abnormalities, except for those with exencephaly. 
Brains were not sectioned as the whole brain (or in some experiments 
the cerebellum or cerebral cortex) was solubilised and homogenised 
fresh for AChE assay within approximately lh of removal. 
2 • 7 • RECORD ING OF RESULTS 
Maternal parameters 
The weight on the day of mating, day of dosing and the day of 
sacrifice and the physical state of each mouse after dosing and 
until sacrifice were recorded. All mice were healthy at the time 
of sacrifice (two mice with significant abdominal swelling were 
noted to have lost weight and were found to be non-pregnant with intra-
abdominal neoplasm). In some earlier experiments maternal weights 
were not recorded. 
Fetal parameters 
The number of implantation sites, number of resorptions, fetal weights, 
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brain weights and obvious external abnormality or death were recorded. 
Depending on the particular study, the following were investigated: 
brain acetylcholinesterase or its isoenzymes, cholinesterase, choline 
acetyltransferase, total protein content, protein patterns, and DNA 
damage. In the study with preimplantation embryos, viability, cell 
number, mitotic index and chromosome structure were examined. 
2.8. BRAIN SOLUBILISATION AND HOMOGENISATION 
Fetal brains (generally 20mg/ml) were solubilised and homogenised 
in a 2% Triton X-100/0,0SM Tris-HCl buffer, pH 7,4 in earlier experi-
ments, or an 0,5% Triton X-100/0,05 Tris-HCl buffer, pH 8,4 in later 
experiments. A Thomas Teflon pestle homogeniser was used at 1 425 
r.p.m. for one minute per sample. Each homogenate was kept in a 
separate labelled glass tube at 4°c until assayed. 
Note: 
A. Clear homogenates were obtained. The advantages of a clear homo-
genate were: 
(i) centrifugation was unnecessary. Total AChE activity 
of the homogenate was therefore determined. 
(ii) good linear tracings were obtained on the spectropho-
tometer without interference from suspended particles. 
(iii) the clear homogenate was suitable for separation of the 
isoenzymes of AChE by polyacrylamide gel electrophoresis. 
B. Clear homogenates were obtained using fetal or neonatal mouse brains 
but not brains from older mice where the homogenate remained turbid, 
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presumably due to the presence of more fibrous connective tissues. 
2.9. MINIMAL TOXIC DOSE STUDIES 
The minimal toxic dose (M.T.D.) is that dose of a teratogen resulting 
in either significant weight reduction during the treatment period, 
mortality or other signs of toxicity in the parent animal (Chernoff 
and Kavlock, 1982). If doses used are below the M.T.D. for the mother 
this diminishes the chances that maternal toxicity will confound the 
neonatal results. Studies were therefore performed to determine 
whether the doses of the teratogens generally used were below the 
M.T.D. for the C3H mice. 
Non-pregnant C3H females weighing 20-24g were removed from stock 
cages of~ 15 mice per cage and placed 3 per cage a few days prior 
to dosing to enable adjustment to these conditions. The teratogen 
was then administered, animals numbered by means of ear punching, 
and kept 3 per cage under standard conditions. They were given 
food and water ad libitum. The mice were observed for signs of 
toxicity, mortalities recorded, then reweighed! 9 days after dosing 
(the usual duration between dosing and sacrifice in most experiments) 
and the weights compared with the pre-treatment weights. The studies 
with each teratogen used are presented in the respective chapters. 
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C H A P T E R 3 
ACETYLCHOLINESTERASE 
3.1. INTRODUCTION 
Apart from frank congenital malformations prenatal toxicity may 
also result in more subtle biochemical abnormalities (Snell, 
1982 b). Alterations of enzyme activity, modifications of iso-
enzyme patterns or other enzyme changes may reflect perturba-
tions of fundamental biochemical processes. Enzymes are one of 
the largest and most varied classes of specific chemical consti-
tuents involved in metabolicprocesses and are probably ubiqui-
tous in all aspects of differentiation and growth. Hence they 
would almost certainly be interfered with by factors adversely 
affecting these developmental processes. Some teratogenic me-
chanisms may in fact involve enzyme inhibition as the primary or 
initiating event in abnormal embryogenesis (Wilson, 1977:70). 
Detection of metabolic lesions, particularly in the absence of 
morphological abnormalities, would greatly extend the sensitivity 
of standard teratological investigations. Quantifiable deviations 
in the activity of organ-characteristic enzyme systems may be 
sensitive and reliable indicators for estimating threshold levels 
for deleterious effects (Andrew and Lytz, 1981}. It would there-
fore be of interest to study enzymes as potential markers of pre-
natal toxicity. 
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There were several reasons why acetylcholinesterase CAChEl was 
chosen as a suitable enzyme or potential marker for studying drug 
injury to the fetal central nervous system lCNS1, but the idea 
arose from the recent surge in the literature on the measurement 
of amniotic fluid AChE in the prenatal diagnosis of neural tube 
defects. 
Acetylcholin~sterase has been found to be -elevated with such CNS 
abnormalities as anencephaly and spina bifida lDale et al.,1981; 
Smith et al.,1979; Wald and Cuckle, 1981, and many others). 
However, although the finding demonstrates the presence in the 
fetal CNS of AChE, it appears that the abnormal presence of AChE 
in amniotic fluid depends on there being an open defect to enable 
a leak from neuronal tissue to the amniotic fluid, rather than 
being the result of any intrinsic abnormality in the CNS. Thus, 
although the recent work on amniotic fluid sowed the seed, it 
cannot be considered a valid reason for choosing AChE. 
The first reason why AChE was chosen was because the enzyme is 
an integral component of CNS function, and could therefore serve 
as a useful biochemical marker for toxic or teratogenic effects 
on neuronal tissues. Components essential for neurotransmission, 
which includes enzymes, serve as specific biochemical markers 
for neuronal systems (Johnston and Coyle, 19811. The cholinergic 
system provides significant innervation to most regions of the 
brain and AChE is needed for the rapid hydrolysis of the acetyl-
choline released during neurotransmission. AChE activity is thought 
to be directly related to the amount of acetylcholine present 
(Burkhalter et al. ,1957), or to be a measure of acetylcholine 
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metabolism in the brain (Bennett et al., 1958a; Bennett et al., 1958b), 
It has been postulated that central neurotransmitter disturbances may 
account for the teratogenic effects of drugs acting on the developing 
brain (Mirmiran, 1984}. Secondly, AChE is an index of fetal brain de-
velopment. A steady increase in the enzyme parallels CNS development in 
the fetus and is thought to be related to maturation of nervous pathways 
(Bus and Gibson, 1974; Pryor, 1968; Metzler and Humm, 1951). Any per-
turbation of normal brain development could therefore potentially be 
accompanied by an alteration in AChE. For example, Eckert et al., (1976) 
noted changes in rat brain AChE activity resulting from undernutrition 
imposed during gestation. Thirdly, the well known teratogenic agent, 
X-irradiation, has been shown to produce changes in rat brain AChE. 
(Maletta and Timiras, 1966; Maletta et al., 1967; Altman and Anderson, 
1969; Adlard and Dabbing, 1972}. Finally, if one of the teratogenic 
mechanisms causing abnormal embryogenesis. is enzyme inhibition (Wilson, 
1977 : 70} or an abnormality of enzyme function, this should be evident. 
3.2. CHOLINESTERASES DEFINITION AND NOMENCLATURE 
A composite definition which incorporates their main characteristics 
is that cholinesterases are hydrolases which, under optimal conditions, 
catalyse the hydrolysis of choline esters at a higher rate than that of 
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other esters and which are inhibited by low concentrations (10 Mor 
less} of inhibitors such as physostigmine and organophosphorus compounds. 
They constitute a family of enzymes which fall broadly into two types: 
those which preferentially hydrolyse acetyl esters such as acetylcholine 
(ACh) and those with a preference for other types of esters such as 
butyrylcholine (BuCh}. 
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The naming of cholinesterases represents a long standing contro-
versy. True cholinesterase has been given various names. In 1964 
the Enzyme Commission proposed acetylcholinehydrolase (EC 3.1.1.7) 
as the systematic name with acetylcholinesterase as the trivial 
name. This latter name, or its abbreviation, AChE is the one used 
in this thesis. The term pseudocholinesterase has been widely 
used for the non-specific types of enzyme. The term "pseudo" 
however, implies "false" and this makes the term rather unaccep-
table. Perhaps a better term is butyrylcholinesterase. The 
En~yme Commission (1964) recommended acylcholine acylhydrolase 
(EC 3.1.1.8) as the systematic name and simply cholinesterase as 
the trivial name. I have chosen to use the term cholinesterase 
(ChE) for the non-specific enzyme, in contradistinction to acetyl-
cholinesterase for the specific enzyme. 
3.3. THE VARIABILITY OF ACETYLCHOLINESTERASE ACTIVITY 
A knowledge of various biological factors which may influence 
AChE activity is important as these are potential variables which 
must be accounted for and standardised when studying the effects 
of teratogens on the enzymes' activity. The activity of AChE 
is affected by physical factors which as temperature, pH and 
substrate concentration. Activity increases with increasing 
temperature, the optimum temperature for AChE activity for 
mammalian tissues being 37-4o
0 c (Augustinsson, 1948}. With acetyl-
thiocholine as substrate the activity of AChE increases with pH up 
to 7, but thereafter is unaffected by any further rise in pH and 
remains maximal (Bergman et al. ,1958). The activity of AChE is 
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affected by substrate concentration, inhibition occurring when 
substrate is present in excess (Ellman, 1961; Garry and Routh, 
1965) . 
A number of biological factors bear relevance to enzyme activity. 
Age is important since a steady increase in brain AChE activity 
has been noted during development (Metzler and Humm, 1951; Pryor, 
1968; Bus and Gibson, 1974; Sung and Ruff, 1983). Strain 
differences in AChE activity have been noted in both the rat and 
the mouse (Pryor et al.,1966; Pryor 1968; Ebel et al.~973; 
Waller et al., 1983). The possibility that seasonal changes in 
enzyme activity occur (Silver, 1974), and that embryotoxicity 
may be subject to seasonal modifications (Sauerbier, 1981) may 
be of relevance to any long term study. There do not appear to 
be significant~ differences in brain AChE activity (Woolley, 
1963; Pryor, 1968). Maternal undernutrition results in changes 
in brain AChE in the offspring (Sereni et al_,1966; Adlard and 
Dobbing, 197la,b; Eckhert et al.,1976). 
Because of the influence of the above parameters the variability 
of AChE activity was accounted for in this study as follows: 
(i) A control group under identical conditions was included 
with each experiment and comparisons of enzyme activity made only 
with the control group in that particular experiment. 
(ii) Experiments were performed at a standard temperature 
and pH, using an optimal substrate concentration as determined in 
section 3.4.8. 
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(iii) Timed matings were performed so that all fetuses were 
the same age in any particular experiment. 
(iv) Only one strain of mouse, C3H, was used. 
(v) By comparing treated fetuses with controls each time an 
experiment was performed to some extent obviated the possibility of 
a confounding seasonal effect. 
(vi) All animals received a balanced diet and were given food 
and water ad libitum (see Chapter 2). 
3.4. QUANTITATIVE MEASUREMENTS OF ACETYLCHOLINESTERASE 
3.4.1. Introduction 
There are numerous methods for recording AChE activity, but the 
colorimetric method based on the Ellman reaction (Ellman, 1959; 
Ellman et al. ,1961; Garry and Routh, 1965; Dietz et al·, 1973) 
was chosen because it is extremely sensitive and is rapid and 
simple. The method has been used to study AChE activity in rat 
and mouse brain homogenates (Ellman, 1961; Maletta and Timiras, 
1966; Pryor, 1968; Valcana and Timiras, 1974; and others). 
Acetylcholinesterase hydrolyses acetylthiocholine to yield free 
thiocholine. The enzyme activity is measured by following the 
increase of yellow colour produced from thiocholine when it reacts 
with dithiobisnitrobenzoate ion. It is based on coupling of these 
reactions: 
(AChE) 
acetylthiocholine thiocholine + acetate 
thiocholine + dithiobisnitrobenzoate----:i> yellow colour 
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The principle of the method is the measurement of the rate of 
production of thiocholine as acetylthiocholine is hydrolyzed. 
This is accomplished by t.~e continuous reaction of this thiol 
with DTNB (5:5-dithiobis-2-nitrobenzoate ion) to produce the 
yellow anion of 5-thio-2-nitro-benzoic acid. 
acetylthiocholine 








The reaction with the thiol has been shown to be sufficiently 
rapid so as not to be rate limiting in the measurement of the 
enzyme, and in the concentrations used does not inhibit t.~e enzymic 
hydrolysis (Ellman, 1961; Garry and Routh, 1965). 
The rate of colour production is measured at 410nm Cthe absorption 
maximum of the yellow nitro-benzoate - see section 3.4.7 . DTNB 
absorbs maximally at 320nm). 
3.4.2. Materials and methods 
Fetal mouse brains were solubilised and homogenised as described 
36 
in section 2.8. A 0,4ml aliquot of the homogenate was added 
to each of two cuvettes, containing 3,0ml of phosphate buffer 
(pH 8,0; O,lM) and lOOpl of lOmM dithiobisnitrobenzoic acid 
(DTNB). All aliquots of 0,4ml and smaller were measured by means 
of micropipettes. (The one cuvette serves as the test sample and 
the other as a blank. The blank corrects for any spontaneous 
degradation of DTNB, for the release of any thiol material from 
fetal Lissue, and for the absorbance of other materials in the 
homogenate). 
0 
The two cuvettes, prewarmed in a water bath to 37 C, 
were placed in the spectrophotometer, (a Cary Varian 219 spectro-
photometer was used) one as the test sample and the other as the 
blank. The reaction was started by adding SOpl of 0,075M acetylthio-
choline iodide (Jneasured in a Hamilton syringe} to the test cuvette. 
The contents were mixed thoroughly by up and down strokes with a 
specially designed mixer (made from glass capillary tubing with 
the end flattened at right angles to the shaft). The absorbance 
was recorded at 410nm against the blank. (Linear tracL~gs 
were obtained with fetal mouse brain homogenate}. 
Approximately equal numbers of test and control homogenates were 
assayed in each experiment, alternating 5 test with 5 control 
samples until all assays were completed. This ensured that an equal 
number of test and control samples were subjected to the same time 
delay prior to assay. The maximum delay between brain removal and 
assay was approximately 4 h. All samples were stored in the fridge 
at 4°c until assayed. 
3.4.3. Calculation of AChE. activity 
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Rates are calculated as follows: 
Change in absorbance/minute (6A) is calculated from the slope of 
the spectrophotometric tracing. 
The following explanation of the calculation is taken from Silver 
(Silver, 1974 63), and is based on Ellman's work (Ellman et al., 
1961). Results of the rate of enzymic hydrolysis are expressed 
in the more common form of nmol/min/mg. 
The extinction coefficient for a molar solution (1 mole/litre) 
of coloured anion is 1,36 x 104 (Ellman, 1959), therefore the 
extinction coefficient for 1 nmol in a cuvette of volume Vml = 
-2 1,36 X 10 
V 
The rate of hydrolysis of substrate is therefore 
6 A X V 




If the concentration of the enzyme preparation is Cmg/ml and the 
volume used is Yml the rate of hydrolysis in runol/min/mg is 
6 A X V 1 
1 36 X 10
-2 , X C X y 
Calculation of enzyme activity can also be calculated in units per 
litre (Bonham et al .. ,1981). 
(The units are arbitrary and are calculated per unit volume (e.g. 
litre) if a weight of sample cannot be obtained, e.g. using serum). 
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Enzyme activity in units/1 
9 = Total vol, V (ml) x 10 x t A 
Sample vol, V(pl} Em 
4 (Em= 1,36 x 10 - the extinction coefficient of the anion 
of 5-thio-2-nitro-benzoic acid). 
If results are to be expressed in units: 
The standard unit (U) is defined as follows: 
One U of an enzyme is that amount which will catalyse the trans-
formation of 1 pmol of the substrate per minute under standard 
conditions. e.g. 1 unit of AChE will hydrolyse 1 )llllOl of acetyl-
choline to choline and acetate per minute at pH 8,0 at 37°c. 
Note: 
Ellman et al, ll961) noted that the rate of hydrolysis given by 
the above method using acetylthiocholine as opposed to acetyl-
choline as substrate can be taken as a good indication of the rate 
of hydrolysis of AChE. However, as the authors themselves showed, 
. the kinetic constants obtained with the two substrates are not 
identical and this must be recognised in any comparison with results 
from other methods. 
3.4.4. Accuracy, sensitivity and reproducibility of spectrophoto-
metric measurement of acetylcholinesterase 
To determine the accuracy, sensitivity and reproducibility of the 
spectrophotometric assay of AChE, two experiments were performed. 




1 mg pure AChE was dissolved in 5ml distilled water lconcentration 
o,2mg/mll. 400pl of this was added to 3,0ml phosphate buffer (O,lM, 
pH8,0) and 100~1 of DTNB. The reaction was started by adding SOpl 
0 AThCh (75mM) and the change in absorbance was measured at 37 C. 
The experiment was repeated six times. Enzyme activity was calcu-
lated in nmol/min and converted to enzyme units (U). 
Result: 
The mean activity of AChE was 0,70U/mg (~ 0,01). The result is acceptably 
accurate, being very similar to the stated activity of the Sigma 
AChE, o,72U/mg.(The slightly lower activity is probably explained 
by some decrease in activity with storage}. 
In the second experiment a range of dilutions of pure AChE (Sigma, 
0,72U/mg) was assayed to determine the degree of sensitivity of the 
spectrophotometric assay. 
Method 
2,13mg pure AChE (Sigma} was dissolved in 4,0ml distilled water 
and then diluted as follows: 1/2; 1/4; 1/10; 1/20; 1/100; 1/200. 
The Ellman assay was performed as described above and was repeated 
three times for each dilution. The rate of spontaneous hydrolysis 
of AThCh (0,007 ~/min, see section 3.4.6. ),was subtracted from the 
rate of reaction for each dilution to give the corrected 6A/min. At 
the lower dilutions (i.e. 1/20; 1/100; 1/200} the sensitivity range 
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of the spectrophotometer was increased i.e. from 1,0 to 0,5 to 0,1. 
Results are shown in Table 3.1. A good correlation (r = 0,9995) 
between recovered and initial dilutions at least to a dilution of 
1/20 was apparent. 
Conclusion 
The sensitivity of the assay was very satisfactory to a dilution 
of at least 1/20 and was acceptable for the studies in this thesis. 
Reproducibility was acceptable at all dilutions tested. 
3.4.5. Determination of acetylcholinesterase activity in C3H fetal 
mouse brains and comparison of activity between individuals 
of the same age 
In order to study the effects of teratogens on AChE in fetal mouse 
brain there should ideally be (i) substantial amounts of enzyme 
present and (ii) limited variation in enzyme activity between 
individuals of the same age. To investigate these parameters AChE 
activity was determined in 20 fetuses. 
Method 
The brains from twenty 19-day C3H mouse fetuses from 4 litters were 
solubilised and homogenised as described in section 2.8. Acetyl-
cholinesterase activity was determined as described in section 3.4.2. 
Results are shown in Table 3.3. Fetal mouse brain AChE activity 
is compared with pure bovine AChE activity in Table 3.2. 
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T A 8 L E 3.1. 
T.<\c3LE SHOluING ,~83iJR 8A1\JCE ( 6 A/f'iIN) AT HJCREASING 
DILUTIONS OF PURE ACETYLCHOLI NE3TER ASE ANO THE RE~ULTING 









Corrected* Initial Recovered Coefficient of 
~ A/min Dilution Dilution variation { ,s ) 
(= so Recovered 
dilution ) 
D,525 1,006 
0,525 l 1,006 o,3 
0,527 1,01 
0,247 D,477 
0 ,254 0,5 0 ,49 0,31 
0,265 0 ,511 
0 ,1735 0,223 
0 ,126 0 ,25 0,246 o,ss 
0 ,120 0 ,235 
0,052 0 ,1 05 
0 , 0485 O,l 0,0985 1,4 
0 , 049 0,0994 
0 , 0233 G, 0505 
0 , 0222 0 , 05 0,0484 3 ,o 
0,0226 0,0491 
C,008 0,0213 
0,0056 o, :n 0,0168 9,5 
0 , 0049 0, 0154 
0 , 0043 0,0143 
0 , 0013 0 , 005 0 , 0086 14,8 
0 , 0044 0,0145 
Linear Regression: Correlation coefficiant r = 0 ,99 95 
Slope (SO)= 0 ,525 (0,004) 
Intercept (SD) = -0,003 (0 , 002) 
* Recorded 6A - 6 A of spontaneous hydrolysis . 
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TABLE 3.2. 
COMPARISON OF FETAL MOUSE BRAIN ACETYLCHOLINESTERASE ACTIVITY 
WITH PURE BOVINE RED CELL ACETYLCHOLINESTERASE ACTIVITY 
Source of AChE AChE 
activity 
A/min U/1 nmol/min/mg 
Pure Bovine AChE 
0,2mg/ml (0, 72 
Units/mg 0,212 138,32 682,0 
Brain 40mg/ml 0,218 142,26 3,55 
Brain 20mg/ml 0,104 67,87 3,37 
Comment and conclusion 
The brain AChE results of 19-day C3H mouse fetuses (mean 3.37 nmol/min/ 
mg) confirmed substantial AChE activity. Limited inter-individual va-
riation in brain enzyme activity was apparent (S.D.=0,23, see Table 3.3.). 
The high value for bovine red cells was explicable on the basis that 
pure enzyme was used as opposed to AChE in brain which was considerably 
attenuated by brain tissue. 
The substantial enzyme activity and limited inter-individual variation 
suggested that AChE was suitable for the quantitative studies in this 
thesis. 
3.4.6. Non-enzymic hydrolysis of the substrate acety lthiocholine iodide 
Some non-enzymic or spontaneous hydrolysis of the substrate acetylthio-
choline iodide (AThCH) is known to occur (Ellman et al., 1961; Garry 
and Routh, 1965). 
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T A B L E 3. 3. 
ACETYLCHOLINESTERASE ACTIVITIES CALCULATED FOR TWENTY 
19-DAY FETUSES FROM FOUR DIFFERENT LITTERS 
Litter No. Fetus No. M/min AChE activity 
nmol/min/mg 
1 0,107 3,49 
2 0,108 3,52 
1 3 0,1075 3,51 
4 0,104 3,39 
5 0,1115 3,64 
6 0,1105 3,60 
7 0,1005 3,28 
8 0,101 3,29 
9 0,101 3,29 
2 10 0,094 3,07 
11 0,100 3,26 
12 0,101 3,29 
13 0,106 3,46 
14 0,108 3,52 
15 0,103 3,36 
3 
16 0,101 3,29 
17 0,101 3,29 
18 0,097 3,16 
4 19 0,1095 3,57 
20 0,100 3,26 
Mean 0,104 3,37 * 
S.D. 0,005 0,23 
* This AChE. actiyity is equivalent to 67,87 U/1. 
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The extent of this hydrolysis was determined under the conditions 
of this study and the contribution to total hydrolysis calculated. 
Method 
Non-enzymic hydrolysis was demonstrated by reading the change in 
absorbance, 6 A, of a test cuvette containing 3.4ml phosphate 
buffer, pH 8.0, Sopl AThCh (75mM; stock cone.) and 100µ1 DTNB at 
37°c against a blank conta.ining 3. 45ml phosphate buffer and 100µ1 
DTNB at 410nm. The assay was performed on 6 samples. 
Results 







Mean t. A = 0,00205 (.S. D. 0 ,00085) 
The following are six representative 6 A results for 18 day fetal 
mouse brains using 400pl brain homogenate (_20mg/ml} , 3ml phosphate 
buffer, SOpl AThCh and 100µ1 DTNB. 







Mean 6 A = 0,103 (S. D. 0, 003) 
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Spontaneous hydrolysis of the substrate acetylthiocholine accounts 
on average for 
0,00205 X 100 
0,103 
= 1,97% of total change in absorbance. 
Comment 
Spontaneous hydrolysis is the same for each sample since 50µ1 of 
substrate are used in every case. It can be seen that this non-
enzymic hydrolysis contributes a very small amount to the total 
hydrolysis (.enzymic plus non-enzymic) of a sample. AChE results 
were therefore not corrected for this component which was accepted 
as representing an insignificant constant. In any case it would not 
affect statistical tests based on comparison of mean values. 
3.4.7. Determination of the absorption maximum of the 5-thio-
2-nitro-benzoate ion 
The absorption maximum of the 5-thio-2-nitrobenzoate ion is variably 
quoted as 410 or 412nm by different workers (Dietz et al-,1973; 
Ellman et al.,1961; Silver, 1974 : 63; Garry and Routh, 1965). 
Method 
Using the Varian spectrophotometer the visible light absorption 
was read in a cuvette containing 3ml phosphate buffer, pH 8,0; 
0, 4ml 18 day C3H fetal mouse brain homogenate ( 20mg/mD ; 50)-11 
0 acetylthiocholine iodide and lOOpl DTNB at 37 c. The experiment 
was performed 6 times. 
The AChE in the brain hydrolyses acetylthiocholine to yield free 
thiol which reacts with DTNB to yield the 5-thio-2-nitrobenzoate 
ion as described in section 3.4.1. 
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Results 
With each of the six experiments the absorption maximum was 410nm, 
as shown in the spectrophotometric tracing, Fig. 3.1. This wave-
length was therefore chosen for all spectrophotometric experiments 
using DTNB. 
3.4.8. Determination of the optimal substrate concentration of 
acetylthiocholine iodide CAThCh) 
An important characteristic of AChE is that it shows increasing 
activity with increasing substrate concentration at lower substrate 
concentrations, but demonstrates enzyme inhibition when substrate 
is present in excess (Ellman, 1961; Garry and Routh, 1965; Silver, 
1974 : 10). It was therefore necessary to determine the optimal 
substrate concentration of AThCh for C3H fetal mouse brain AChE. 
Materials and Methods 
1. Ci) Pooled fetal mouse brains were solubilised and homogenised 
in O,OSM Tris-HCl, 0,5% Triton X-100 (pH 8,4)to give a final con-
centration of 20mg/ml brain homogenate. 
(ii) AChE activity (i.e. hydrolysis of substrat~ was assayed 
using the Ellman technique as described in section 3.4.2., with 
varying substrate concentrations. Rate of hydrolysis was expressed 
as a change in absorbance C 6A) per minute. The actual rate of 
hydrolysis for each substrate concentration was calculated by sub-
tracting the rate of spontaneous hydrolysis of substrate from the 
measured rate of hydrolysis. 
(iii) Spontaneous (non-enzymic) hydrolysis of the substrate 
was measured in the absence of brain homogenate. 
























































































































































































































































































































































































































































2. The. a.bova experiment was repeated to determine the. rate of 
hydrolysis at varying substrate concentrations for three different 
brain homogenate concentrations (10, 20, 40mg/ml). Results are 
given in Table 3.4. and shown graphically in Fig. 3.3. 
Results 
(i) As demonstrated in Fig. 3.2., enzyme activity increases 
with increasing substrate concentrations at lower AThCh concen-
trations, but enzyme inhibition occurs at high substrate con-
centrations. 
(ii) Using this method the optimum stock concentration of 
substrate was found to be 73mM. 
(iii) The rate of spontaneous hydrolysis increases with increasing 
substrate concentration. This increase becomes exponential at high 
substrate concentrations Ci. e. AThCh '> lOOmM) . 
(iv) As demonstrated in Figs. 3.2. and 3.3., the optimal substrate 
concentration is approximately the same for the three brain homo-
genate concentrations. As expected, the maximum rate of hydrolysis 
(~A/min) is approximately double for each two fold increase in brain 
homogenate concentration (Fig. 3.3.) 
Similarly, the Km (substrate concentration at which the rate of 
hydrolysis is half the maximum rate) is similar for the three 
homogenate concentrations. 
3.4.9. The effect of storage on acetylcholinesterase activity 
The effect of freezing and storage at -20°c for 48 hours 
Acetylcholinesterase activity of twenty C3H 18 day fetal brain homogenates 
so 
T .l\ 8 L E 3.4. 
THE EFFECT OF SU8STR ~TE CONCE NTRATION ON AChE ACTIVITY 
IN 19-0 ~Y FETAL MOUSE BRAIN 
I Sponta.neous I Brain Brain ! Brai/ [i\ Th Ch] I Log 10 Hydrolysis· lOmg/ml 20mg/ml: 40mg ml 
I M ( [•:\ThCh) xlO~ I 
6 A/mi n .6 .-i/min I 6A/min I 6 .0./.11in I 
6,89xl0- 6 0,84 0,001 0,004 0,0085 0,016 
2,76xl0 -5 1,44 0,000 0,016 0,03 0,0515 
l,lOxlO -4 2,04 0,0005 0, 032_ 0,062 0,1275 
l,4xlJ -4 2,15 0,001 0,035 0 ,067 0,142 
2, 19 xl 0 -4 2,34 0,002 0,038 0,076 0,161 
I ~ -4 2,64 Q,003 0,044 O,Oa6 0,182 4,4lxl0 
8,82xl0 -4 2,94 0,006 0,044 0,086 0,1875 
l,llxlO -3 3,04 0,0075 0,043 0,0855 0,189 
l,4lxl0- 3 3, 15 0,008 0,043 0,09 0,1815 
l,76xl0 -3 3,24 0,009 0,042 0 ,0885 0,182 
7,06xl0 -3 3,85 0,034 0,039 0,072 0,147 





















Fig. 3. 3. 
TI-IE EFFECT OF SUBSTRATE CONCENTRATION ON 18-DAY 
FETAL tvOUSE BRAIN AChE USING 3 DIFFERENT BRAIN 
HOOGENATE CONCENI'RATIONS 
KEY: A= lOmg/ml brain homogenate 
B= 20mg/ml brain homogenate 
C= 40mg/ml brain homogenate 
D= Spontaneous hydrolysis 
(The rate of hydrolysis for curves A, Band C was 
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was first determined as described in section 3.4.2. on the fresh 
samples and repeated after storage. Results are given in Table 
3.5. 
(Note: Brains were homogenised in 0,5% Triton X-100/0,05M Tris-
glycine, pH 8,6 which accounts for the high enzyme activity (see 
section 3 • 4 .11. ) 
Comment 
As can be seen in Table 3.5. a 20,99% (median estimate) decrease 
in activity occurred after 48h at -20°c compared with that in 
fresh samples. These findings are in agreement with other workers. 
Cryer and Bartley (1974) noted diminished enzyme activity of rat 





any length of time. All assays have therefore been performed on 
fresh samples. (Of interest is that this decrease in activity 
contrasts with human amniotic fluid which is thought not to be 
- 2 0 associated with decline in AChE activity when stored at- - O C for 
up to years. Presumably the action of proteases, lysozymes, etc. 
released by cell disruption during homogenisation of brain accounts 
for the loss of activity. These substances would not be antici-
pated to be present in significant concentrations in amniotic fluid.) 
0 
The effect of storage at 4 C for up to 4h on acetylcholinesterase 
activity in fetal mouse brain homogenates 
With a particular group of fetuses allwere sacrificed within a short 
period of time (+ lh) so as to minimise any discrepancy in age. 
The brains were removed immediately, solubilised and homogenised, and 
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T A B L E 3.5. 
THE EFFECT OF STORAGE FOR 48 HOURS AT -20°c ON AChE ACTIVITY 
IN BRAIN HOMOGENATES 
AChE activiti'. ~ nmol Lminlmg) % decrease in 
Sample No. activity 
Initial After storaae 
Cl 3,908 2,390 38,84 
C2 5,745 4,913 14,48 
C3 5,85 4,761 18,62 
C4 6,661 I 4,296. 35,51 
cs 5,934 4, 6.55 21,55 
C6 6,381 5,077 20,44 
C7 6., 498 4,142 36,26 
CB 7,134 6,092 14, 61 
C9 6.,094 4,800 21,24 
ClO 6,008 4,486. 25,33 
Tl 6,153 5,606 8,89 
T2 6,464 4,98 22,96 
T3 6,078 5,562 8,49 
T4 6,414 4,247 32,73 
TS 6,480 4,860 25,00 
T6. 5,299 5,508 12,56 
T? 6,057 5,184 14,41 
TB 5,655 4,438 21,52 
T9 6,04 4,778 20,89 
TlO 5,694 4,807 15,58 
Median 6,119 4,828 20, 9 9 
95% Con- I 
fidence 5,929 4,548 16,95 
Iimits 6,317 5,135 25,68 
54 
0 
the homogenates stored separately in numbered glass tubes at 4 C in 
the. re~rlgerator. 
When large numbers of assays were to be performed, the delay from 
time of sacrifice to time of enzyme assay was 
hours. 
as long as four 
To observe whether any change in enzyme activity occured during a 
4h period of storage, assays were performed on fresh brain homogenates, 
0 and repeated after 4h storage at 4 c. AChE activity was determined 
by the Ellman method as described in section 3.4.2. 
Results are presented in Table 3.6. 
TABLE 3.6. 
TABLE SHOWING COMPARISON OF CHANGE IN ABSORBANCE /MIN ( /5. A) OF 
FRESH HOMOGENATE AND THE SAME HOMOGENATE FOUR HOURS LATER 




1 0,046 0,047 
2 0,047 0,046 
3 0,046 0,046 
4 0,046 0,048 
5 0,047 0,046 
6 0,047 0,047 
Mean 0,0465 0,0467 
(+ 0 ,0016) (+ 0,0019) 
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Comment 
It is apparent that storage of up to 4hwas not associated with any 
significant change in enzyme activity. 
3.4.10. The effect of water and various buffers on acetylcholines-
terase activity 
It became apparent during preliminary experiments that AChE activity 
was not the same in different buffers. To demonstrate this 1mg pure 
bovine AChE (Sigma} was dissolved in 1ml distilled water. 200µ1 of 
this solution was added to BOOpl of each of the following buffers to 
give a final concentration of 0,2mg/ml pure AChE: 
Water 
Tris-HCl O,OlM, pH7,4 
Tris-HCl O,OlM, pH8,6 
Tris-HCl O,OSM, pH8,6 
Tris-glycine, O,OSM, pH8,6 
Each sample was assayed separately as follows: 0,4ml of enzyme/ 
buffer solution was placed in a cuvette containing 3ml phosphate 
buffer, pH8,0, 100µ1 DTNB and SOpl acetylthiocholine iodide. 
The change in absorbance, ~A, was determined spectrophotometrically 
and enzyme activity calculated in U/1. 
Results are shown in Table 3.7. 
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TABLE 3.7. 
CHANGE IN ABSORBANCE, 4A, AND ACETYLCHOLINESTERASE ACTIVITY 
IN U/L WITH DIFFERENT BUFFERS 
Buffer f::. A Activity -- in U/1 
Water 0,281 183,37 
Tris-HCl ,O,OlM, pH 7,4 0,268 174,88 
Tris-HCl , O,OlM, pH 8,6 0,265 172, 93 
Tris-HCl ' 0,05M, pH 8,6 o,241 157,27 
Tris-glycine, 0,05M, pH 8,6 0,353 230,36 
Comment 
As expected, some difference in enzyme activity is apparent with 
variation in pH or molarity. However, a striking increase in ac-
tivity is noted with Tris-glycine which is not readily explicable. 
The effect of different buffers on fetal mouse brain AChE was de-
termined in the next experiment. 
3.4.11. Determination of the effect of Triton X-100 and different 
buffers on fetal mouse brain AChE activity 
Introduction 
Most neuronal AChE is believed to exist in membrane bound form al-
though a small percentage is soluble (Toschi, 1959; Chubb and Smith, 
1975) . Solubilisation is therefore necessary to release the enzyme. 
The most widely adopted solubilisation procedure is that using the 
non-ionic detergent Triton X-100 (Ho and Ellman, 1969; Crone, 1971; 
Chubb and Smith, 1975; Srinivasan et al.,1972; Rieger and Vigny, 
1976; Vijayan and Brownson, 1974). Cotman et al., (1971) found that 
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over 75% of AChE was solubilised at pH8,0 whi.le Srinivasan et al 
(1976) noted that a final concentration of Triton of 1% was capable 
of complete or nearly complete extraction of AChE. 
MeL.'lod 
To determine the effect of Triton X-100 and different buffers on fetal 
mouse brain AChE activity, fetal mouse brains were weighed and homoge-
nised separately in each of the following: 
O,OSM Tris-HCl (pH8,6)/0?% Triton X-100; O,OSM Tris-HCl, pH8,6; H20; 
O,OSM Tris-glycine (pH8,6)/0,5% Triton X-100; O,OSM Tris-glycin~ pH8,6. 
0,4ml brain homogenate was placed in a cuvette containing: 
3ml phosphate buffer, pH8,o, lOOpl DTNB and 50µ1 acetylthiocholine 
iodide. The change in absorbance, ~ A, of each brain sample was de-
termined spectrophotometrically, and the AChE calculated in nmol/min/mg. 
Results are given in Table 3.8. 
TABLE 3.8. 
ACETYLCHOLINESTERASE ACTIVITY IN NMOL/MIN/MG FOR BRAINS 
HOMOGENISED IN VARIOUS MEDIA 
Sample Tris-HCl/ Tris/HCl H
2
o Tris-glycine/ 
No. Triton X Triton X 
1 2,87 2,35 2,22 6,09 
2 3,31 2,42 2,32 6,01 
3 3,06 2,52 2,69 5,93 
4 3,36 2,41 2,13 6,50 
5 3,65 2,00 2,46 6,38 
Mean 3 ,25 2,34 2,364 6,182 











Results and discussion 
(i) Similar AChE activities were obtained using water and Tris-HCl 
without Triton, which were approximately one third lower than using 
Tris-/HCl with Triton. The higher enzyme activity with Triton 
X-100 can be explained by the solubilising effect of the detergent 
with release of membrane bound enzyme. The increase in activity of 
the enzyme in homogenates utilising Triton X-100 has been used to 
attest to the efficacy of solubilisation with the detergent (Crone, 
1971; Harwood and Hawthorne (1969). Jackson and Aprison (1966) 
postulated that the non-ionic detergent enhances AChE activity by 
virtue of its surface active properties. Kazennov et al.,(1979) 
support this idea stating that the detergent causes lysis of the 
structural elements of nervous tissue which are not destroyed by 
homogenisation. These authors also suggested two other mechanisms 
of activation, namely the exposure of previously masked active sites 
of the enzyme, and the destruction of vesicular membrane structures 
containing AChE located on the inner surface of the vesicles. 
(ii) High enzyme activities using Tris-glycine, with or without 
Triton are apparent, as noted with pure AChE in the previous section, 
and are presumably due to an enhancing effect of glycine either on 
AChE activity, or on one of the steps in the Ellman reaction. Although 
this is of interest it is a side issue and I have not pursued the 
mechanisms involved. However, because the buffer can influence enzyme 
activity it is important to note what buffers are used when comparing 
results. Brains were solubilised in o,5% Triton X-100/0,0SM Tris-HCl, 
pH8,4 in all teratological experiments. 
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3.4.12. Determination of the effect of the concentration of Triton-X-
100 on fetal mouse brain acetylcholinesterase activity 
Introduction 
The effect of varying the concentration of Triton X-100 on enzymatic 
activity has been commented on by various workers. Srinivasan et al 
(1972) using concentrations from 0,2 to 2% noted no alteration in 
enzyme activity, but when the concentration was increased to 5% and 
above, inhibition was demonstrable. Rieger and Vigny (1976) found 
the best solubilisation of AChE in brain tissues was obtained using 
an o,5% to 1% Triton X-100 solution. 
Method 
Pooled 19 day fetal mouse brains (20m.g/ml brain homogenate) were 
homogenised in O,OSM Tris-HCl containing varying concentrations of 
Triton X-100 (0 - 5%). The change in absorbance, ~ A, of each sample 
was determined spectrophotometrically (repeated x 3) and the AChE 
activity calculated in nmol/min/mg. 
Results are given in Table 3.9. and shown graphically in Fig. 3.4. 
TABLE 3.9. 
THE EFFECT OF THE CONCENTRATION OF TRITON X-100 ON 
FETAL MOUSE BRAIN ACETYLCHOLINESTERASE ACTIVITY 
Concentration of Triton X-100 (%) 
0 O,l o,s 2 ,o 
AChE activity 2,871 3,328 4,111 3,850 
nmol/min/mg 2,888 3,165 4,046 3,850 
2,936 3,132 4,176 3,768 
MEAN 2,898 3,208 4 ,111 3,823 









Fig. 3 . 4. 
THE EFFECT OF TI-IE CONCENTFATION OF 
TRITON X- 100 ON FETAL ~ !OUSE BRAIN AChE ACTIVI1Y 
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Error bars shown are observed scatter (3 observations) 
Discussion and conclusion 
With 0% and o,1% Triton X-100 the brain homogenate remained turbid, 
and as shown in Table 3.9 and Fig. 3.4. the AChE activity was lower 
than that obtained with the higher concentrations of Triton. These 
observations are in keeping with inadequate solubilisation. The 
higher enzyme activity with 0,1% Triton X-100 compared with no Triton 
demonstrated, however, that some solubilisation occured even with this 
low concentration. With 0,5%, 2% and 5% Triton X-100 the brain homoge-
nates were almost clear and higher enzyme activities were apparent. 
AChE activity was similar with the higher concentrations suggesting that 
maximal solubilisation occured with a concentration of 0,5% Triton. 
With 2% and 5% Triton no change in AChE activity was demonstrable. 
It was therefore apparent that a concentration of Triton from 0,5% 
to 5% was suitable. Two percent Triton X-100 was used in earlier ex-
periments and o,5% in all subsequent experiments. 
3.5. DETERMINATION OF THE CONTRIBUTION OF ACETYLCHOLINESTERASE ACTIVITY 
IN BLOOD TO TOTAL BRAIN ACETYLCHOLINESTERASE ACTIVITY 
3.5.1. Introduction 
A problem in performing quantitative measurements of brain AChE is that 
blood is inevitably present and blood is rich in both AChE in the red 
cells and cholinesterase in the serum. It is important to know the con-
tribution of this enzyme activity in blood to total brain AChE activity. 
If t..1-ie -::ontribution is s 1.ilistanti.al, a:1.y changes observed in "brai:1." 
AChE could in fact be due to alterations in blood enzyme activity. Un-
fortunately, on reviewing the literature, it was apparent that this aspect 
62 
/ 
had not been taken into account when performing AChE assays on brain. 
Maletta and Timiras (1966) actually measured total esterase activity 
of blood when looking at brain AChE activity in developing rats after 
X-irradiation, but did not consider the contribution of this blood 
esterase to the results they obtained in brain. 
A method was therefore devised for determining the contribution of the 
enzyme activity in blood to total brain AChE activity. 
3.5.2. Materials and Methods 
The principle of the method was to determine the amount of haemoglobin 
in blood and brain using haemoglobin concentration as an index of the 
amount of blood present. Acetylcholinesterase activity in blood and 
brain was then measured and the contribution of blood calculated. 
Eighteen day C3H mouse fetuses were sacrificed by decapitation. Blood 
was collected from the decapitation wound into dry test tubes, weighed 
and homogenised in0,5% Triton X-100, using a Thomas Teflon pestle 
homogeniser at 1200 rev/min for 1 minute. Brains were removed whole 
within 2 min of death, weighed, and homogenised in 0,5% Triton X-100. 
Homogenates were not centrifuged as a clear pink homogenate was obtained. 
Haemoglobin determination was performed using the cyanmethaemoglobin 
method (van Kampen and Zijlstra, 1965; Drabkin and Austin, 1932, 1935). 
One Aculute diluent pellet (Orthadiagnostics, Raritan, New Jersey. 
Active ingredients sodium bicarbonate, potassium ferricyanide, 
potassium cyanide) was dissolved in 250ml distilled water ("Drabkin's 
reagent"). 200µ1 of blood or brain homogenate was added to 3ml of 
Drabkin's reagent, mixed well and allowed to stand for 10 min to permit 
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cyanmethaemoglobin to form. The absorbance was then read at 540nm in 
a spectrophotometer (540nm is the light absorption maximum of hemiglo-
bincyanide (HiCN) against a blank containing 200µ1 of o,5% Triton X and 
3ml Drabkin's reagent. This technique takes into account the fact that 
the haemoglobin solutions may contain the following substances : 
heamoglobin, oxyhaemoglobin, carboxyhaemoglobin, hemiglobin and other 
haemoglobin derivatives. All of these are converted to HiCN with 
Drabkin 's reagent. 
Acetylcholinesterase activities in blood and brain were determined 
colorimetrically by measuring the rate of hydrolysis of the substrate 
acetylthiocholine with a Cary Varian Spectrophotometer (see section 3.6.} 
The final reaction mixture consisted of 3ml O,l M-phosphate buffer pH 8,0; 
200µ1 homogenate, 100µ1 DTNB (0,01 M) and 50µ1 acetylthiocholine iodide 
(0,075 M) • Absorbance was determined at 410nm against a blank. Enzyme 
activity was expressed as nmol/min/mg to tissue. 
3.5.3. Results 
The results of absorbance at 540nm and AChE activity of brain and blood 
from six 18 day C3H mouse fetuses are presented in Tables 3.10 and 3.11. 
Substantial blood enzyme activity is apparent (median AChE activity 
1,71 nmol/min/mg) which is 52,8% that of brain (3,24 nmol/min/mg). The 
absorbance of haemoglobin (more correctly HiCN) at 540nm in brain is 1/16 
that in blood. The contribution of blood to enzyme activity in brain is 
calculated as follows: Median brain weight = 85,6mg; median blood 
absorbance = 0,037; median blood weight= 24,63mg. For l mg blood, 
the absorbance is 0,037/24,63. For 85,6mg blood, the absorbance is 85,6 
x (0,037/24,63) = 0,129. For 85,6mg brain, absorbance is 0,008. For 
























































































































































































































































































































































































































































































































































































































































greater than absorbance of brain. Alternatively, the contribution 
of blood to brain or amount of blood in brain is 1/16,13. But the 
median blood AChE activity is 1,71 runol/min/mg. Therefore, the con-
tribution of blood to enzyme activity is 1,71/16,13 = 0,106 nmol/min/mg, 
compared with 3,24 runol/min/mg mean brain AChE activity. Expressed as 
a percentage the contribution of AChE activity in blood to total brain 
AChE activity is 0,106 x 100/3,24 = 3,3%. 
3.5.4. Discussion and Conclusion 
In this experiment decapitation resulted in maximal drainage of blood 
from the brain and presumably accounts for the low contribution of blood 
to brain AChE activity. The same method of sacrifice was used through-
out in this thesis. The amount of blood remaining in fetal brains was 
therefore likely to be similar and the contribution was accepted as 
representing an insignificant constant and was not determined indepen-
dently in each assay. 
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C H A P T E R 4 
CHOLINESTERASE 
4.1. INTRODUCTION 
Cholinesterase (ChE, EC 3.1.1.8) is widely distributed in the central 
nervous system. The enzyme is located in white matter, principally 
in the supportive glial cells, fibrous astrocytes and Schwann cells 
of myelinated nerves (Koelle, 1950; 1952; Cavanagh et al., 1954; 
Mayer, 1980). In the cerebral white matter of man ChE activity ex-
ceeds that of AChE (Ord and Thompson, 1952). Studies with glioma 
tissue indicate that tumours of the astrocyte series in man are rich 
in ChE (Cavanagh et al.,1954). Although the enzyme has been shown 
histochemically to be present in the walls of blood vessels of brain 
(Koelle, 1952) this is not thought to contribute significantly to the 
activity in brain (Cavanagh et al.,1954). The physiological role in 
the brain is unknown but the association of ChE with the white fibre 
tracts of the brain has led to the suggestion that the enzyme is con-
cerned with the metabolism of the myelin sheath or of neuroglial ele-
ments (Maletta and Timiras, 1965). 
The aim of this study was to determine the ChE activity in C3H fetal 
mouse brains, before investigating the effect of teratogens on the 
enzyme. Four methods were used in the determination of cholinesterase 
activity utilising the following: 
a) the preferred substrate of ChE; b) a selective ChE inhibitor; 
c) a selective AChE inhibitor; d) polyacrylamide gel electrophoresis. 
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4.2. DETERMINATION OF CHOLINESTERASE ACTIVITY USING THE PREFERRED 
SUBSTRATE, BUTYRYLTHIOCHOLINE IODIDE (BuThCh) 
The preferred substrate of ChE is butyrylcholine (BuChl or butyryl-
thiocholine (Silver, 1974:7). (In contrast AChE activity towards 
BuThCh is very low). 
McJ.terials and Methods 
A. Pooled 18-day C3H fetal mouse brains were solubilised and homoge-
nised as described in section 2.8. to give a brain concentration of 
20mg/ml. 
B. Brain homogenate was assayed for 
a) Acetylcholinesterase activity using 50µ1 of 0,075M AThCh, 
as described in section 3.4.2. and 
b) Cholinesterase activity using 0,037M BuThCh (Bonham et al., 
1981). Volumes of components and the· technique used were the same 
as those used for AChE assay, as described in section 3.4.2. 
C. Each experiment was repeated three times. The rate of hydrolysis 
of ChE and AChE in brain homogenate was calculated as described in 
section 3.4.3. and the mean results are given in Table 4.1. 
Results 
TABLE 4.1. 
ACTIVITY OF ACETYLCHOLINESTERASE AND CHOLINESTERASE IN U/1 USING 




Brain homogenate 87,44 3,26 
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Comment 
The enzyme activity of brain homogenate using BuThCh as substrate is 
approximately 3,7% ( 3126 x 100) of that using AThCh as substrate, 87,44 
suggesting that a very small amount of ChE is present in fetal brain 
compared with AChE. 
Some of this hydrolysis of BuThCh may be caused by AChE as BuThCh 
is not a totally specific substrate for ChE. (This was confirmed 
in a subsequent experiment using a specific AChE inhibitor - see 
section 4.4. 
4.3. DETERMINATION OF CHOLINESTERASE ACTIVITY USING THE SELECTIVE 
CHOLINESTERASE INHIBITOR LYSIV~~'1E (ETHOPROPAZINE HYDROCHLORIDE) 
4.3.1. Introduction 
The selective inhibitor of ChE, lysivane (ethopropazine hydrochloride 
or 10-(°'-diethylaminopropyl) phenothiazine hydrochloride, May and 
-5 Baker, South Africa) at a working concentration of 1.42 x 10 M has 
been found to produce 94.2% inhibition of ChE whilst producing 5.8% 
* inhibition of AChE. (Dale et al., 1977; Dale et al., 1981). However, 
both the concentration of lysivane as well as the amount of enzyme 
present influence the degree of inhibition of the enzymes (Brock, 1981; 
Hullin and Elder, 1981). 
Prior to determining cholinesterase activity the optimal concentration 
of lysivane to be used with C3H fetal mouse brain homogenates was 
therefore calculated (i.e. that concentration which gave maximum 
inhibition of ChE with minimum inhibition of AChE). 
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4.3.2. Preliminary experiments to determine the optimal concentration 
of lysivane using pure AChE (bovinel and ChE (seruml 
Materials and Methods 
A. 0,2mg pure bovine ACh.E (Sigma, o,72 U/mgl was dissolved in 
1,0ml distilled water. 
B. Human serum provided a source of ChE. 
c. Pure AChE and human serum were assayed for enzyme activity using 
the Ellman technique as described in 3ection 3.4.2. 
D. Sorl of stock lysivane solution was added to the test cuvette 
after allowing the initial reaction with substrate to proceed for 
2 - 3 min. The change in the rate of hydrolysis was calculated. 
A range of concentrations of lysivane were used (see Table 4.2.) to 
determine that concentration which gave the maximum inhibition of 
ChE with the minimum inhibition of AChE. 
E. The percentage inhibition of enzyme activity was calculated by 
subtracting the rate of hydrolysis after addition of lysivane (y) 
from the original rate of hydrolysis (x) and dividing the difference 
by the original rate of hydrolysis. i.e. 
% inhibition= x - y 
X 
X 100 
% remaining activity= y_ 
X 
X 100 
Results are shown in Table 4.2. and are plotted graphically in 
Fig. 4 .1. 
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T A B L E 4. 2. 
RESULTS SHOWING: i) THE PERCENTAGE INHIBITION OF PURE BOVINE 
ACETYLCHOLINESTERASE AND ii) THE PERCENTAGE REMAINING ACTIVITY 




10 M % INHIBITION OF % REMAINING ACTIVITY 
(STOCK CONC. ) PURE AChE OF SERUM ChE 
4,5 2,29 5,95 
6,8 4,25 4,65 
9,12 4,38 4,09 
13, 7 7,32 3,62 
18,2 9,27 3,47 
27,4 16,13 2,77 
36,4 15,74 2,35 
a) A progressive increase in lysivane concentration caused an increase 
in the inhibition of both AChE and ChE activity. 
b) From Fig. 4.1. the intercept of lines A and B indicates that the 
-4 optimal concentration of lysivane was 8,5 x 10 M producing 4,3% inhi-
bition of pure bovine AChE and 95,7% inhibition of serum ChE. 
4.3.3. Determination of the optimal concentration of lysivane using 
fetal mouse brains and human serum, and estimation of brain ChE 
The previous experiment was repeated using fetal brains to 
i) determine whether the optimal concentration of lysivane as 

































































































fetal brain (20mg/ml brain homogenatel 
ii) to estimate the ChE activity in fetal mouse brain. 
Materials and Methods 
A. Pooled 18 day C3H mouse brains were solubilised and homogenised 
as described in section 2.8. to give a brain concentration of 20mg/ml. 
B. Human serum was used as a source of ChE. 
C. Brain homogenate and human serum were assayed and the percentage 
inhibition of enzyme activity calculated as in section 4.3.2. 
D. Different concentrations of lysivane were used (see Table 4.3.) 
to determine that concentration which gave maximum inhibition of ChE 
with minimum inhibition of AChE. 
Results and discussion 
Results are given in Table 4.3. and plotted graphically in Fig. 
4.2. 
a) A similar graph to that obtained in the pre~~ous experiment was 
obtained. The intercept of lines C and D also gives an optimal 
-4 
lysivane concentration of 8,5 x 10 M. 
b) 
-4 
With the optima.l lysivane concentration of 8,5 x 10 M the 
percentage inhibition of total brain esterase (i.e. AChE and ChE) 
was 4,6%. However, this concentration of lysivane produced 4,3% 
inhibition of AChE in t.~e previous experiment, suggesting that only 
0,3% of this total% was ChE. 
c) The lines for (i) the percentage inhibition of brain AChE and 
ChE and (ii) the percentage remaining activity of ChE, have been 
drawn to best fit the available points and therefore may be approxi-
mate. However, this is unlikely to have caused more than a few percent 
error in the above deductions. 
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TABLE 4.3. 
RESULTS SHOWING i) THE PERCENTAGE INHIBITION OF BRAIN 
ACETYLCHOLINESTERASE AND ii) THE PERCENTAGE REMAINING ACTIVITY 
OF HUMAN SERUM CHOLINESTERASE WITH INCREASING 
LYSIVANE CONCENTRATION 
LYSIVANE CONC. % REMAINING 
4 % INHIBITION 
xlO- M (STOCK ACTIVITY OF 
OF BRAIN AChE 
CONC.) SERUM ChE 
1,14 1,46 * 
1,83 3,27 * 
3,67 1,56 * 
4,56 1,38 6,95 
7,33 6,59 5,64 
9,12 5,18 4,66 
14,7 10,01 3,86 
18,2 9,2 3,03 
29,3 15,47 2,46 
36,5 20,79 2,05 





















































































































































































































4.4. DETERMINATION OF CHOLINESTERASE ACTIVITY USING THE SELECTIVE 
ACETYLCHOLINESTERASE INHIBITOR, 1,5-BIS (4 ALLYLDIMETHYL AMMONIUM 
PHENYL}-PENTAN-3-0NE DIBROMIDE (B.A.P.l 
Acetylcholinesterase can be distinguished from ChE by the use of a 
so-called "specific" inhibitor such as B.A.P. which inhibits AChE but 
not ChE (Silver, 1974:9}. Using the Ellman technique as described in 
section 3.4.2., if AChE activity in fetal brain homogenate is inhibited 
by the selective inhibitor B.A.P., any remaining enzyme activity should 
be due to ChE. 
Materials and Methods 
A. Pooled 18-day C3H fetal mouse brains were solubilised and homo-
genised as described in section 2.8. to give a brain concentration of 
20mg/ml. 
B. The brain homogenate was assayed for enzyme activity using 
a} 0,075M AThCh and bl 0,037M BuThCh as substrates as described 
in section 3.4.2. and 4.2. 
C. SOpl of 0,0125M B.A.P. (this was found to be a suitable concen-
tration from preliminary experiments} was added to the cuvette after 
allowing reaction with substrate for 2 - 3 min. 
D. The rate of hydrolysis before and after addition of B.A.P. was 
calculated. Each experiment was performed three times. 
Results and discussion 
Results (t.~e mean of 3 assays} are given in Table 4.4. 
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TABLE 4.4. 
ENZYME ACTIVITY IN BRAIN HOMOGENATE BEFORE AND 
AFTER ADDITION OF B.A.P. 
ENZYME ACTIVITY 




AThCh 4,37 0,297 





a) When AThCh was used as the substrate, addition of the selective 
AChE inhibitor to the reaction mixture resulted in 93,2% inhibition 
of enzyme activity, demonstrating that most of the enzyme activity 
in brain was due to AChE. 
b) The relative amount that ChE activity contributed to the total 
enzyme activity (AChE and ChE) in brain homogenate was determined 
in two ways: 
i) using AThCh as substrate, the remaining enzyme activity 
after the addition of B.A.P. was calculated and expressed 
as a percentage of the total enzyme activity: 
0,297 
---~- x 100 = 6,8 % of total brain enzyme activity. 4,37 
iiL using BuThCh as substrate, the remaining enzyme activity 
after the addition of B.A.P. was calculated and expressed 
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as a percentage of total enzyme activity using 
AThCh as substrate = 0,132 x 100 = 3,0% 
4,37 
i.e. calculated in this way 3% of the total brain 
esterase activity was due to ChE (i.e. the relative 
amount that ChE contributed to total brain esterase 
activity was small.) 
The discrepancy between this latter result of 3% and the 
former result of 6,8% is probably explained by the fact 
that enzyme activities in the latter calculation were 
compared using different substrates. 
c) Using BuThCh as substrate, the 19% inhibition of enzyme activity 
after addition of B.A.P., demonstrates that some of the hydrolysis of 
BuThCh is due to AChE, as B.A.P. is a selective AChE inhibitor. 
4.5. ATI'EMPTS TO DEMONSTRATE THE PRESENCE OF CHOLINESTERASE IN FETAL 
MOUSE BRAIN USING POLYACRYLAMIDE GEL ELECTROPHORESIS 
If significant amounts of ChE are present in 18 day C3H fetal mouse 
brain, this should be demonstrable as a distinct zone on polyacrylamide 
gel electrophoresis, as for example in human amniotic fluid (Seller and 
Cole, 1980; Smith et a~, 1979). Attempts were made to demonstrate 
ChE in fetal mouse brain by 
i) incubating a gel with the preferred ChE substrate BuThCh, 
and 
ii) by comparing a control gel incubated with AThCh as substrate 
with gels incubated with AThCh and 
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a) the ChE inhibitor, lysivane and 
b) the AChE inhibitor, B.A.P. 
Materials and Methods 
A. Polyacrylamide gels were prepared as described in Chapter 5. 
B. 18-day C3H fetal mouse brains were solubilised and homogenised 
as described in section 2.8. 
C. To confirm that a ChE band could be demonstrated on the gels, 
human serum (as a source of ChE) was used in a separate well. Fetal 
mouse serum was also used to demonstrate the position of fetal mouse 
ChE on the gel. 
D. Pure bovine AChE (Sigma) was run in a separate well (250µ1 of a 
0,2mg/ml AChE solution was mixed with 150µ1 of sample buffer). 
E. Samples for electrophoresis were prepared as follows: 
i) 400µ1 of brain homogenate was used with 80µ1 of a glycerol/ 
sucrose solution and 20µ1 bromophenol blue (tracking dye) -
see Chapter 5. 
ii) 100µ1 human serum or fetal mouse serum was mixed with 300µ1 
sample buffer (0,05M Tris-HCl, o,5% Triton X-100, pH 6,4); 
80µ1 glycerol/sucrose and 20µ1 bromophenol blue. 
F. Eight µl samples were loaded into separate wells of the gel with a 
Hamilton syringe. 
G. Electrophoresis was performed at 20mA/gel for approximately 4h. (A 
full description of the electrophoresis is given in Chapter 5). 
H. Gels were incubated as follows: 
a) with AThCh as substrate only (0,116mg/100ml) (see Fig. 4.3.) 
b) with AThCh as substrate and lysivane (1,5ml of 8,85 x 10-4 
stock in 100 ml) (see Fig. 4.4.) 
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Fig. 4. 3. 
POLYACRYLAMIDE GEL 
INCUBATION WITH ACETYLTI!IOCHOLINE IODIDE 
TRACK 
Key: 
2 3 4 5 
Note: 




18"'1ay fetal mouse brain homogenate 
18"'1ay fetal mouse serum 
Ruman serum 
Pure bovine AChE 
- the typi.,cal 5 band pattern of CJR fetal mouse brain 
- the 2 bands in fetal mouse serum 
the single band in human serum 
- the single band with pure bovine AChE. 
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Fig. 4 . 4. 
POLYACRYLAMIDE GEL - INCUBATION WITH ACETYLTHIOCHOLINE IODIDE 
AND LYSIVANE 
TRACK 2 3 4 5 
Key: As for Fig. 4.3. 
Note: 
Compare with Fig. 4.3. 
the marked decrease in the intensity of the. slow 
moving band in fetal serum (track 2) and the band 
in human serum (track 3), confirming that these 
are ChE. 
no decrease in intensity of pure bovine AChE 
(track 4) or of fetal brain bands (.tracks 1 and 
5) • 
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c) with AThCh as substrate and B.A.P. (0,028g in 100ml, 5 x 10 
-4 
final M) (see Fig. 4.5.) 
d) with BuThCh as substrate only (0,116mg/100ml) (see Fig. 4.7. 
and compare with AThCh as substrate, Fig. 4.6.) 
Results 
Note: 
i) with lysivane there was no demonstrable change in the fetal 
brain isoenzyme bands (compare tracks 1 and 5 in Fig. 4.3. and 
4.4.), although very significant inhibition was apparent with 
serum. The fetal mouse serum ChE band was almost completely 
inhibited (track 2, Fig. 4.4.) and there was a decreased staining 
intensity of the human serum ChE band (track 3, Fig. 4.4.) (see 
note b). This suggested that the isoenzyme bands in fetal brain 
were all AChE with no ChE demonstrable. Alternatively, a ChE band 
could have been obscured by an AChE band and was therefore not 
apparent. 
ii) with the selective AChE inhibitor B.A.P. complete inhibition 
of all fetal mouse brain isoenzyme bands occured (track 3, Fig. 4.5.), 
revealing that there was no demonstrable residual ChE band. The 
bovine AChE band was also completely inhibited (track 1, Fig. 4.5.) 
The slow-moving ChE band in mouse fetal serum was not inhibited 
whereas the fast moving AChE band was (track 3, Fig. 4.5.) (see note 
"a") . Similarly, the ChE band in human serum was not inhibited 
(track 4, Fig. 4.5.) 
iii) with the preferred substrate BuThCh, ChE activity could also 
not be demonstrated in fetal mouse brain (Fig. 4.7.) even though a 
ChE band was well demonstrated with human serum (track 3, Fig.4.7.) 
a) Some AChE was present in mouse fetal serum. i.e. the fast 
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Fig. 4 .5. 
POLYACRYLAMIDE GEL: INCUBATION WITH ACETYLTHIOCHOLINE IODIDE 
AND B.A.P. 







pure bovine AChE 
18 day fetal mouse brain homogenate 
18 day fetal mouse serum 
human serum 
- in track. 1 no band is visible (compare track 4 in Fig. 
4 .3. incubated without B.A.P.) showing complete inhibi-
tion of AChE. 
- in track 2 all the 5 brain bands have disappeared (com-
pare tracks 1 and 5 in Fig. 4 .3. without B.A.P.) sugges-
ting these are AChE. 
- in track 3 the fast moving band of fetal mouse serum has 
disappeared (compare track 2 in Fig. 4 .3. without B.A.P.) 
suggesting this is AChE. 
- in track 4 there is no inhibition of the band (compare 
track 3 in Fig. 4 .3.) demonstrating no inhibition of ChE. 
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Fig. 4 .6. 




2 3 4 
Tracks 1 and 2: mouse amniotic fluid 
Track. 3 human serum 
Track. 4 18 day fetal mouse brain homogenate 
(__COMPARE WITH FIG. 4. 7 . )_ 
the typical 5 band pattern of C3H fetal mouse brain 
(see Chapter 6) 
the faint fast-moving band of AChE in amniotic fluid 
the dark slow-moving band in human serum 
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Fig. 4. 7. 
POLYACRYLAMIDE. GEL · · INCUBATION .WITH BUTYRYLTHIOCHOLINE 
TRACK: 
Key: 
2 3 4 




18-day fetal mouse brain homogenate 
Note: (_Compare with Fig. 4 . 6.) 
the faint slow-moving band in amniotic fluid (.tracks 1 
and 2) - demonstrating the small amount of ChE in 
amniotic fluid 
the very dark ChE band in human serum (_track 3} showing 
the high concentration of ChE 
- no ChE band in fetal brain (track 41 (The 5 AChE bands are 
not apparent when incubated with BuThCh.) 
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moving band which was not inhibited by lysivane (track 2, 
Fig. 4 .4.) This was probably due to some red cell contamination 
of serum as it was impossible with the quantities available to 
separate pure serum. 
b) Complete inh.ibiti.on of human serum ChE W:\~ not a,chieved 
J?re.sumalily necause. o,! the high. concentration of ChE present for 
the. ;relatively low concentration of lysivane used (track 3, Fig. 
4 .4.) 
4.6. DISCUSSION AND CONCLUSIONS 
al Cholinesterase activity in 18-day C3H. fetal mouse brain is very 
low, contributing only 3 ... 6, 7% to the total enzyme activity (AChE 
and ChEl, depending on the technique used. With polyacrylamide gel 
electrophoresis of fetal mouse brains, no ChE activity could be demon-
strated. 
As far as I can ascertain there are no studies in the literature on 
fetal mouse brain ChE activity. However, the above findings are consis-
tent with those of other workers with the postnatal rat and mouse. In 
adult rat whole brain the activity of C~E in hydrolysing butyrylcholine 
has been found to be approximately 6% of that of AChE in hydrolysing 
acetylcholine (Woolley, 1963). Ellman (1961) found the average rate 
of hydrolysis of butyrylthiocholine by adult rat brain was 3% that of 
the average rate of hydrolysis of acetylthiocholine. Cholinesterase 
activity in C3H adult mouse brains was found to be 2% of AChE activity 
(Pryor, 1966) whilst in C57BL/6 and DNA/2 mice at birth ChE activity was 
8% of AChE activity (Pryor, 1968). With polyacrylamide gel electrophoresis 
of 30-day-old rat brain esterases Vijayan and Brownson (1974) were only 
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able to demonstrate a single weakly reactive cholinesterase isoenzyme in 
the brain stem. 
b) Due to the low ChE activity, the effect of teratogens on its 
activity was not assessed. 
c) Because the contribution of ChE to total "AChE" activity was very 
small, and would have been approximately the same in different brains, 
it was accepted as representing an insignificant constant and was not 
determined independently for each assay nor subtracted from the 
AChE activity. 
d) The low ChE activity is further support for the very small amount 
of residual blood in fetal brain with the decapitation technique used. 
(Blood serum is rich in ChE). 
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C H A P T E R 5 
SEPARATION OF THE ISOENZYMES OF FETAL MOUSE BRAIN 
ACETYLCHOLINESTERASE : POLYACRYLAMIDE GEL ELECTROPHORESIS 
5.1. INTRODUCTION 
Several investigators have reported varying numbers of acetyl-
cholinesterase isoenzymes in rat and mouse brain. In the rat brain 
Vijayan and Brownson (1974) detected 3 isoenzymes of AChE on 
polyacrylamide gel electrophoresis. Each of the 3 zones was noted 
to consist of several subzones on densitometry. The fastest moving 
band was designated isoenzyme one and the slowest moving band iso-
enzyme three. Zone three exhibited maximum staining and accounted 
for more than 50% of the total enzyme activity. Comparison of the 
isoenzyme patterns of serum, liver, skeletal muscle and intestine 
revealed that brain alone exhibited a marked preponderance of iso-
enzyme three. Although AChE activity is known to vary in different 
parts of the brain, it was noted that the relative percentage values 
for each isoenzyme remained constant in the various regions. There 
was also no difference between males and females, and the three 
isoenzymes responded to inhibitors in a similar way. Using a similar 
technique Cambon et al., (1980) separated 3 isoenzymes from fetal 
and maternal rat brain. Also using polyacrylamide gel electrophoresis, 
Bajgar (1979) found 4 isoenzymes in the supernatant of rat brain 
homogenate, and noted different thermal stabilities of the isoenzymes. 
With microgel gradient electrophoresis 3 to 4 AChE zones were noted 
during post natal development in the rat brain (Bischoff et al.,1982). 
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Wenthold et aL,(1974) observed six isoenzymes in rat brain using 
electrofocusing, whereas Ho and Ellman (1969), after treatment with 
bacterial protease observed three different forms of AChE in rat 
brain. In the adult mouse, Adamson et aL,(1975} noted two major 
zones of enzyme activity after polyacrylamide gel electrophoresis 
of fresh extracts of brain. A third zone which migrated more slowly 
was noted in aged extracts. It is apparent that the number of iso-
enzymes detected varies with different workers, the experimental 
technique used, and the species. 
Several workers have suggested that the isoenzymes appear to corres-
pond to aggregates (Bernsohn et al., 1963; Chan et al., 1972; Adamson 
et al., 1975; Wenthold et al.., 1974) 7 whilst ·· others have noted differen-
ces in the physico-chemical and enzymatic properties of the isoenzymes 
such as the Km . and pH optima (Bajgar and Zizkovsky, 1971), or differen-
ces in the 3 forms in bovine brain (Chan et al., 1972) or of thermal 
stabilities (Bajgar, 1979), suggesting they are indeed isoenzymes. 
As far as I can ascertain from the literature the AChE isoenzymes of 
fetal mouse brain have not been characterised. The first aim of this 
study, which is addressed in this chapter, was to establish a satisfac-
tory technique for the separation of the isoenzymes of AChE. Subsequent 
studies to investigate the effects of three teratogens, vitamin A in 
large doses, cyclophosphamide and sodium valproate, on these isoenzymes 
are presented under the relevant chapters. The potential of the iso-
enzymes as markers of teratogenic injury was considered because terato-
gens can altar normal development and may be toxic to the CNS. Also the 
possibility exists that the isoenzymes may exhibit differential sensitivi-
ty to embryotoxins. Alterations in AChE isoenzymes have been reported 
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during the normal maturation of the nervous system (Iqbal and Talwar, 
1971). Similarly, Rieger and Vigny (1976) found an increase in one 
AChE isoenzyme relative to another in rat brains during development. 
Alterations in AChE isoenzymes have also been demonstrated in experi-
mental brain injury in the absence of a significant change in total 
AChE levels (Lim et al.,1972). Differential AChE isoenzyme inhibition 
has been noted with parathion (Vijayan and Brownson, 1975) and in rat 
fetuses after maternal carbamate poisoning (Cambon et al.,1980). 
Polyacrylamide gel electrophoresis of the isoenzymes of AChE was 
performed on vertical slab gels (Raymond, 1964; Allen and Moore, 1966) 
utilizing a non-dissociating continuous Tris-glycine buffer system. 
Under non-dissociating buffer conditions, electrophoresis results in 
retention of biological activity of the isoenzymes (Hames, 1981 : 7). 
Separation is on the basis of size and charge of the molecules (Chram-
bach and Rodbard, 1971). The technique used was based on that of 
Allen and Moore (1966), Vijayan and Brownson (1974) and Haddow (1981) 
and modified. Significant detail has been included so that the proce-
dure can be easily followed. The lack of relevant technical detail 
in the literature on the separation of the isoenzymes of AChE resulted 
in many months of trial and error before satisfactory separation and 
resolution could be obtained. 
5.2. MATERIALS AND METHODS 
A. Preparation of gels 
A 7,5% gel mixture was prepared as follows: 10ml 30% Acrylogel 
(BDH biochemicals), 10ml gel buffer (0,05M Tris, 0,386 M glycine, 
pH 8,4), 20ml distilled H
2
o, 0,2ml Triton X-100 and 20µ1 Terned . ~ 
(catalyst : N,N,N ,N - Tetramethylethylenediamine were stirred on 
a magnetic stirrer until the Triton had dissolyed. Just prior to 
91 
pouring 200µ1 of 10% ammonium persulphate (initiator) was added. 
The mixture was poured between two glass plates, dimensions 16cm x 
14cm, 1,5mm apart. A leak-proof seal was obtained by using a thin 
layer of Celloseal between the bottom of the glass plates and the rubber 
washer of the casting stand. Using a Pasteur pipette the gel mixture 
was overlaid with water (to help exclude oxygen which inhibits polymeri-
sation). Polymerisation occurred in 45 min, giving a clear or faintly 
opaque gel. After lh the layer of water was decanted off and a second 
7,5% gel (prepared as above except that 300µ1 ammonium persulphate and 
40µ1 Temed were used) poured on top of the gel. Sample wells (25mm deep, 
volume 300µ1) were placed in the second gel by means of a 10 well perspex 
comb inserted at the top of the glass plates. Polymerisation of the 
second gel took approximately 15 min and the comb was removed after 45 -
60 min. The wells were washed with reservoir buffer. 
B. Sample preparation (brain) 
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Fetal brains (20mg per ml brain homogenate) were solubilised and homogenised 
as described in section 2.8. To 100µ1 of homogenate was added 20µ1 of 1:1 
glycerol-water/85% sucrose mixture and 5µ1 of tracking dye (bromophenol blue). 
C. Electrophoresis 
A Hoefer SE 600-10-1.5 vertical slab electrophoresis unit and a PS 1200 power 
supply unit (Hoefer) were used (Fig. 5.1). Bubbles were removed from the 
bottom of the gel as these prevent uniform electrical contact between gel 
and reservoir buffer. Tris-glycine buffer (O,OlM Tris, 0,077M glycine, pH 
8,4) was used in both the lower and upper tanks. Seven microlitre samples 
were carefully layered into the sample wells with a Hamilton 1701N syringe. 
Electrophoresis was performed at a constant current of 20mA per gel for 
Fig. 5.1. 
HOEFER ELECTROPHORESIS EQUIPMENT 
Nata: 
- the. IIoefer SE 600~10~1.S vertical slab electrophoresis 
unit and the PS 1200 power supply unit. 
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3 - 3~h at which stage the marker dye was 4cm from the bottom of the 
gel. Starting voltage was! 300 volts and final voltage after 3h was 
+ 670 volts. During electrophoresis the temperature was maintained 
between 18 and 20°c by circulating water at 18 to 20°c continuously 
through the heat exchanger. 
D. Enzyme development and staining 
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The development medium was based on that of Haddow (1981). After elec-
trophoresis the gel was placed as follows: a) In 100ml pre-incubation 
mixture (20g sodium sulphate (Na
2
so
4), 1,25g maleic acid, 0,15g glycine, 









adjusted to pH 6.5 with 6M sodium hydroxide) for 30 min; 
b) in 100ml incubation medium containing 116mg acetylthiocholine iodide 
as substrate in 100ml pre-incubation solution for 20h; 




) and 1,25g 
maleic acid, adjusted to pH 6.5 with 6M sodium hydroxide) for 30 min before 
thoroughly washing with distilled water. (If thorough washing was not 
carried out blotchiness of the background gel could result which posed 
problems for densitometric analysis). 
For better visualisation of the isoenzymes the gels were stained with a 
saturated solution of dithio-oxamide for 2h. The isoenzymes showed up 
as dazkgreen-black bands against a uniform faint green background. 
5.3. RESULTS 
Figure 5.2. is a photograph of a typical polyacrylamide gel demonstrating 
the AChE isoenzymes of 19-day C3H fetal mouse brains. 
Fig. 5.2. 
POLYACRYLAMIDE GEL DEMONSTRATING THE AChE ISOENZYMES OF 19-DAY 
FETAL MOUSE BRAINS 
Note: 
each. track. is from a different fe.tus. 







- the bands are numbered 1 to 5, band 1 being the fastest 
moving, rather faint zone at the bottom and band 5 the slowest 
moving diffuse zone. 
- bands 2 and 3 stain most intensely. 
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Five distinct bands are apparent and are numbered 1 to 5, band 1 
being the fastest moving, rather faint zone and band 5 the slowest 
moving diffuse zone. Bands 2, 3 and 4 were well resolved and of 
these bands 2 and 3 had the highest activity. 
5.4. SOME PRACTICAL POINTS AND PROBLEMS 
5.4.1. Polyacrylamide gels 
A. Slab gels 
Slab gels were used for the following reasons (Hames, 1981 : 5): 
a) slab gels enabled direct side by side comparison of samples; 
b) heat produced during electrophoresis was easily dissipated, thus 
reducing distortion of bands due to heating effects; c) their 
rectangular cross section allowed densitometry and photography with 
little risk of optical artifacts; d) a large number of samples 
could be electrophoresed under identical conditions. 
B. Choice of gel concentration 
Running gel 
The best separation and resolution of isoenzymes was obtained using 
a 7,5% uniform gel (see Fig. 5.2.) There was no advantage in using 
a gradient gel. A 4,5 - 9% gradient gel, which gave the best results 
of various concentration gradients used, also yielded comparable 
quality bands to those of the 7,5% gel, except that with the 7,5% 
gel 5 distinct bands were evident as opposed to only 3 with the 
gradient gel. Also, the 7,5% gel gave more reproducible results. 
"Stacking" gel 
Using a large pore stacking gel, e.g. 4,5%, there was no improvement 
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in resolution of the bands. A 7,5% gel was therefore used. This 
was layered onto the resolving gel as the higher concentration of 
ammonium persulphate needed to give adequate polymerisation with 
the perspex combs in position can result in streaking if incorpora-
ted in the resolving gel. 
C. Acrylogel versus bis-acrylamide (NN'-methylene bisacrylamide) 
and acrylamide 
There was no advantage using bis-acrylamide and acrylamide as opposed 
to Acrylogel. Acrylogel (BDH bioche~icals) was used in all definitive 
experiments. 
D. Inclusion of Triton X-100 in the gel 
Triton X-100 was included in the gel at the same concentration (0,5%) 
as that used for solubilisation. Very poor resul~s were obtained 
if Triton was omitted from the gel, such as bizarre separation and 
aggregation of the isoenzymes (Fig. 5.3.) 
E. "Wavy Lines" 
Wavy transparent lines were commonly seen at t he tops of gels, no 
doubt related to the higher oxygen concentration at the top of the 
gel which is closest to the atmosphere. The oxygen interferes with 
polymerisation and leads to uneven pore formation. The wavy lines 
result in uneven wavy bands of isoenzymes. Degassing both the water 
layered on the top of the gels and the gel mixture did not solve the 
problem. However, by choosing the appropriate gel concentration the 
bands move well down into the gel away from the wavy lines. 
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Fig. 5. 3. 
Note.: 
POLYACRYLAMIDE GEL ELECTROPHORESIS OF FETAL MOUSE BRAIN 
HOMOGENATE : OMISSION OF TRITON X-100 FROM THE GEL 
the absence of separation cf isoenzyme. bands and 
the bizarre aggregation. 
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5.4.2. Buffers 
Choice of buffer system 
Using continuous or discontinuous buffer systems quoted in the litera-
ture (e.g. Haddow, 1981; Clarke, 1964; Vijayan and Brownson, 1974) I 
was unable to obtain satisfactory separation and resolution of isoenzymes. 
After much trial and error the following buffer system was selected: a 
continuous low ionic Tris/glycine buffer system (gel buffer: 0,05M Tris, 
0,39M glycine, pH 8,4; reservoir buffer: O,OlM Tris, 0,077M glycine, 
pH 8,4). 
Sample buffer 
In preliminary experiments the same Tris/glycine buffer was used as in 
the gel. There was no difference in the quality of the isoenzyme bands 
with either Tris-glycine or Tris-HCl and a 0,05M Tris-HCl buffer, pH 
8,4 was used in all definitive experiments. At lower ionic strengths 




This was found to be unnecessary, i.e. there was no difference in the 
separation and resolution of the bands compared with non-pre-electro-
phoresed gels. 
B. Electrophoresis with constant current versus constant voltage 
Electrophoresing with constant voltage as opposed to constant current 
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gave poorer results, presumably because the longer time required 
allowed significant diffusion to occur. 
c. Duration of electrophoresis 
Three to 3~ hours was found to be the optimal duration for electro-
phoresis at 20 mA/gel (at this time the dye front was 3-4cms from 
the bottom of the gel). Shorter runs gave inadequate separations 
whilst protracted runs resulted in excessive diffusion with loss of 
resolution of the bands. 
D. Temperature control during electrophoresis 
Water was circulated continuously at 18 - 20°c through the cooling 
system during electrophoresis. Temperature must be controlled if 
electrophoretic separations are to be reproducible because heat is 
generated during electrophoresis and the mobility of migratory ions 
is increased as temperature increases (Hames, 1981 18). 
5.4.4. Brain samples 
A. Brain concentration 
Good results were obtained using a brain concentration of 20mg/ml. 
With lower concentrations the bands were too faint. Above this 
concentration there was no significant improvement whilst adding 
the problem of minimal volumes of homogenate to work with. 
B. Sample load 
If sample loads were too large aggregation of enzyme occurred 
resulting in streaking (protein streaks running parralel to the 




POLYACRYLAMIDE GEL ELECTROPHORESIS OF FETAL MOUSE BRAIN 
HOMOGENATE : EXCESSIVE SAMPLE LOAD RESULTING IN STREAKING 
- the vertical streaks and aggregation of enzyme along the 
margins of the tracks from excessive sample loading. 
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20mg/ml of brain was chosen because this gave good visualization of 
isoenzymes with negligible streaking. 
C. Centrifugation 
Centrifugation of brain homogenates (e.g. at 8000g for 30 minutes) 
prior to electrophoresis did not result in any improvement in resolu-
tion or separation of the isoenzymes and was therefore not performed. 
This was an advantage as centrifugation would inevitably lead to some 
loss of enzyme in the centrifugate. 
D. Sonication 
Sonication offered no advantage over homogenisation and solubilisation 
with Triton X-100 nor did submitting the sample to both procedures. 
5.5. QUALITY OF ISOENZYME SEPARATION 
After overcoming the various problems detailed above the technique 
was reproducible with good resolution and separation of the isoenzymes 
of AChE (see Fig. 5.2.). rsoenzyme separation appeared superior to that 
published in the literature where photographic documentation of isoenzyme 
zones after polyacrylamide gel electrophoresis was given (e.g. Vijayan 
and Brownson, 1974; Seller and Cole, 1980). The bands were suitable for 
densitometric analysis. 
The only poorly resolved zone was band 5 i.e. the diffuse slow moving 
first zone which was a constant feature and may have represented a 
poorly resolved isoenzyme. However, increasing the duration of the run 
did not resolve this zone into a distinct band. Alternatively, it may 
have been due to isoenzyme aggregation, or to the enzyme being caught 
up with protein moieties. Incorporating trypsin in the hope that this 
would digest possible protein moieties unfortunately resulted in 
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loss of all enzyme activity. Varying sample load or the ionic 
strength of sample buffer, centrifugation, or increasing the concen-
tration of Triton in which the brains were solubilised made no demons-
trable difference. It was not due to non-specific staining of non-
enzyme substances as omitting the substrate acetylthiocholine iodide 
resulted in no staining. 
5.6. INHIBITOR STUDIES 
To confirm the composition of the isoenzyme bands inhibitor studies 
were performed. 
A control gel incubated with AThCh as substrate (0,116mg/100ml} was 
compared with gels incubated with AThCh and a) the AChE inhibitor 
-4 B.A.P. (0,028g/100ml = 5 x 10 final M) and b) the ChE inhibitor 
-4 l ysivane (1,5ml of 8,85 x 10 M stock in 100ml). 
Human serum as a source of ChE was run in a separate well. Fetal 
mouse serum was run in another well to demonstrate the position of 
fetal mouse ChE, and pure bovine AChE in a further well. 
Results 
With the selective AChE inhibitor B.A.P. complete inhibition of all 
fetal mouse brain isoenzyme bands occured (see Fig. 5.6. and compare 
with control gel, Fig. 5.5.), indicating that the bands were indeed 
AChE. Note that the ChE band in human and fetal mouse serum was not 
inhibited with B.A.P. (Fig. 5.6.) and that no inhibition of fetal mouse 
brain isoenzymes occured with lysivane (Fig. 5.7.), which was further 
support as stated in section 4.5., that the isoenzyme bands were AChE 




INCUBATION WITH ACETYLTHIOCEOLINE IODIDE 
TRACK 
Key: 
1 2 3 4 5 
Note: 




18-day fatal mouse brain homogenate 
18-day fetal mouse serum 
Human serum 
Pure bovine AChE 
- the typical 5 band pattern of CJR fetal mouse brain 
- the 2 bands in fetal mouse serum 
- the single band in human serum 
- the single band with pure bovine AChE. 
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Fig. 5. 6 • . 
POLYACRYLAMIDE GEL: INCUBATION WITH ACETYLTHIOCHOLINE IODIDE 
AND B.A.P. 






Track 4 : 
pure. bovine AChE 
18-day fetal mouse brain homogenate 
18-day fetal mouse serum 
human serum 
- in track 1 no band is visible (compare track 4 in Fig. 
5.5. incubated without B.A.P.) showing complete inhibi-
tion of AChE. 
- in track 2 all the 5 brain bands have disappeared (com-
pare tracks 1 and 5 in Fig. 5.5. without B.A.P.) sugges-
ting these are AChE. 
- in track 3 the fast moving band of fetal mouse serum has 
disappeared (compare track 2 in Fig. 5 .5. without B.A.P.) 
suggesting this is AChE. 
- in track 4 there is no inhibition of the band (compare 
track 3 in Fig. 5.5.) demonstrating no inhibition of ChE. 
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Fig. 5 .7. 
POLYACRYLAMIDE GEL - INCUBATION WITH ACETYLTHIOCHOLINE IODIDE 
AND LYSIVANE 
TRACK 2 3 4 5 
Key: As for Fig. 5.5. 
Note: 
Compare with Fig. S.S. 
the marked decrease in the intensity of the slow 
moving band in fetal serum (track 2) and the band 
in human serum (track 3), confirming that these 
are ChE. 
no decrease in intensity of pure bovine AChE 





Densitometry was chosen as a quantitative technique for comparing the 
activity in the various isoenzyme bands of AChE. 
Densitometry (as opposed to other techniques for quantitative analysis 
of gel patterns) was chosen because it has been successfully used for 
similar purposes - the analysis of AChE isoenzymes in mouse brain 
(Adamson et al, 1975}; rat brain (Srinivasan at al, 1976; Vijayan 
and Brownson, 1974} and amniotic fluid (Goldfine et al, 1983). Densi-
tometry appears to be a sensitive technique for comparing the relative 
amounts of AChE in different isoenzymes and is a simple, rapid method 
which can be used to analyse a large number of samples in intact gels. 
5.7.2. Principles of technique 
Densitometry measures the relative density (s_tain intensity) of a band 
with respect to a reference or standard and the background and depends 
on the amount of light absorbed by the band or fraction. 
Absorbance of light is described by the Beer-Lambert law where: 
Absorbance or A= ale; (c = concentration of sample (moles/1; 
1 = light path length Ccm); a= absorptivity). 
From this equation, the concentration Cc) of a sample can be determined 
directly. 
In the case of an electrophoresis pattern, the whole pattern is scanned 
by the densitometer and a graph is produced, plotting the position of 
each fraction in the sample. The concentration of each fraction can 
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then be determined by calculating either the area under the respective 
peaks (total c of the sample and total area under curve) or the peak 
heights of the fractions. 
5.7.3. Materials and methods 
a) Each gel (wet) was placed onto a clean glass plate and covered 
with a sheet of transparent plastic. Any air bubbles present were 
removed. The plastic covering prevented the gels from drying out or 
being damaged during scanning and provided a smooth, even surface to the 
gel. 
b) The gel was positioned on the scanning stage of the densitometer 
and the start and end points of the scan set. 
c) The densitometer used was a Zeiss KM3 Chromatogram Spectrophoto-
meter - set up for measuring transmission as opposed to reflectance. 
Gels were scanned at a wavelength of 610 nm, using a tungsten lamp 
(325-2500 nm) and a slit size of 8 mm x 0.1 mm (Note 
the isoenzyme bands was 8 mm). 
the width of 
d) Before scanning, a zero value was obtained by placing the measuring 
head over a blank region of the gel. Maximum peak height was obtained 
by placing the measuring head on the densest band of the gel. 
e) Gels were scanned at a speed of 100 cm/min and the scan was recor-
ded at 500 mV full scale deflection. 
5.7.4. Densitometric analysis of 18-day C3H fetal mouse brain AChE 
isoenzymes 
Fetal mouse brain homogenate was prepared as described in section 2.8. 
Separation of the isoenzymes of AChE by polyacrylamide gel electropho-
resis was performed as described in Chapter 5. 
Densitometry was performed as described in section 5.7.3. and a typical 
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trace is shown in Fig. 5.8. 
Results and discussion 
Five main peaks were visible on the densitometric scans and their 
positions corresponded well to the 5 bands on the gels (Fig. 5.8. and 
5.9.). 
Background noise tended to vary between samples on one gel and between 
individual gels. This variation in the background was probably due to 
uneven staining. 
Individual peak heights and the sum of peak heights for each sample, 
were analysed statistically using the Mann Whitney U test (non parametric); 
modified Wilcoxen Median test and the Kalmogarov-Smirnov test. 
5.7.5. Preliminary experiments 
To determine (i) whether there was a linear relationship between stain 
intensity and AChE concentration; (ii) the sensitivity of the densi-
tometer. 
Methods 
A. (a) Serial dilutions of pure bovine AChE (Sigma 0,72 Units/mg) 
were prepared as follows: 400; 200; 100; 50; 25; 12,5µg/ml. 
(b) 250µ1 of each AChE dilution was mixed with 150µ1 sample 
buffer (0,05M Tris-HCl; 0,5% Triton X-100, pH 8,4l and 20µ1 bromophenol 
blue (B.P.B.} and 80µ1 of glycerol/sucrose solution (sample loading 
buffer) 
(c) 8µ1 of each sample was layered onto a 7,5% polyacrylamide gel. 
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Fig. 5. 8. 
Note: 
DENSITOMETER TRACING OF AChE ISOENZYME PATTERN OF 
19-DAY FETAL MOUSE BRAIN 
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- tha five isoenzyme peaks numbered 1 ..... 5 
The peak heights for the 5 peaks were measured from an arbitrarily 
determined, best apparent baseline on each recorded scan. Peak 
lie.i.ghts were chosen as opposed to area under the curve (a.u.c.). 
Peak heights are acceptably accurate and were better suited to the 
tracings because of the difficulty in measuring a.u.c. for the 
following reasons: ( i) there was high background noise; (ii) 
the peaks were not always smooth; and (iii) the troughs of some 





















































































































B. (a) Eighteen day fetal mouse brain homogenate was prepared as 
described in section 2.8. (30mg/ml). 
(b) Dilutions were made up as follows: 400; 300; 200; 100µ1 
brain homogenate mixed with sample buffer to give a total volume of 400µ1. 
Cc) 20µ1 of B.P.B. and 80µ1 of glycerol/sucrose solution was added 
to the above and 8µ1 of each sample was loaded onto a gel. 
Electrophoresis was performed at 20 IDA/gel for 4 hours. The gels were 
scanned on a Zeiss KM3 chromotagram spectrophotometer, at a wavelength 
of 510 nm and with a slit size of 8 mm x 0,1 mm. The densitometer scans 
were analysed by measuring the amplitude of the peaks. 
Results and conclusions 
Figure 5.10. is a photograph of the gel showing the 6 serial dilutions 
of pure AChE (tracks 1 - 6) and the 4 serial dilutions of fetal mouse 
brain homogenate (tracks 7 - 10). With a dilution ratio of 0,25 (track 
10) - the bands were too faint and were not subjected to densitometric 
analysis. The results of the relationship between pure AChE concentra-
tion and peak heights measured at 3 different sensitivities (+2V, +lV 
and +500 mV) on the densitometer are given in Table 5.1. and shown gra-
phically in Fig. 5.11. 
The results of the relationship between fetal mouse brain homogenate 
concentrations and peak heights measured at+ 500 mV on the densitometer 
are given in Table 5.2. and shown graphically in Fig. 5.12. 
There was a linear relationship between peak heights and AChE concen-
tration at lower AChE concentrations (i.e. 0,05 - 0,2µg/8µ1 but not at 
concentrations above 0,2µg/8µ1 (see Fig. 5.11.) - this is inevitable 
given the absorptiometric nature of the assay. 
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Fig. 5.10. 
POLYACRYLAMIDE GEL WITH SERIAL DILUTIONS OF PURE AChE AND 
18-DAY FETAL MOUSE BRAIN HOMOGENATES 
TRACK 1 2 3 4 5 6 7 8 
Key: 
Note.: 
Tracks 1-6: serial dilutions of pure AChE from 
1,6 pg/8 pl to 0,05 pg/8 µl. 
Tracks 7-10: serial dilutions of fetal mouse brain 
homogenates from 24 mg/ml to 6 mg/ml. 
the stain intensity of "undiluted" brain homogenate 
(track 71 is less than that of 0,2 pg/8 µl of pure 




T .~8 LE s.1. 
~ELATI0NSHI? 3ETWE~N PUR E AC ETYLC HJ LINE3TERASE -
CONCENTRATION AN O PE AK H~IGHTS MEASUR ED 
AT THR EE DIFFE~ENT SENSITIVITIES 
AChE cone .. PEAK HEIGHTS (mm) 
pg/ml )-JQ/8,J.Jl + 2V + lV + 500mV 
12,5 0,05 11 24 49 
25 0,1 21 42 89 
50 0,2 39 83 177 
100 0,4 59 126 * 
. 
200 o,s 78 l 71 * 
400 1,6 90 * * 
* Scan off scale. 
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RELATIONSHIP BETWEEN PEAK HEIGHTS AND PURE AChE 
(µg/8µ1 ) MEASURED ON THE ZEISS DENSITOMETER AT 
; 
C 
A : + 2V 
B: + lV 
C : + 500 mV 
B 
-------------~ A 
0,2 0,4 0,6 0,8 1,0 1,2 1,4 1,6 
µg AChe 
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T A B. L E 5. 2. 
RE LATIONS HIP 3ETWEEN FETAL MOUSE GRAIN HOMOGENATE 
CO NCENTRATIO NS AND PEAK HEIGHTS MEASURED AT+ 500 mV 
1'10USE BRAIN H Oi~O GE ;J,; TE 
mg/mL 12m g/rnl 18mg/ml 24mg/ml 
Dil ution ratio 0,5 0 ,75 1,0 
Peak 8 18 21 
l 
(Dilution 
( Q , 38 ) (p, 8_6) 0!' 0) Kaflo) -
-
2 32 46 58 
1 
'-' (Ratio) (J),55) (0 ;79 ). .. ( 1, 0) 
r./) 
r' 
3 34 42 58 
::c: 
c..:, (Ratio) ( 0 , 59 ) (0,72) (1,0) 
H 
~ -::c: 4 13 14 14 
~ 
( Ratio) (0,93) (1, 0 ) (1, 0) 
c::r: 
i:.u 5 34 41 47 
0... 
I 
(Ratio) ( 0 ,72) co,e1) I ( 1, D) 
Sum 121 16.1 198 
1-5 
































































































































































The linear relationship was most apparent at a high sensitivity 
setting of the densitometer (i.e.+ 500 mV full scale deflection as 
opposed to+ 1 or+ 2V). 
Peak heights are a measure of the stain intensity of the AChE band. 
Therefore, at low AChE concentrations, stain intensity or dye uptake 
should be proportional to the actual concentration of AChE. The in-
tensity of staining of fetal mouse brain AChE isoenzyme bands fell 
within this region of lower AChE concentrations above (see Fig. 5.10). 
The assumption was therefore made of a linear relationship between peak 
heights and AChE concentration for fetal mouse brain isoenzymes. The 
loss of linearity at high concentrations was explicable on the basis 
of excessive staining i.e. as the staining became denser the illumi-
nating light could no longer penetrate adequately (the problem was 
apparent on examining the darker bands in Fig. 5.10). 
There appeared to be an approximate linear relationship between peak 
heights and brain homogenate AChE concentration but this was not apparent 
for all the isoenzyme bands. The peak heights for bands 2 and 3 showed 
a 1 : 0,79 0,55 and 1 : 0,72 : 0,59 ratio respectively, which was com-
parable with the dilution ratio of 1 : 0,75 : 0,50. 
The ratios for the peak heights for bands 1, 4 and 5 were less comparable 
with the dilution ratios but the sum of the peak heights for all 5 bands 
had similar ratios to those of the dilutions (see Fig. 5.12). Band 4 
tended to be very faint, (see Fig. 5.12) particularly at the lower homo-
genate concentrations. The accuracy with which the densitometer could 
measure the intensity of this band against the relatively high background 
level, was therefore probably reduced quite considerably. 
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The peak heights for band 5 showed a 1 : 0,87 : 0,72 ratio. Although 
not a linear relationship there was nevertheless a relationship between 
peak height and concentration. The lack of a true linear relationship 
may be explained by the fact that band 5 was a rather poorly resolved 
band. Similarly, for band 1, although there was not a linear relation-
ship, a relationship between peak height and concentration was apparent. 
A lack of a true linear relationship in this instance is probably best 
explained by the higher proportion of interference from other peaks. 
From the above results for fetal mouse brain homogenate, it appeared 
that bands 2 and 3 and the sum of all 5 bands, and probably bands 5 
and 1, were likely to give reasonable AChE representations. If there 
was increased activity of band 4 a similar assumption could probably be 
made. 
5.8. POLYACRYLAMIDE GEL ELECTROPHORESIS OF THE ISOENZYMES OF 18 DAY C3H 
MOUSE BRAIN ACETYLCHOLINESTERASE : CONCLUSIONS 
a) Five distinct zones were apparent. 
b) Inhibition studies confirmed that the bands were AChE. 
c) The technique was reproducible. 
d) There was good separation and resolution of the bands, the best 
resolved being bands 2, 3 and 4. Bands 2 and 3 had the highest activity. 
e) The bands were suitable for densitometric analysis where 5 main peaks 
were demonstrable and corresponded well to the 5 zones on the gel. 
f) The assay gave a reasonable representation of AChE isoenzyme concen-
tration with bands 2 and 3 and the total sum of the peaks, and probably 
with band 5. 
g) The concentrations of the isoenzymes represented by peaks 1 and 4, 
however were probably difficult to measure since the peaks were short 
and their amplitude was much confounded by background scatter. 
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C H A P T E R 6 
A STUDY OF THE EFFECTS OF IN VIVO MATERNAL ADMINISTRATION OF 
LARGE DOSES OF VITAMIN A ON THE C3H MOUSE FETUS 
6 .1. INTRODUCTION 
A discussion on vitamin A as a teratogen, with particular reference to 
its effects on the developing CNS, has been given in section 1.3. 
The aims of this study were: 
i) To investigate the effects of vitamin A when administered 
during embryonic development, including an important period 
of CNS development, on gross fetal parameters in C3H mice 
including embryolethality, morphological abnormalities, fetal 
weight and brain weight; 
ii) to compare these with the effects on brain AChE and its 
isoenzymes, and with brain choline acetyltransferase; 
iii) to evaluate AChE as a biochemical marker of teratogenic 
injury; 
iv) to elucidate the teratogenic mechanisms of vitamin A 
with particular reference to the CNS. 
6.2. MATERIALS AND METHODS 
6.2.1. Experimental mice 
Timed matings were performed with young healthy virgin female C3H mice 
aged 8 - 12 weeks and weighing 20 - 23g, as described in section 2.4, 
and kept under standard experimental conditions (section 2.3). Over-
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night matings were performed for most experiments in the pilot study, 
but for the definitive study 2h matings were performed. For over-
night matings the following day was designated day~ of pregnancy. 
For 2h matings the day of copulation was designated day O p.c. 
nant females were randomly divided into test and control groups. 
6.2.2. Drug administration 
Preg-
Vitamin A was administered by gastric intubation using a 1ml Tuberculin 
syringe with a special blunt ended needle on one or more days from day 
7 - 13 p.c. The doses used were 1 000 - 50 000 IU vitamin A per mouse. 
An equal volume of arachis oil was administered to controls. 
6.2.3. Records of maternal and fetal parameters and statistical analysis 
Maternal parameters 
The weight on the day of mating, day of dosing and the day of sacrifice 
and the physical state of each mouse after dosing and before sacrifice 
were recorded. 
Fetal parameters 
Resorptions, intra-uterine deaths (IUD's) and gross morphological abnor-
malities were recorded in the preliminary study. These parameters were 
also recorded in the definitive study as well as fetal weight, brai.~ 
weight, brain AChE activity, and in some experiments AChE isoenzymes and 
choline acetyltransferase activity. 
Statistical analysis 
The incidence of resorptions, intra-uterine deaths and morphological ab-
normalities was compared with controls using the Chi-square two-tailed 
test. Fetal weights, brain weights and brain AChE values were compared 
with controls using the non-parametric Mann-Whitney U two-tailed test. 
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Medians and 95% confidence limits were calculated from the Walsh 
averages, after Tukey (.Steinijans and Diletti, 1983). 
6.3. PRELIMINARY EXPERIMENTS 
Aims 
As discussed in section 1.2. the toxic expression of a teratogenic agent 
may be influenced by the genotype of the conceptus, the developmental 
stage at the time of exposure, and the dose used. Guided by the experi-
mental literature, as presented in section 1.2, the susceptibility of the 
C3H inbred strain to vitamin A under the experimental conditions used was 
determined. The second aim of the study was to determine a suitable dosage 
range and time of administration of vitamin A for subsequent experiments 
with brain AChE with the following in mind: a) to find a suitable "sub-
teratogenic" dose using standard criteria of resorption rate, fetal death 
and morphological abnormalities; and b) to find a suitable teratogenic 
dose (without producing too high an incidence of resorption or IUD's which 
would preclude AChE analysis, and without producing an excessive incidence 
of gross CNS abnormalities which would be expected to be associated with 
enzyme changes). Further aims of the study were (i) to determine that the 
doses used were less than the minimal toxic dose for the mothers and (ii) 
to determine whether vitamin A per se affects AChE. 
The dose range of vitamin A chosen was 1 000 - SO 000 IU per mouse which 
from the literature was considered likely to give a spectrum of effects 
from non-teratogenic to embryolethal. The time of administration chosen 
was from day 8 to 10 p.c., generally a single administration, since this 
falls within an important period of CNS development (see section 1.2.) 
Dams were sacrificed and fetal parameters recorded on days 18 and 19 
p.c. Table 6.1. lists the preliminary experiments performed. 
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T A B L E 6. 1. 
VITAMIN A PRELIMINARY EXPERIMENTS 
Dose of Day of administration 
Vitamin A (post conception) 
so 000 9~ 
15 000 8~ and 9~ 
15 000 9~ 
10 000 9~ 
10 000 10 
5 000 9~ 
1 000 9~ 
6.3.1. Vitamin A, So 000 IU per mouse, administered on day 9~ p.c. 
Four C3H female mice were used in the test group and three in the 
control group. 
Results are shown in Tables 6.2T and 6.2C (pp. 327 and 328). 
Note Tables of original data are presented at the end of the thesis 
Postscript "T" attached to a Table number designates test group 
and "C" the control group. 
By the day of sacrifice the treated dams were noted to have become 
scrawny with hair loss suggesting a maternal toxic effect. All dams 
were pregnant but there was a 100% resorption rate with no live 
fetuses. In the control group there were 21 normal fetuses with one 
resorption and one intra-uterine death. 
123 
6.3.2. Vitamin A, 15 000 IU per mouse, administered on days 8~ and 
9~ p.c. 
Five mice were used in the test group and three in the control group. 
Results are shown in Tables 6.3T and 6.3C (pp. 329 and 330). 
Although the dams appeared to be healthy at the time of sacrifice 
there were 27 resorptions in the test group (96,4%) and only one live 
abnormal fetus with exophthalmos, a hypoplastic face and short tail. 
In the control group there were 17 fetuses, 16 of which were normal 
and one had exomphalos. 
6.3.3. Vitamin A, 15 000 IU per mouse, administered en day 9~ p.c. 
Five mice were used in the test group and four in the control group. 
Results are shown in Tables 6.4T and 6.4C (pp. 331-334). 
In the test group there were 21 fetuses. There was a 25,8% resorption 
rate compared with 3,7% in controls (p<0,001, Chi-square test), a 6,4% 
incidence of intra-uterine deaths which was not significant, and a 66,6% 
incidence of morphological abnormalities compared with 4,2% in controls 
(p<0,001). Abnormalities noted were exopthalmos, abnormal shaped head 
and absent or crooked tail. One fetus had a myelomeningocele and can 
best be described as a monster. In the control group there were two 
macerated IUD's, and one of the 24 live fetuses was abnormal with exom-
phalos. 
6.3.4. Vitamin A, 10 000 IU per mouse, administered on day 9~ p.c. 
Nine mice were used in the test group and eight in the control group 
(two separate experiments). 
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Results are shown in Tables 6.5T, 6.5C, 6.6T and 6.6C (pp. 335-339). 
In the test group there was a 13,4% resorption rate, a 2,4% incidence 
of intra-uterine deaths and 40,8% of fetuses had gross morphological 
abnormalities. The most common abnormality in 41% of 
the fetuses was proptosed eyes with open eyelids (exophthalmos), which 
was associated with a characteristic abnormal shape of the head (see 
Figs. 6.1. and 6.2. and compare with a normal fetus, Fig. 6.3). 
Two. fetuses were exencephalic. In the control groups there were 37 
fetuses, 36 of which were normal. One had exomphalos (Fig. 6.4). 
There were 7 resorptions (15,2%) and two intra-uterine deaths. 
6.3.5. Vitamin A, 10 000 IU per mouse, administered on day 10 p.c. 
(Two hour mating) 
Two separate experiments were performed, each with three mice in the 
- test group and three in the control group. 
Results are shown in Tables 6.7T, 6.7c, 6.8T and 6.SC (pp. 340-343). 
In the test group 64,7% of fetuses had gross morphological abnormalities. 
The most common abnormalities were defects of the tail which were either 
absent (Fig. 6.5i, short, broad or curled. There were 12,2% resorptions 
and 4,9% intra-uterine deaths. In the control group there were 43 
fetuses, all of which were normal, three resorptions and three intra-
uterine deaths. 
6.3.6. Vitamin A, 5 000 IU per mouse, administered on day 9~ p.c. 
Four mice were used in the test group and four in the control group. 
Fig. 6 .l. 
18-DAY FETUS WITH EXOPHTHALMOS AND ABSENT TAIL 
Mother treated with. 10 000 IU vitamin A on day 9~ post conception. 
Magnification x 3. 
Note: 
- exoph.thalmos 
- abnormal shaped head 
- shortened tail 
- shortened mandible 
- absent tail 
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Fig. 6 .2. 
~other treated with. 10 000 IU vitamin A on day 9~ post conception. 
Magnification x 22. 
Note: 
- protruding eyes (exophthalmos} 
- abnormal shaped head 
- (~rtifacts are air-bubbles) 
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Fig. 6.3. 
NORMAL 18-DAY FETUS 
Magnification x 5. 
Note: 
- shape of head 
- closed eye 
- normal tail 
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Fig. 6 .4. 
18-DAY FETUS WITH EXOMPEALOS 
Motlier untreated (sponta,neous abnormalityl. Magnification x 1,8. 
Note: 
""' herniation of intestines 
- short tail 
Fig. 6.5. 
18-DAY FETUS WITH ABSENT TAIL 
(MAGNIFIED VIEW OF FETAL HIND-QUARTERS} 
Mother treated with_ 10 000 IU vitamin A on day 10 post conception. 
Magnification x 20. 
Note.: 
absent tail with. probable unde.rlying me.ningocoele. 
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Results are shown in Tables 6.9T and 6.9C (pp. 344-346). 
In the test group there were 28 fetuses. Twenty-five were normal, 
two had slightly prominent eyes, possibly suggesting mild exophthalmos, 
and one fetus had exomphalos. There was one resorption and no intra-
uterine deaths. In the control group there were 27 fetuses, all normal 
(two pairs of twins were small), one intra-uterine death and one resorp-
tion. 
6.3.7. Vitamin A, 1 000 IU per mouse, administered on day 9~ p.c. 
Three mice were used in the test group and three in the control group. 
Results are shown in Tables 6.lar and 6.lOC (pp. 347-348). 
In the test group there were 19 fetuses, all normal, one resorption 
and one intra-uterine death. In the control group there were 18 normal 
fetuses, one resorption and one intra-uterine death. 
6.3.8. Study to determine whether doses of vitamin A used were below 
the minimal toxic dose level (M.T.D.) for the adult C3H females 
used. 
If an agent is toxic to the mother this maternal toxicity can obviously 
confound the fetal results. It was therefore important to know whether 
the doses of vitamin A used were below the M.T.D. for the C3H female 
mice used (see Section 2.9). Non-pregnant female C3H mice weighing 19 -
23g were removed from stock cages of 10 - 15 mice per cage and placed 
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3 per cage 10 days prior to dosing to enable adjustment to these conditions. 
Ten thousand IU vitamin A was administered to 15 animals on day o by gastric in-
tubation. Animals were numbered by means of ear-punching and kept 3 per cage 
under standard conditions. They were given food and water ad libitum and 
observed for signs of toxicity. The mice were reweighed 9 days after 
dosing (a commonly used time of sacrifice for pregnant females). 
Results 
No signs of toxicity or deaths were noted during the 9 days after dosing. 
Table 6.11. gives the mouse weights on the day of dosing (day 0) and on 
day 9 and the change in weight. Nine of the mice gained weight, in 3 
the weight remained the same and with 3 there was a slight reduction of 
o,4 - o,Sgms. 
These results suggest that a dose of 10 000 IU vitamin A did not have 
a significant toxic effect on adult C3H female mice. (A dose of 10 000 
IU was the maximum dose used in all but 2 subsequent experiments in this 
study). 
6.3.9. Experiment to determine whether vitamin A, independent of its 
teratogenic effects, alters brain AChE activity 
Vitamin A, 10 000 IU, which had been shown to be teratogenic when ad-
ministered on day 9 or 10 p.c., was administered on day 17 p.c. i.e. 
during the late period of fetogenesis when susceptibility to teratogenic 
effects is unlikely. The mice were sacrificed on day 19 p.c. 
Results are shown in Table 6.12T and 6.12C (pp. 349-350). A summary of 
results is given in Table 6.13. 
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There were no gross abnormalities in the treated group and no resorptions 
in either the test or control groups. There was no significant difference 
in brain AChE activity between tests and controls, nor in fetal nor brain 
weight. The absence of any difference in AChE between the group treated 
with vitamin A and controls suggests that vitamin A, independent of its em-
byrotoxic effects, does not alter fetal brain AChE activity. 
T A B L E 6.11. 
MOUSE WEIGHTS ON DAY OF ADMINISTPATION OF VITAMIN A (DAY 0) 
AND 9 DAYS LATER (DAY 9} 
WEIGHT IN GRAMS 
Day 0 Day 9 Weight Change 
21,5 21,5 0 
20,0 20,2 + 0,2 
19,5 19,8 + 0,3 
21,0 20,6 - 0,4 
19,5 20,0 + 0,5 
--
22,5 22,5 0 
20,0 22,0 + 2,0 
20,0 19,5 - o,5 
20,5 21,0 + 0,5 
22,0 21,5 - 0,5 
19,5 20,0 + o,5 
19,5 19,5 0 
21,5 22,0 + 0,5 
19,5 20,0 + o,5 
22,0 22,5 + o,5 
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T A B L E 6 .13. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A 
ADMINISTERED ON DAY 17 p.c. 
TEST CONTROL 
Total 
Conceptions 19 18 
Resorptions 
(%) 9,5 5,26 
Intra-uterine 
Deaths 0 5,26 
(%) 
Abnormalities 
(%) 5,26 0 
Median Fetal 1,28 1,285 
Weight (1,25 - 1,32) (l,25 - 1,32) 
(g) 
Median Brain 
Weight 84,88 83,85 
(mg) (83,2 - 85,9) (82,6 - 84,5) 
Median AChE 
Activity 3,36 3,265 
nmol/min/mg (3,25 - 3,43) (3,18 - 3,34) 
Figures in brackets are the 95% confidence range 










6.3.10. The basis for exophthalmos 
Exophthalmos was a striking and common abnormality induced by vitamin A. 
There is controversy in the literature regarding the basis of the 
anomaly and this was briefly examined. 
Materials and methods 
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After maternal administration of 10 000 IU vitamin A on day 9 p.c., fetu-
ses with exophthalmos, and normal control fetuses, were fixed in 10% 
neutral buffered formalin on day 18 p.c. Heads were processed for paraffin 
sections and cut at 7µm thickness before staining with haematoxylin and 
eosin. Frontal sections taken through the centre of the eyeball of treated 
fetuses were compared. Measurements were obtained with the aid of a MOP -
videoplan Image Analysis System (Kontron, Munich, West Germany). 
Results 
Fig. 6.6 and 6.7 are photographs of frontal sections through the centre of 
the orbit and eyeball of a normal fetus and of a fetus with exophthalmos, 
respectively. Although the exophthalmic eyeball appears normal it was shor-
ter than that of the normal eye (43,8mm versus 54,2mm, respectively), and the 
exophthalmic eye is obviously proptosed due to the shallow orbit (24,7mm 
versus 55,8mm of the control). 
Discussion 
The above findings are in agreement with those of Kalter and Warkany (1961) 
who suggested that the basis for exophthalmos induced by vitamin A in the 
fetal mouse was reduction in the size of the orbit, probably due to defective 
development of the facial skeleton. The eye itself was normal. Geelan (1979) 
also noted that the ocular bulb protruded due to underdevelopment of the 
orbit. The foregoing is at variance with the findings of Padmanabhang and 
Singh (1981) who intimated that exophthalmos in rat fetuses was due to an 
increased amount of primary vitreous and a larger retroretinal space. 
Fig. 6.6. 
Magnification x 40 
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- Eyelid 
layer of opti c cu_ 






Frontal section through the centre of the eyeball of a 
normal 18-day fetus 
Note: The closed eyelids 
The normal ocular bul b 




• - - Outer layer of optic cup 
,-Retina (inner layer of optic cup) 
- --Lens 
Magnification x 40 
length 
length 
Frontal section through the centre of the eyeball in an 18-day 
fetus with exophthalmos after maternal administration of 
10 000 IU vitamin A on day 9 p.c. 
Note: The open eyelid 
The proptosed eye 
The grossly normal ocular bulb 
The shallow orbit 
6.3.11. Discussion and Conclusions of Preliminary Experiments 
Table 6.14 gives a ~ummary of the effects of vitamin A on fetal outcome 
and the level of significance. Table 6.15 gives the details of the 
gross abnormalities produced by vitamin A. 
A single dose of 10 000 IU vitamin A administered on day 9~ or on day 
10 p.c. was obviously teratogenic with a 40,8% and 64,7% incidence of 
abnormalities respecti•Iely, compared with 2, 7% and 0% in controls 
(p = 0,(X)l, Chi-square test). The most common abnormality with dosage 
on day 9~ p.c. was exophthalmos which was present in 41% of fetuses. 
Other abnormalities were exencephaly (4,1%) and absent tail (8,2%). 
Dosage on day 10 resulted mainly in tail abnormalities, which were 
present in 50% of fetuses. Exophthalmos was present in 5,9% and nasal 
blebs in 8,8% (! 1mm cystic blebs, one on either side of the midline 
over the maxillo-frontal region. These were not observed as spontaneous 
abnormalities and were a feature of vitamin A embryotoxicity). 
With a dose of vitamin A of 1 000 IU on day 9~ p.c. there were no 
morphological abnormalities, one resorption and one intra-uterine 
death which was no different to controls (p = o,5, Chi-square test). 
Although a small sample the results suggested that 1 000 IU was not a 
teratogenic dose. 
With.a dose of 5 (X)O IU on day 9~ p.c. there was no significant 
difference in the incidence of resorptions or intra-uterine deaths 
but the presence of slightly prominent eyes in two of the fetuses, 
perhaps indicating mild exophthalmos, may have suggested a teratogenic 
effect in these two fetuses. 
A dramatic increase in resorption rates was apparent with increasing 























































































































































































































































































































































































































































TABLE NO. 6.15. 
PRELIMINARY EXPERIMENTS : GROSS MORPHOLOGICAL ABNORMALITIES 
PRODUCED BY VITAMIN A 
DOSE IU 10 000 15 000 10 000 
Day of 
9~ 9~ 10 Dosing 
Tot.al no. 
of Fetuses 49 21 34 
No. % No. % No. % 
Exencephaly 2 4,1 0 0 0 0 
Exophthalmos/ 20 41 11 52,4 2 5,9 
abnormal (.3 pro-
shaped head minent 
eyes) 
Exomphalos 2 4,1 0 0 2 5,9 
Tail 
abnormalities 4 8,2 0 0 17 so 
Nasal blebs 0 0 0 0 3 8,8% 
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with 15 000 IU on day 9~ p.c. to .96,4% with 15 000 on days 8~ and 9~ 
p.c. and 100% with 50 000 IU on day 9~. For the purposes of studying 
brain enzymes these latter two doses were therefore unsuitable. The 
resorption rates of 13,4% and 12,2% with 10 000 IU were higher than 
those with 1 000 and 5 000 IU (4,7% and 0%) and are compatible with an 
embryolethal effect, although the wide variation in resorption rates 
observed in controls (3,4 - 15,2%) precludes any meaningful conclusion. 
There was no significant difference in the incidence of intra-uterine 
deaths compared with controls with any of the doses used (the 96,4% 
and 100% resorption rate with 30 000 and 50 000 IU precluded the possi-
bility of IUD's). 
With doses of vitamin A up to 10 000 administered on day 9~ or 10 p.c., 
gross morphological abnormalities were a useful indicator of a terato-
genie effect. Dysmorphogenic effects (Table 6.15} differed between 
dosing on day 9~ (exophthalmos in 41% of fetuses, exencephaly in 4,1% 
and tail abnormalities in 8,2%) and day 10 (tail abnormalities in 50% 
of fetuses, exophthalmos in 5,9% and nasal blebs in 8,8%). This is con-
sistent with the different developmental stages at the time of exposure. 
The dosage range of vitamin A selected for further experiments was 
1 000 - 10 000 IU, which appeared to be below the M.T.D. for adult C3H 
mice. One thousand IU on day 9~ p.c. appeared to be non-teratogenic. 
This was considered to be a useful dose for determining whether a "sub-
teratogenic"dose for gross fetal abnormalities might still be associated 
with a biochemical abnormality, such as a change in AChE. Five thousand 
IU on day 9~ p.c. was possibly teratogenic, whereas merely doubling the 
dose to 10 000 IU on day 9~ or 10 p.c. was obviously teratogenic. Ten 
thousand IU administered on day 9~ or 10 p.c. was therefore considered a 
suitable teratogenic dose. 
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It was apparent that dosing on a single day i.e. day 9 or 10 with 
vitamin A was adequate to produce teratogenic effects. However, for the 
definitive study dosing was also performed on more than one day, to 
enable longer fetal exposure to the teratogen, and also on various days 
of gestation to compare the effects during different developmental 
stages. 
Although fetal weight is another useful parameter for monitoring em-
bryotoxic effects fetuses were not weighed in the above experiments. 
The incidence of morphological abnormalities, resorptions and intra-
uterine deaths was adequate for the purposes of this preliminary study. 
However, for further definitive studies all fetal and brain weights were 
recorded. 
The only gross macroscopically apparent spontaneous abnormality among 
controls was exomphalos (herniation of the intestines through a defect 
in the anterior abdominal well), present in 2 of all fetuses. Exompha-
los was also present in 4 of all test fetuses. 
6.4. RESULTS OF DEFINITIVE VITAMIN A STUDIES 
Tables of original data are presented at the end of the thesis. 
Summary Tables are given with the text. 
Table 6.16. shows the doses used, the day(s) of administration and the 
day of sacrifice and the specific assay performed. 
6.4.1. Vitamin A, 1 000 IU per mouse, administered on day 9 p.c. 
(sacrifice day 18) 
See Tables 6.17T and 6.17C for original data (pp. 351-354). 
Summary of results in Table 6.18. 
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T A B L E 6.16. 
VITAMIN A STUDY : SUMMARY OF EXPERIMENTS PERFORMED SHOWING 
DOSE OF VITAMIN A, DAY OF ADMINISTRATION AND SACRIFICE, 
AND THE SPECIFIC ASSAY PERFORMED 
Dose of Day(s) of Day of 
Vitamin Administration Sacrifice Assay 
A (I.U.) 
l 000 9 18 Whole brain AChE 
5 000 9 18 II 
5 000 10 14 II 
5 000 10 12 II 
10 000 10 18 II 
10 000 10 19 11 
10 000 13 18 II 
10 000 9 19 II 
10 000 9 12 11 
10 000 9 18 Cerebellum AChE 
10 000 9 18 II 
10 000 9 18 Cortex AChE 
5 000 8,9 19 * 
7 500 8 19 * 
2 500 7,8,9 18 * 
2 500 7,8 19 * 
3 000 8,9 18 Whole brain AChE 
10 000 10 18 Total protein content 
10 000 10 18 Whole brain ChAT 
15 000 10 18 11 
10 000 10 18 Isoenzymes 
* Embryolethality precluded AChE assay. 
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T A B L E 6 .18. 
SUMMARY OF RESULTS OF 1 000 IU VITAMIN A 
ADMINISTERED ON DAY 9 p.c. 
TEST CONTROL 
Total 
Conceptions 31 32 
Resorptions 
(%) 3,2 3,1 
Intra-uterine 
Deaths 10,0 3,1 
(%) 
Abnormalities 
(%) 0 0 
Median Fetal 
Weight 0,866 0,85 
(g) 
(0,83 - 0,92) (0,81 - 0,87) 
Median Brain 
Weight 63,6 62,35 
(mg) 
(61,5 - 65, 7) ( 61, 3 - 63 ,4) 
Median AChE 
Activity 2,25 2,32 
nmol/mir../mg 
(2,15 - 2,45) (2, 28 - 2,37) 
Figures in brackets are the 95% confidence range 











There were no signs of maternal toxicity in this or any of the 
subsequent experiments with vitamin A in this chapter. Weight gain 
appeared similar after dosing to that of controls but was not statis-
tically compared because of the small numbers in each group. 
There were no gross morphological abnormalities. There was one resorp-
tion in the test group and one in the control group, and there were 
three intra-uterine deaths in the test group and one in the control 
group. There was no significant difference in fetal weight, brain weight 
or brain AChE compared with controls. 
Discussion 
There was no significant difference in any of the above six parameters 
compared with. controls. As was suggested by the pilot study a single 
dose of 1 O(X) IU vitamin A administered on day 9 p.c. did not appear 
to be teratogenic. 
6.4.2. Vitamin A, 5 (X)Q IU per mouse, administered on day 9 p.c. 
(sacrifice day 18) 
See Tables 6.19T and 6.19C for original data (pp. 355-357). 
Summary of results in Table 6.20. 
Two of the fetuses in the test group had exophthalmos and one was a 
runt. In the control group two of the fetuses were runts and had a 
slight abnormality in th.e form of a haemorrhagic bullus over the dorsal 
midline of the nose. There were five resorptions in the test group and 
three in the control group. There were three intra-uterine deaths in 
the test group and none in the control group. No significant difference 
was apparent in fetal weight, brain weight or brain AChE compared with 
controls. 
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T A B L E 6.20. 
SUMMARY OF RESULTS OF 5 000 IU VITAMIN A 
ADMINISTERED ON DAY 9 p.c. 
TEST CONTROL 
Total 
Conceptions 30 23 
Resorptions 
(%) 16,7 13,0 
Intra-uterine 
Deaths 10,0 0 
(%) 
Abnormalities 
(%) 9,1 0 
Median Fetal 
Weight o,97 1,012 
(g) 
(0,92 - 1,03) (0,96 - 1,06) 
Median Brain 
Weight 71,0 70,0 
(mg) (67, 7 - 72,3) ( 66 , 5 - 72 , 3) 
Median AChE 2,69 2,75 
Activity 
(2 ,60 - 2, 79) ( 2 I 68 - 2 t 81) nmol/min/mg 
Figures in brackets are the 95% confidence range 











From the pilot study and subsequent studies exophthalmos was a chara-
teristic abnormality induced by vitamin A when administered on day 9 
p.c. and was never observed in control animals. A gross teratogenic 
effect was therefore apparent in two of the treated fetuses. How-
ever there was no significant difference in brain AChE activity nor 
' 
fetal or brain weight of treated animals compared with controls. The 
three intra-~terine deaths in the test group compared with none in the 
control group (p = 0,1) could have been due to an embryotoxic effect 
of vitamin A, but as many as three IUD's have been noted in the same 
sized sample of untreated animals in other experiments and is therefore 
of questionable significance. Similarly, the five resorptions in the 
test group compared with three in the control group could be explained 
on either basis. The presence of gross abnormalities in only two fetuses 
in the absence of any other significant effects could have indicated that 
this dose of vitamin A exerted a teratogenic effect only on a small num-
ber of highly susceptible fetuses with no effect on the majority of 
fetuses. Alternatively, if the dose response curve for biochemical 
changes was close to that for malformations a low teratogenic response 
with regard to malformations would be expected to be associated with a 
low incidence of biochemical changes. Further larger studies to increase 
the chance of achieving statistical significance were not performed. 
Another explanation for the lack of a significant change in AChE with 
lower doses of vitamin A i.e. 1 000 and 5 000 IU is that repair of 
any teratogenic damage to the CNS could have, been complete by the time 
of sacrifice (day 18 p.c.) (see section 1.1). Sacrifice was therefore 
performed earlier (day 14) in the next experiment. 
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6.4.3. Vitamin A, 5 000 IU per mouse, administered on day 10 p.c. 
(sacrifice day 14) 
Because of the technical difficulty of removing brains from such minute 
friable 14-day fetuses and because most of the head is occupied by the 
developing brain at this age, whole heads were assayed for AChE activity. 
Decapitation was performed by a horizontal incision in line with the 
bottom of the lower jaw. 
See Tables 6.21T and 6.21C for original data (pp. 358-359). 
A summary of results is given in Table 6.22. 
There were two resorptions in the test group and two in the controls. 
No gross morphological abnormalities were apparent but because of the 
small size of the fetuses minor abnormalities might have been missed. 
Compared with controls, no difference in fetal weight, head weight or 
AChE activity was established. 
Discussion 
As with sacrifice on day 19 there was no significant difference in AChE 
compared with controls. It would therefore appear unlikely that repair 
accounted for the normal AChE activity, unless repair was complete by 
day 14. Of note was the lower AChE activity in 14-day fetuses compared 
with 18 or 19 day fetuses (approximately 1/3). Although this is expli-
cable on the basis of the younger age and more immature nervous system 
(see section 3.3) using the whole head would have contributed some 
dilutional effect. Unfortunately, this lower enzyme activity made 
demonstration of subtle changes in AChE levels more difficult. 
Because of the possibility that repair might have been complete by day 
14, in the next experiment sacrifice was performed earlier on day 12. 
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TABLE 6.22. 
SUMMARY OF RESULTS OF 5 000 IU VITAMIN A ADMINISTERED 
ON DAY 10 p.c. (SACRIFICED DAY 14 p.c.) 
TEST CONTROL 
Total 
Conceptions 24 24 
Resorptions 
(%) 8,3 8,3 
Intra-uterine 
Deaths 0 0 
(%) 
Abnormalities 
(%) 0 0 
Median Fetal 
Weight 182,5 187,8 
(mg) (174,0 - 191,01) (181,0 - 194,0) 
Median Head 
Weight 66,50 68,55 
(mg) (66,95 - 70,85) (65,45 - 70,90) 
Median AChE 
Activity 1,017 1,033 
::mol/mi.."1/~g (0,96 - l,06) 
I 
(l ,O - 1,06) 
Figures in brackets are the 95 % confidence rang_e 










6.4.4. Vitamin A, 5 000 IU per mouse, administered on day 10 p.c. 
(sacrifice day 12) 
See Tables 6.23T and 6.23C for original data (pp. 360-361). 
A summary of results is given in Table 6.24. 
There were no resorptions in the test group and two in the controls. 
No gross morphological abnormalities were apparent and there were no 
IUD's. The fetal weight of 72,1mg was higher for test animals than 
for controls (64,4mg, p<0,05), although the difference in head weights 
(22,8 and 19,4mg respectively) was not significant. There was no 
proven difference in AChE activities between test and controls. 
Discussion 
The higher fetal weight is not readily explicable. (It could have 
occurred by chance, or possibly by some transient phenomenon such as 
mild fetal oedema induced by vitamin A. No difference in fetal weights 
was apparent on day 14 in the previous experiment}. 
Examination of fetuses 48h after dosing reduced the possibility that 
repair of any CNS damage might have accounted for an absence of altered 
AChE activity. However, as already mentioned, using the whole head, 
and with the lower enzyme activity of the younger embryos, small changes 
might have been missed. 
6.4.5. Vitamin A, 10 000 IU per mouse, administered on day 10 p.c. 
(sacrifice day 18 and 19) 
At this stage I decided to proceed with experiments using an obviously 
teratogenic dose i.e. 10 000 IU vitamin A. Two consecutive experiments 
were performed. 
See Tables 6.25 and 6.26 for original data (pp. 362-368). 
A summary of results is given in Tables 6.27 and 6.28. 
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T A B L E 6.24. 
SUMMARY OF RESULTS OF 5 000 IU VITAMIN A ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 12 p.c.) 
TEST CONTROL 
Total 
Conceptions 20 20 
Resorptions 
0 9,1 (%) 
Intra-uterine 
Deaths 0 0 
(%) 
Abnormalities 0 0 
(%) 
Median Fetal 
Weight 72,1 64,4 
(mg) (67,9 - 75,0) (57 ,2 - 70,1) 
Median Head 
Weight 22,8 19,4 
(mg) 
(20,4 - 24,8) (17,1 - 21,6) 
Median AChE 
Activity 0,75 0,78 
n.mol/mL .. /mg 
(0, 72 - 0,80) (0, 75 - 0,85) 
Figures in brackets are the 95% confidence range 











SUMMARY OF RESULTS OF 10 000 IU VITAMIN A ADMINISTERED 
ON DAY 10 p.c. (FIRST EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 32 29 
Resorptions 
(%) 9,4 6,9 
Intra-uterine 
Deaths 9,4 10,3 
(%) 
Abnormalities 
(%) 42,3 · 0 
Median Fetal 
Weight 1,025 1,004 
(g) (0,975 - l,,061J (0,98 - 1,035) 
Median Brain 
Weight 72,7 68,2 
(mg) (70,2 - 74,9) (67 ,o - 69 ,4) 
Median AChE 
Activity 3,155 2,995 
nmol/min/mg 
I 
(3,02 - 3,25) (2,93 - 3,05) 
Figures in brackets are the 95% confidence range 











SUMMARY OF RESULTS OF 10 000 IU VITAMIN A ADMINISTERED 
ON DAY 10 p.c. (SECOND EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 27 23 
Resorptions 
(%) 11,1 8,7 
Intra-uterine 
Deaths 7,4 0 
(%) 
Abnormalities 
(%) 54,S 0 
Median Fetal 
Weight 1,227 1,258 
(g) 
(1,168 - 1,27) (1,16 - 1,32) 
Median Brain 
Weight 86,65 84,6 
(mg) (84,5 - 88,4) (80, 2 - 87, 1) 
Median AChE 
Activity 3,55 3,185 
nmol/min/mg ( 3, 40 - 3, 61) (3,04 - 3,34) 
Figures in brackets are the 95% confidence range 










Although there was no difference in the rate of resorptions or intra-
uterine deaths, the incidence of gross abnormalities in the test groups, 
42,3% in the first experiment and 54,5% in the second experiment, was 
higher than controls(p<0,01). The most common gross abnormality was a 
defect of the tail, (50%) which was either absent, short, broad or 
curled. Two fetuses had exophthalmos (4,2%),9 (18,8%) had nasal blebs 
(1mm cystic blebs on either side of the midline over the maxilla) and 
10 fetuses (20%) had shortened forelimbs. 
In the first experiment the median fetal weight for treated fetuses was 
higher (1 025mg) than controls (1 004mg), although this was not sig-
nificant. In the second experiment the median fetal weight was lower 
for test animals (1 227mg) than controls (1 258mg), but this was also 
not significant. No conclusion can therefore be drawn. 
The median brain weight of 72,7mg in the treated group in the first 
experiment was significantly higher than in controls (68,2mg, p = 0,001), 
but no difference in brain weight was established in the second experiment. 
In the first experiment the median brain AChE activity in the treated 
fetuses of 3,20nmol/min/mg was significantly higher than in controls 
(2,99nmol/min/mg, p = 0,005). In the second experiment median brain 
AChE activities of test and control fetuses were 3,55 and 3,19nmol/min/mg 
respectively (p<0,0005}. The difference in AChE activity in the test 
and control groups in the second experiment is demonstrated graphically 
in Fig. 6.8. The well defined population of treated fetuses with higher 
brain AChE activity is apparent. 
Discussion 





















Fig. 6 .8. 
TEST 
n =22 
AChE ACTIVITY IN FETAL MOUSE BRAIN 
(10000 IU VITAMIN A ADMINISTERED 10 DAYS p.c.) 







2,6 2,8 3,0 3,2 3,4 3,6 3,8 
AChE ACTIVITY (nmol/min/mg) 
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tions or intra-uterine deaths in the treated group compared with controls 
demonstrated that a dose of 10 000 IU vitamin A administered on day 10 was 
not embryolethal. (However, subsequent experiments showed that smaller 
doses administered l to 3 days earlier could be embryolethal, resulting 
in a 100% resorption rate). 
The high incidence of gross malformations (42,3% and 54,S%)respectively 
compared with none in controls, confirmed the teratogenicity of this 
dose and time of administration of vitamin A, as was noted in preliminary 
experiments (section 6.3.5.) 
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There was no proven difference in fetal weights between the test and control 
groups and this suggested that 10 000 IU vitamin A on day 10 p.c. did not 
have an effect on fetal growth. It also indicated that embryotoxicity 
associated with maternal nutritional deprivation of ·the fetus, either at a 
placental or other level, was unlikely. In the face of no significant 
difference in fetal weights the significantly higher brain weights in the 
test group in the first experiment is difficult to explain (in the second 
experiment there was no significant difference in brain weights). 
The significant increase in brain AChE activity in the treated group in 
both experiments may have been the result of a teratogenic effect of 
vitamin A on the CNS. It was unlikely that this increase in AChE was 
related to an effect on fetal growth since no difference in fetal weights 
of treated fetuses compared with controls was established. However, it 
is possible that the increase in AChE was related in part to an increase 
in brain weight because brain weight was significantly increased in the 
first experiment, and the median brain weight (86,65mg) was greater than 
controls (84,6mg) in the second experiment although this was not significant. 
Acetylcholinesterase is a protein and the possibility that its increase 
was a reflection of a general increase in brain protein content, which 
may have accounted for the increased brain weight, was considered and pur-
sued in section 6.5. 
Another potential mechanism for the increase in AChE activity was relative 
sparing of cholinergic neurons from the CNS damage of the teratogen, or 
more rapid repair of cholinergic neurons, compared with other neuronal 
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cell types such as neuroblasts. Investigations with another enzyme involved 
in the cholinergic system, choline acetyltransferase were performed in an 
attempt to help elucidate this possibility (see section 6.6). 
To determine whether the increase in AChE activity was associated with a 
particular isoenzyme, the isoenzymes of AChE were analysed (see section 
6. 7) • 
The increased AChE cannot be explained on the basis of increased blood 
in the brain (compare 12 day fetuses treated with cyclophosphamide -
see Chapter 7). Milligram for milligram the blood of 18-day fetuses has 
a substantially lower AChE activity than brain and any increase in blood, 
for example with haemorrhagic necrosis would be expected to decrease AChE. 
Having demonstrated that a significant increase in brain AChE was produced 
by administration of 10 000 IU vitamin A on day 10 p.c. the effect of 
administration later in gestation, during the period of fetogenesis when 
the CNS is less likely to be sensitive to teratogenic insults, and the 
effect of 10 000 IU or smaller doses of vitamin A administered on one or 
more days earlier in gestation, when the CNS is likely to be more vulnera-
ble, was determined. 
6.4.6. Vitamin A, 10 000 IU per mouse, administered on day 13 p.c. 
(sacrifice day 18) 
Vitamin A 10 000 IU, which had now been shown to be teratogenic and 
associated with a change in brain AChE when administered on day 10 p.c., 
was administered later in gestation on day 13 p.c. 
See Tables 6.29T and 6.29C for original data (pp. 369-370). 
Summary of results in Table 6.30 
There were no resorptions, two intra-uterine deaths in the test group 
and one in the control group, and no gross abnormalities in either group. 
There was no significant difference in fetal weight, brain weight or brain 
AChE activity. 
Discussion 
The absence of any significant differences between test and controls 
suggested an absence of any teratogenic effect. This is in keeping with 
the concept that the fetus is less susceptible to embryotoxic effects 
when exposed later in gestation. 
6.4.7. Vitamin A, 10 000 IU per mouse, administered on day 9 p.c. 
(sacrifice day 19) 
See Tables 6.31T and 6.31C for original data (pp. 371-373). 
Summary of results in Table 6.32. 
This experiment was performed to compare the effects of dosing a day 
earlier during the period of brain development. 
There were four resorptions iu the test group and none in the control 
group (.p~O,l), two intra-uterine deaths in the test group and none , in 
the control group. All the fetuses in the treated group were abnormal. 
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T A B L E 6.30. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A 
ADMINISTERED ON DAY 13 p.c. 
TEST CONTROL 
Total 
Conceptions 21 22 
Resorptions 
(%) 0 0 
Intra-uterine 
Deaths 9,5 4,5 
(%) 
Abnormalities 
(%) 0 0 
Median Fetal 
Weight 0,985 o,97 
(g) (QI 94 - 1, 03) (0, 92 - 1,03) 
Median Head 
Weight 74,2 71,8 
(mg) (71,0 - 76,8) (68, 5 - 74, 2) 
Median AChE 
Activity 2,48 2,44 
nmol/min/mg (2,37 - 2, 60) 
I 
(2,37 - 2,53) 
Figures in brackets are the 95 % confidence range 











SUMMARY OF RESULTS OF 10 000 IU VITAMIN A 
ADMINISTERED ON DAY 9 p.c. 
TEST CONTROL 
Total 
Conceptions 27 19 
Resorptions 14,8 0 
(%) 
Intra-uterine 
Deaths 7,4 0 
(%) 
Abnormalities 100 0 
(%) 
Median Fetal 
Weight 1,16 1,25 
(g) (l, 10 - 1,22) (1,2 - 1,32) 
Median Brain 
Weight 78,40 82,73 
(mg) (74,75 - 82, 1) (80,55 - 84, 5) 
Median AChE 
Activity 3,375 3,375 
nmol/min/mg 
( 3 I 30 - 3 I 4 7) (3,30 - 3,45) 
Figures in brackets are the 95% confidence range 










The main abnormalities were exophthalmos and tail defects. Two fetuses had 
spina bifida. The median fetal weight of test animals (1 160mg) was lower 
than that of controls (1 250mg p = 0,055). Median brain weight was also 
lower for tests (78,4mg) compared with controls (82,73mg, p = 0,067). 
There was no significant difference in brain AChE activity in the treated 
group. 
Discussion 
In the face of an increased AChE activity with 10 000 IU vitamin A ad-
ministered on day 10, the absence of any significant difference in AChE 
activity in treated animals compared with controls in this experiment was 
at first sight surprising, especially in view of the higher incidence of 
gross morphological abnormalities, which suggested a more pronounced 
teratogenic effect of the vitamin when administered on day 9. However, 
the lower fetal and brain weights in the treated group suggested some 
growth inhibitory effect which is consistent with the findings of others 
(Kochar, 1968; Morriss and Steele, 1974; 1978). This would be expected 
161 
to be associated with a lower AChE activity (see cyclophosphamide experiments , 
Chapter 7) but could have been offset by another effect of vitamin A, which 
in the previous experiment was associated with an increase in enzyme acti-
vity, the net result reflecting no significant change. 
Alternatively, just as dysmorphogenic manifestations on day 10 are different 
to those on day 9, biochemical changes might also differ. If biochemical 
repair in the brain was complete by the time of sacrifice (despite the per-
sistence of other gross morphological abnormalities) no change in AChE ac-
tivity would have been anticipated. To attempt to determine whether the 
absence of any significant change in AChE in the previous experiment was due 
to repair (and return to normal of the enzyme by the time of sacrifice), 
fetuses were examined earlier on the 12th day post conception in the 
following two experiments. 
The possibility also exists that changes in enzyme activity may vary in 
different parts of the brain, such that an increase in one area may be 
offset by a decrease in another, resulting in no net change in total 
brain activity. Specific brain areas were therefore examined (see 
sections 6.4.9. and 6.4.10). 
6.4.8. Vitamin A, 10 000 IU per mouse, administered on day 9 p.c. 
(sacrifice day 12) 
See Tables 6.33T and 6.33C (pp. 374 and 375) for original data of the 
first experiment. 
See Tables 6.35T and 6.35C (pp. 376 - 378) for original data of second 
experiment. 
Summary of results in Tables 6.34. and 6.36. 
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There was no difference in the incidence of resorptions in either experiment. 
No intra-uterine deaths or fetal abnormalities were noted in the first ex-
periment. In the second experiment there were three IUD's in the one preg-
nancy with haemorrhagic, necrotic fetal tissue and blood stained amniotic 
fluid, and in three of the viable fetuses abnormal shaped heads were noted 
and one fetus had a hypoplastic face. These features were all consistent 
with a teratogenic effect of vitamin A. There was no significant difference 
in fetal weight, brain weight or head AChE activity between tests and controls 
in either experiment. 
Discussion 
These results tended to exclude the possibility that the absence of any 
significant difference in head AChE activity in treated fetuses compared 
with controls in the previous experiment was due to repair, since repair 
is less likely to be complete by day 12 compared with day 18. However, 
repair appears to be a rapid process and the possibility exists that it 
T A B L E 6. 34. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A ADMINISTERED ON 
DAY 9 p.c. (SACRIFICE DAY 12 p.c.) (FIRST EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 24 24 
Resorptions 
(%) 0 4,2 
Intra-uterine 
Deaths 0 0 
(%) 
Abnormalities 
(%) 0 0 
Median Fetal 0,075 0,073 
Weight (0,07 - 0,078) (0 ,067 - 0,078) 
(g) 
Median Brain 30,5 28,05 
Weight 
(mg) (29,2 - 32,3) (25,3 - 31,0) 
Median AChE 
Activity 0,669 0,718 
nmol/min/mg (QI 64 - QI 72) (0,65 - 0,80) 
Figures in brackets are the 95% confidence range 










T A B L E 6.36. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A ADMINISTERED ON 
DAY 9 p.c. (SACRIFICE DAY 12 p.c.) (SECOND EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 23 21 
Resorptions 
0 0 (%) 
Intra-uterine 
Deaths 13,0 4,8 
(%) 
Abnormalities 
(%) 20 0 
Median Fetal 
Weight 0,07 0,073 
(g) (0,066 - 0,072} co ,069 - 0,078) 
Median Head 
Weight 23,38 25,65 
(mg) 
(21,05 - 26 ,OS) (23,9 - 27,65) 
Median AChE o,761 0,845 
Activity (0, 68 - 0 ,82) (0, 76 - 0,93) 
nmol/min/mg 
Figures in brackets are the 95% confidence range 










could have been accomplished within 72 hours (Langman et al., 1980}. 
Because of the technical difficulty in assessing brain or head AChE 
in younger fetuses this avenue was not pursued further. 
6.4.9. Vitamin A, 10 000 IU per mouse, administered on day 9 p.c. 
(sacrifice day 18 p.c.) Determination of cerebellar AChE 
activity 
Two experiments were performed. 
See Tables 6.37T, 6.37C, 6.39T and 6.39C for original data (pp. 379-384). 
Summary of results in Tables 6.38. and 6.40. 
The cerebellum was dissected free in toto from adjoining brain with a 
small spatula and weighed, solubilised and homogenised as for whole brain 
(_section 2. 8} . 
No difference in the incidence of resorptions or intra-uterine deaths in 
the treated group was proven in either experiment compared with controls. 
There was a 85,7% and 100% incidence of malformations respectively com-
pared with 0% in controls. Median fetal weights of test fetuses were sig-
nificantly lower (1,026g and 0,930g) than controls (1,086g and 1,036g, 
p<0,02 and 0,003 respectively), although there was no significant 
difference in brain weight, cerebellar weight or cerebellar AChE activity 
of vitamin A-treated fetuses compared with controls. 
Discussion 
See discussion in section 6.4.10. 
6.4.10. Vitamin A, 10 000 IU per mouse, administered on day 9 p.c. 
(sacrifice day 18 p. c . ) Determination of AChE activity in 
cerebral cortex 
See Tables 6.41T and 6.41C for original data (pp. 385-387). 
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T A B L E 6. 38. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A ADMINISTERED 
ON DAY 9 p.c. (SACRIFICE DAY 18) FIRST EXPERIMENT 
TEST CONTROL p 
Total 
Conceptions 25 23 -
% 
Resorptions 4,0 4,3 N .S. 
% 
Intra-uterine 
Deaths 12,0 0 < 0,001 
% 
Abnormalities 85,7 0 < 0,001 
Median Fetal 
Weight (g) 1.,026 1,086 < 0,02 
(0,92-1,14) (1,03-1,16) 
Median Brain 
Weight (mg) 69,4 70,6 N.S. 
(57 ,1-79,2) (63,2-76,1) 
Median Cerebellar 




nmol/min/mg 4,24 4,28 N.S. 
(3,7-5,5) (3 ,8-4,6) 
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T A B L E 6.40. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A ADMINISTERED 
ON DAY 9 p.c. (SACRIFICE DAY 18) SECOND EXPERIMENT 
TEST CONTROL p 
Total 22 20 
Conceptions 
% 
Resorptions 0 0 N.S. 
% 
Intra-uterine 




Abnormalities 100 0 < 0,001 
Median Fetal 
Weight (g) 0,930 1,036 0,003 
(0, 79-1,06) (0,9 - 1,11) 
Median Brain 
Weight (g) 69,l 74,l N.S. 
(60,4-75,4) (67,5-78,8) 
Median Cerebellar 
Weight (mg) 25,0 27,0 N.S. 
(21 5-28 4 l (25.0-30-0l 
Median Cerebellar 
AChE Activity 
nmol/min/mg 3,98 4,01 N.S. 
C 3. 5-4 53) (3.6-4 631 
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Summary of results in Table 6.42. 
Using blunt dissection the cerebral cortices were separated from the 
underlying corpus callosum and adjacent brain, and weighed, solubilised 
and homogenised as for whole brain (section 2.8). There was no signi-
ficant difference in the incidence of resorptions or intra-uterine deaths 
compared with controls. Median fetal weights of test fetuses were sig-
nificantly lower than controls (0,975g and 1,041g respectively, 
po, 006 ) , although there was no significant difference in brain weight 
or cerebral cortical weight or AChE activity compared with controls. 
Discussion 
The specific brain areas used were the cerebellum and cerebral cortex 
owing to the small size of fetal mouse brains and because these are 
ontogenetically newer CNS areas than, for example, the mid brain or brain 
stem, which are more likely to be sensitive to teratogenic insults. 
The absence of a change in whole brain AChE activity in the presence of 
differences in specific brain areas has been noted by other workers. 
Eckhert, Barnes and Levitzky (1976) found changes in rat forebrain and 
brain stem AChE activity in opposite directions which cancelled out one 
another, resulting from undernutrition during development. Furthermore, 
the effect of another teratogenic agent, X-radiation on rat brain AChE 
activity was found to depend on the brain region, the cerebellum showing 
more marked alteration than the cortex (Valcana and Timiras, 1974). In 
the present study, however, a teratogenic dose of vitamin A was not 
associated with a change in AChE activity in either the cortex or the 
cerebellum and the absence of a change in the whole brain in section 6.4.7. 
cannot be ascribed to a differential effect in these brain regions. 
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T A B L E 6.42. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A ADMINISTERED 
ON DAY 9 p.c. (CORTEX EXPERIMENT) 
TEST CCNI'ROL p 
Total 
Conceptions 23 21 -· 
Resorptions 
(%) 0 0 NS 
Intra-uterine 
Dea~hs 4,3 4,8 NS 
. ( %) 
Abnormalities 
(%) 100 0 <0,001 
Median Fetal 0,975 1,041 0,006 
Weight 
(0,929 - 1,014) (1,009 - 1,068) (g) 
Median Cortex 29,1 28,1 NS 
Weight 
(27 ,4 - 30,6) (25,9 - 31,0) (mg) 
Median AChE 0,557 o,539 NS 
Activity 
(0,51 - 0,61) (0,48 - 0,61) nmol/min/mg 
Figures in brackets are the 95% confidence range 
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The AChE activity of cerebellum of approximately 4runol/min/mg was higher 
than that in the cortex or the whole brain. The relative distribution 
of AChE activity varies with species, strain and age. In the adult rat 
the highest activity is in the brain stem followed in decreasing order 
by the hypothalamus, cerebellum and cerebral cortex (Maletta and Timiras, 
1966; Vijayan and Brownson, 1974), although the cerebellum is usually 
reported to have the lowest activity (Maletta, Vernadakis and Timiras, 
1967). However, in 18-day rat fetuses the highest AChE activity was 
noted in the cerebellum with the lowest in cerebral cortex (Maletta, 
Vernadakis and Timiras, 1967), which is in agreement with the findings 
of this study. 
The low activity in the cerebral cortex suggests a small cholinergic 
comporent of this ~egion in the mouse fetus. This exposes a potential 
limitation of AChE as a brain marker of teratogenic injury in the mouse 
fetus since the ontogenetically new cerebral cortex would be expected to 
be particularly susceptible to teratogenic insult. 
Further experiments with different vitamin A dosing regimens on days 
7, 8 and/or 9, (when the CNS is particularly susceptible to teratogenic 
insults)were next performed with a view to comparing the effects of 
longer exposure to the teratogen with those obtained in the previous ex-
periments. 
6.4.11. Vitamin A, 5 000 IU per mouse, administered on each of days 8 
and 9 p.c. (sacrifice day 19) 
See Table 6.43. for original data (p. 388). 
Five dams were used in test group. There were 35 resorptions and no live 
fetuses. Controls were not sacrificed in this experiment. 
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Discussion 
Five thousand IU administered on each of days 8 and 9 p.c. was therefore 
embryolethal and unsuitable for study of brain AChE. 
6.4.12. Vitamin A, 7 500 IU per mouse, administered on day 8 p.c. 
(sacrifice day 19) 
See Table 6.44. for original data (p. 389). 
Five dams were used in the test group. There were 36 resorptions and one 
intra-uterine death with blood stained hydramnios (the fetus was exen-
cephalic). There were no live fetuses. Controls were not sacrificed 
in this experiment. 
Discussion 
Seven thousand five hundred IU vitamin A administered on day 8 p.c. was 
therefore also embryolethal and unsuitable for study of brain AChE. 
6.4.13. Vitamin A, 2 500 IU per mouse, administered on each of days 7, 
8 and 9 p.c. (sacrifice day 18) 
See Table 6.45T and 6.45C for original data (pp. 390 and 391). 
Four dams were used in the test group. There were 22 resorptions and 
only five live fetuses, one of which had exencephaly. There were no 
resorptions in the control group, one intra-uterine death and 20 live 
fetuses. 
Discussion 
This regimen was also largely embryolethal and was unsuitable for study 
of brain AChE because the number of fetuses would have been too small 
for meaningful statistical analysis. 
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6.4.14. Vitamin A, 2 500 IU per mouse, administered on each of days 7 
and 8 p.c. (sacrifice day 19) 
See Table 6.46 for original data (p. 392). 
Four dams were used in the test group. There were 21 resorptions and 
only five live fetuses, one of which had anophthalmia. 
Discussion 
This regimen was also largely embryolethal and was also unsuitable for 
study of brain AChE because of the small number of fetuses. Controls 
were not sacrificed in this experiment. 
6.4.15. Vitamin A, 3 000 IU per mouse, administered on each of days 8 
and 9 p.c. 
See Tables 6.47T and 6.47C for original data (pp. 393 and 394). 
Summary of results given in Table 6.48. 
Five thousand IU administered on days 8 and 9 p.c. was found to be embryo-
lethal (section 6.4.11). A smaller dose of 3 000 IU was therefore used 
in this experiment to enable comparison with results obtained with dosing 
on day 9 alone and on day 10. 
There were five resorptions in the treated group and none in the control 
group (p<0,05), and one intra-uterine death in each group. Three gross 
abnormalities were present in the test group (one fetus with exencephaly 
and two with exophthalmos) and one in the control group with exomphalos. 
The median test fetal weight of 1 063mg was significantly lower than that 
of the control group (1 149mg, p = 0,006). Similarly, the median brain 
weight of the test group (74,9mg) was significantly lower than controls 
(78,4mg p = 0,01). However, the median AChE activity for the test group 
(2,73nmol/min/mg) was higher than that of controls (2,68) although this 
was not significant. 
T A B L E 6.48. 
SUMMARY OF RESULTS OF 3 000 IU VITAMIN A ADMINISTERED 
ON DAYS 8 AND 9 p.c. 
TEST CONTROL 
Total 





Deaths 4,8 s,o 
(%) 
Abnormalities 
(%) 14,3 5 
Median Fetal 1,063 1,149 
Weight (0,96 - 1,09) (1, 12 - 1, 18) 
(g) 
Median Brain 74,9 78,4 
Weight 
(mg) (68, 4 - 77,3) (76,4 - 80,9) 
Median AChE 
Activity 2,73 2,68 
runol / min/mg (2, 65 - 2,81) (2, 63 - 2, 72} 
Figures in brackets are the 95% confidence range 











The characteristic gross morphological abnormalities noted in three of 
the fetuses confirmed that this dosing regimen was teratogenic. The 
lower fetal weights in the treated group also supported this and were 
in keeping with a growth inhibitory effect, as was found with a dose of 
10 000 IU on day 9 p.c. The absence of any significant difference in 
AChE activity between test and controls may be explicable on the same 
basis as with dosing with 10 000 IU on day 9. 
6. 5 • THE EFFECT OF VITAMIN A ON FETAL BRAIN TOTAL PROTEIN CONTENT 
6.5.1. Introduction 
This experiment was performed to help elucidate the mechanism for in-
creased fetal brain AChE activity with a dose of 10 000 IU vitamin A 
on day 10 p.c. Acetylcholinesterase is a protein and its increase may 
have merely been a reflection of a general increase in protein content 
(the significantly increased median brain weight in the test group in 
one experiment may have suggested this). Brain total protein content 
was therefore determined and compared with that of controls. 
6.5.2. Method 
The method used was a modification of the Lowry method (Lowry et al., 
1951) by G.L. Peterson (1977, 1983). A standard curve was constructed 
using a known concentration range (5 - lOOµg) of a standard protein 
(bovine serum albumin - BSA). 
An assay using spiked samples was first performed. Ten standard samples, 
containing 5 lOOµg of BSA protein (10 - 200µ1 of a o,5mg/ml solution) 












; 2 parts 5% sodium dodecyl sulphate (SDS); 1 part 0,8M NaOH) 
was added to each standard, the solution mixed and allowed to stand 
at room temperature for lOmin. O, 5ml of "reagentB" (1 part 2N Folin-
ciocalteu phenol reagent+ 5 parts distilled water) was then added to 
each standard, mixed immediately and allowed to stand at room tempera-
ture for 30min. Absorbance was read at 750nm against a standard blank 
containing 1ml distilled water with no BSA. 
Assay of experimental samples was then performed. Fetal mouse brain 
was homogenised in 0,05M Tris-HCl (pH 8,4), containing 0,5% Triton X-100 
to give a 30mg/ml solution. Samples containing 15µ1 of homogenate were 
made up to 1ml with distilled water. 0,1ml of 0,15% sodium deoxycholate 
was added to each sample, the solution mixed and allowed to stand for 10 
min at room temperature. 0,1ml of 72% trichloroacetic acid was then 
added and each sample centrifuged for 5 - 30min at 1 000 - 3 OOOg. After 
centrifugation, the supernatant was decanted and any remaining supernatant 
removed using a pasteur pipette attached to a vacuum pump. One ml of 
reagent A was added directly to the precipated protein and the assay 
performed in the same way as described under standard assay. The sample 
blank contained 15µ1 of sample buffer made up to 1,0ml with distilled 
water. 
6.5.3. Lowry Total Protein Determination : Results of 10 000 IU vitamin 
A per mouse administered on day 10 p.c. (sacrifice day 18 p.c.) 
Fetal brain total content was measured after maternal administration of 
10 000 IU vitamin A on day 10 p.c. and compared with controls to determine 
whether the increase in brain AChE noted in section 6.4.5. was a reflection 
of a general increase in brain protein. 
See Tables 6.49C and 6.49T for original data (pp. 176 and 177). 
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T A B L E 6.49C. 
LOWRY TOTAL PROTEIN DETERMINATION CONTROLS 
Sample Fetal weight Brain weight mg protein/ 
No. Cmgl (mg) mg brain 
Cl 1141,2 78,1 0,089 
C2 1071,1 75,1 0,084 
C3 1119,3 77,9 0,089 
C4 1015,4 69,8 0,080 
cs 1208,2 75,7 0,076 
C6 992,3 74,6 0,087 
C7 968,6 71, 7 0,084 
cs 1065 o 74,0 0,080 ,. 
C9 1022,7 70,7 0,087 
ClO 1077,5 74,6 0,091 
Cll 1100,2 76,2 0,096 
Cl2 1041,8 71,2 0,084 
Cl3 1062,3 76,6 0,078 
Cl4 1123 ,1 75,8 0,084 
.. 
ClS 1086,1 71,8 0,091 
Cl6 1133,9 72,3 0,096 
Cl7 1113 ,4 75,9 0,084 
Cl8 1099,6 72,0 0,091 
Cl9 1112,4 76,4 0,087 
C20 1053 ,, o 68,7 0,098 
Median 1os2,o 73,95 0,087 
95 % Con-
fidence 
limits 1053 - 1107 72,65 - 75,5 o ,084 - 0,090 
TABLE 6.49T. 
LOWRY TOTAL PROTEIN DETERMINATION: 10 000 ru ·vITAMIN A 
PER MOUSE ON DAY 10 p.c. (SACRIFICE DAY 18 p.c.) 
Sample Fetal weight Brain weight mg protein/ 
No. (mgl (mg) mg brain 
Tl 1084,9 75,9 0,067 
T2 1060 75,7 0,076 
T4 1035,3 76,2 0,064 
T6 1043,9 73,9 0,069 
T7 968,3 72,4 0,084 
TS 1001,2 74,6 0,087 
T9 1065,5 79,0 0,078 
TlO 1101,5 80,7 0,1089 
Tll 1108,5 80,2 0,082 
Tl2 104+,o 76,1 0,100 
.Tl3 102s,0 75,1 0,082 
Tl4 966,4 74,7 0,087 
Tl5 1205,9 77,3 0,084 
Tl6 1059,7 70,8 0,098 
Tl7 1200,6 85,0 0,087 
Tl8 1os3,o 75,5 0,084 
Tl9 1131,9 79,4 0,087 




limits 1034 - 1102 74,9 - 78,15 0 ,077-0, 090 
P · *· NS NS NS 
* Comparison with data in Table 6.49C. 
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There was no significant difference in fetal weights, brain weights or 
brain total protein content between tests and controls. For treated 
fetuses the median brain protein content was 0,084mg protein/mg brain 
and for controls 0,087mg. 
Discussion and conclusion 
Maternal administration of 10 000 IU vitamin A on day 10 p.c. was not 
associated with any change in brain total protein content in 18. day 
fetuses compared with controls. (As no trend for any meaningful diff-
erence was apparent the experiment was not repeated}. The increase in 
brain AChE activity observed in section 6.4.5. therefore does not appear 
to be a reflection of a general increase in brain total protein content. 
This is also in keeping with the findings of other workers. Benett et al., 
(1958a; 1961) were unable to find a positive correlation between AChE 
and brain protein. Similarly, prenatal X-irradiation did not alter brain 
protein content in rats although there was a significant change in AChE 
activity compared with controls (Maletta, Vernadakis and Timiras, 1967). 
6.6. THE EFFECTS OF VITAMIN A ON FETAL MOUSE BRAIN CHOLINE ACETYLTRANS-
FERASE ACTIVITY 
6.6.1. Introduction 
In contrast to AChE which is responsible for the brakdown of acetyl-
choline, choline acetyltransferase (ChAT, E.C.2.3.1.6.) catalyses the 
synthesis of acetylcholine from acetyl-CoA and choline. Choline acetyl-
transferase is found almost exclusively in neural tissue in cholinergic 
neurons. The activity of the enzyme correlates well with the concentra-
tion and synthesis of acetylcholine (Kobayoshi et al., 1975) and has been 
used as an enzymic marker for cholinergic cells (Glover and Green, 1972). 
Because ChAT is also closely involved with acetylcholine metabolism the 
aim of this study was: 
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i) To compare the effects of vitamin A on ChAT activity with those on 
AChE activity; 
ii) to compare ChAT as a potential biochemical marker of teratogenic 
injury with AChE; 
iii) to help elucidate the teratogenic mechanism of action of vitamin 
A. For example, if the increase in AChE activity with dosing on day 10 
of gestation was due to stimulation of cholinergic synthesis or exube-
rant repair then a concomitant increase in ChAT would be anticipated. 
However, if the elevation in AChE was due to a relative sparing of 
cholinergic neurons, ChAT might not be expected to be increased. 
Other workers have compared ChAT and AChE activity in rat brain. Valcana 
and Timiras (1974) studied the effects of X-irradiation; Eckhert et al., 
(1976) studied the effects of undernutrition, whilst Johnson et al (1984) 
studied the teratogenic effects of procarbazine. Also, there is 
a slow continuous rise in ChAT activity in brain tissue during develop-
ment (Bus and Gibson, 1974). Any perturbation of normal development 
could therefore be anticipated to alter ChAT activity • 
• 
A radiochemical assay of ChAT was used based on that of Fonnum (1966; 
1975) which is reproducible, rapid and specific. The method involves 
the formation of labelled acetylcholine from labelled acetyl-CoA. 
14
c acetyl-CoA reacts with choline iodide (ChI) in the presence of 
ChAT to give 
14c acetylcholine. 
14c AcCoA + ChI ACh + CoA 
The labelled ACh is separated from the radioactive substrate by liquid 
cation exchange using sodium tetraphenylboron (Kalignost) in acetonitrile 
with a scintillation mixture acting as extraction solvent, and then de-
termined by liquid scintillation counting. 
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6.6.2. Materials and Methods 
Brains were homogenised with a Thomas teflon pestle homogeniser in 
lOmM EDTA, (pH 7,4), containing 0,5% Triton X-100 to ensure total re-
lease of enzyme activity (Fonnum, 1966). 
The incubation mixture (prepared fresh) contained (final cone.): 
o,2mM 1-14c acetyl CoA (Weil organisation, Amersham; specific 
activity 55mCi/mmol); 300mM NaCl; 8mM choline iodide; 20mM EDTA; 
O,lmM physostigmine sulphate; 50mM sodium phosphate buffer (pH 7,4). 
The concentrations of acetyl-CoA and choline iodide used saturate the 
enzyme. The pH was adjusted to simulate intracellular conditions (pH 7,4) 
although ChAT is most active at pH 8,0 (Glover and Green, 1972). Since 
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the enzyme is inhibited by trace elements of copper, EDTA is added. Physos-
tigmine is added to inhibit AChE, cholinesterases and simple esterases 
which can break down acetylcholine. 
Two microlitres brain homogenate and 5µ1 incubation mixture were placed in 
a microtube. The solution was mixed with a rotamixer for a few seconds 
and incubated for 15min at 37°c in a water bath. The reaction was then 
stopped by immersing the microtube in crushed ice. The contents of the 
microtube were flushed into a glass scintillation vial with 3ml of lOmM 
sodium phosphate buffer (pH 7,4). (If the tube was left in the vial for 
the remainder of the experiment, as described by Fonnum (1975), higher 
background counts were obtained). To this was added 2ml acetonitrile 
containing 10mg sodium tetraphenylborate (Merck) and 10ml of toluene 
scintillation cocktail (0,05% diphenyloxazole and 0,02% 1,4-bis-(4-methyl-
5-phenyloxazole-2-yl) benzene). The vial was shaken gently for 15 to 20 
sec, enabling labelled ACh to be extracted into the toluene or organic 
phase, whereas the acetyl-CoA is left in the aqueous phase. The mixture 
was allowed to stand for 30min which resulted in separation into an upper 
organic and lower aqueous phase. Nine millilitres of the upper toluene 
phase (with the labelled ACh) were decanted into a plastic scintillation 
vial and counted for lOmin in a Packard TriCarb 4640 liquid scintillation 
counter. Each sample was assayed in duplicate. (Note : i) Fonnum (1975) 
did not separate the phases for counting. In this study, however, it was 
found that this resulted in no difference in counts for reactions with or 
without ChAT, which suggested that both phases were being counted. ii) 
As was noted in the technique of Glover and Green (1972), some labelled 
acetyl~oA is also extracted into the organic layer and gives rise to 
substantial blank counts. Spontaneous formation of ACh can presumably also 
occur). 
6.6.3. Relationship between choline acetyltransferase activity and fetal 
mouse brain concentration 
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This experiment was performed to determine whether there was a satisfactory 
relationship between brain concentration (and hence ChAT content) and 
measured ChAT activity. 
Materials and Methods 
Brains were homogenised with a Thomas teflon pestle homogeniser in lOmM 
EDTA (pH 7,4), containing 0,5% Triton X-100 to give brain concentrations 
of 15,30 and 60mg/ml. A fourth sample (the blank) contained no brain. 
The radio-chemical assay, described in the previous section, was used to 
determine ChAT activity as disintegrations per minute, d.p.m. 
six samples were tested for each brain concentration. 
Five or 
Results are given in Table 6.50. and the relationship between ChAT activity 
(d.p.m.) and brain homogenate concentration shown graphically in Fig. 6.9. 
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T A B L E 6 .50. 
OBSERVED CHOLINE ACETYLTRANSFERASE ACTIVITY IN d.p.m. 
FOR DIFFERENT CONCENTRATIONS OF BRAIN HOMOGENATE 
Brain Coefficient 
Concentration d.p.m. mean of S.D. 
(mg/ml} variation 
% 






















Spearman r = 0,878 _ t = 8,18; p ((0,001 
Fig. 6. 9. 
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CONCENTRATION OF BRAIN HOMOGENATE (mg/ml) 
Error bars are 95% confidence limits. 
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Conclusions 
a) A linear relationship is apparent between brain co~centration (and 
hence ChAT content) and ChAT activity (p <0,001). 
b) The results indicate substantial ChAT activity. 
c) High blank readings are apparent but are acceptable in view of the 
substantially higher counts when ChAT is present. 
6.6.4. Vitamin A, 10 000 IU per mouse, administered on d~y 10 p.c. 
This experiment was performed to compare the effects on ChAT with those 
on AChE activity. 
See Tables 6.51T and 6.51C for original data (pp. 395 and 396) • 
Summary of results in Table 6.52. 
There was no significant difference in the incidence of resorptions or 
intra-uterine deaths compared with controls. All treated fetuses had 
gross abnormalities in that the tails were short or kinked, compared 
with only one abnormal control fetus with exomphalos (p<0,001). There 
was no significant difference in fetal weight, brain weight or whole 
brain ChAT activity of treated fetuses compared with controls. 
Comment 
The above results are consistent with those of previous experiments 
(section 6.4.5.), except that, in contrast to AChE activity which was 
greater in treated fetuses, there was no significant difference in 
ChAT activity compared with controls. Discussion regarding the absence 
of any change in ChAT activity is presented later - see section 6.6.6. 
6.6.5. Vitamin A, 15 000 IU per mouse, administered on day 10 p.c. 
With no significant difference in brain ChAT activity with 10 000 IU 
vitamin A on day 10 this experiment was performed to determine the effects 
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T A B L E 6.52. 
SUMMARY OF RESULTS OF 10 000 IU VITAMIN A 
ADMINISTERED ON DAY 10 p.c. (SACRIFICE DAY 19 p.c.) 
TEST CONTROL 
Total 
Conceptions 20 23 
Resorptions 
(%) 0 8,7 
Intra-uterine 
Deaths 5,0 4,3 
(%) 
Abnormalities 
(%) 100 5,0 








as d.p.m. 775,8 804,8 
Figures in brackets are the 95% confidence range 










of a larger dose of the teratogen. 
See Tables 6.53T and 6.53C for original data (pp. 397-399). 
Summary of results in Table 6.54. 
There was a marked increase in the incidence of late resorptions (58,9%) 
with the higher dose compared with none in controls (p<0,001). A feature 
that had not been previously observed was that, although the fetuses had 
largely resorbed, leaving a! 4mm blob of necrotic tissue, the placentae 
were well developed and of almost comparable size to those of viable 
fetuses. Of the viable fetuses all had gross abnormalities such as 
kinked tails and spade-like limbs (a more pronounced effect of the higher 
dose on limb development was apparent). 
The median fetal weight of treated fetuses (0,943g) was lower than that 
of control fetuses (1 002g, p = 0,014) and may have indicated a mild 
growth inhibitory effect of the higher dose. There was no significant 
difference in brain weight or brain ChAT activity. 
6.6.6. Discussion 
The finding of resorbed fetal tissue with well developed placentae was 
compatible with a direct effect cf vitamin A on the fetus, which is in 
agreement with the observations of others (see section 1.2). The high 
incidence of late resorptions (58,9%) with 15 000 IU compared with 10 000 
IU vitamin A (see section 6.4.5.) demonstrated a dramatic increase in 
embryolethality with the increment in dose. Similarly, a higher incidence 
of gross abnormalities (100%) was apparent with the larger dose. 
The absence of any change in ChAT activity in the treated group in the 
above two experiments in the face of the previously demonstrated increase 
in AChE activity with the same dose and time of administration of vitamin 
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T A B L E 6 .54. 
SUMMARY OF RESULTS OF 15 000 IU VITAMIN A 
ADMINISTERED ON DAY 10 p.c. (SACRIFICE DAY 18 p.c.) 
TEST · CONTROL 
Total 
Conceptions 39 23 
Resorptions 
(%) 58,9 0 
Intra-uterine 
Deaths 2,6 8,7 . 
(%) 
Abnormalities 
(%) 100 0 
Median Fetal 
Weight 0,943 1,002 
(g) 
Median Brain 
Weight 69,25 68,3 
(mg) 
Median ChAT 
Activity 352 424 
as d.p.m. 
I 
Figures in brackets are the 95% confidence range 










A, may suggest that the increase in AChE activity was not secondary to 
exuberant repair or hyperplasia of cholinergic neurons. Such a process 
would be expected to be associated with an increase in ChAT, the synthetic 
enzyme of acetylcholine. The result may rather favour a process such as 
relative sparing of cholinergic neurons. 
The above is speculative for two reasons. Firstly, there was a wide 
standard deviation in ChAT between different brain homogenates, which 
would have made detection of more subtle differences in ChAT activity 
difficult. Secondly, the relationship in activity of cholinergic en-
zymes is complex such that the activity of one enzyme does not necessarily 
parallel the other. For example, Eckhert et al., (1976) found that under-
nutrition imposed during development in the rat could be associated with 
an increase in AChE activity in a specific brain region, whereas ChAT 
activity might be unaffected, increased or decreased in the same region. 
Similarly Valcana and Timiras (1974) found that X-irradiation to the 
developing rat brain resulted in increased AChE activity in the cortex 
but no change in ChAT activity. 
Because of the absence of any significant trend in ChAT activity in the 
previous experiments and the problems outlined above, further experiments 
to determine ChAT activity were not performed. It was evident that this 
particular enzyme assay was less sensitive than the AChE assay, and it 
would also appear that ChAT is a poor marker of neuroteratogenicity: 
Johnson et al., (1984) found no change in brain ChAT activity in the rat 
after administration of the well established teratogen procarbazine, from 
day 12 to 15 of gestation, despite causing gross morphological changes 
including microcephaly. 
6.6.7. Conclusions of Choline Acetyltransferase study 
a) No significant change in brain ChAT activity has been demonstrated 
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in C3H mouse fetuses exposed to teratogenic doses of vitamin A on day 10 
of gestation. 
b) The high standard deviation in ChAT activity between different brain 
homogenates would have made detection of subtle changes difficult. 
c) Using this technique, ChAT would appear to have less potential as a 
biochemical marker of teratogenic injury than AChE. 
d) No definite conclusions can be made from these experiments regarding 
the teratogenic mechanism of action of vitamin A. 
6.7. THE EFFECTS OF VITAMIN A ON FETAL MOUSE BRAIN ACETYLCHOLINESTERASE 
ISOENZYMES 
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After maternal administration of 10 000 IU vitamin A on day 10 p.c. mice were 
sacrificed on day 18 p.c. and the AChE isoenzymes from 20 brain homogenates 
of treated ·fetuses were compared with those from 20 controls. 
Separation and densitometric analysis of the isoenzymes of AChE were perfor-
med as described in Chapter 5. 
Results 
Five isoenzymes of AChE were present in all test and control samples. No 
obvious difference was apparent on visual inspection of the gels between 
tests and controls. Peak heights were measured from the best apparent base-
line. The following 3 methods were used in the analysis of the densitome-
tric results obtained. 
Method 1: Comparison of peak heights of peaks 1, 2, 3, 4, 5 and the sum 
of peaks 1 - 5 for test and controls. (The sum of peak heights for peaks 
1 - 5 were analysed in order to establish an overall difference between 
test and controls). 
Results are shown in Tables 6.55T and 6.55c (pp. 400 and 401). 






















T A a L E 6 .56. 
SUMMARY OF DE NSITO METRIC RESULTS 
FOR VITA MIN A GELS 
Method 1 Method 2 Method 
iVledian 
peak hts p ~1edian p Median 
mm ratio ratio 
52,75 o, 637 0,79 
(n=20) 
NS NS 
51,88 0,595 0,745 
(n=20) 
98,13 1,184 1,47 
NS 0,0990 
9 6-, 5 1,095 1,375 
84,5 - 1,243 
NS -
87,0 - 1,235 
51,5 0,595 0,75 
NS NS 
51,13 0,60 0,722 
78,6 0,935 1,18 
o, os 0,032 
64,88 0,77 0,95 
366,8 3,358 5,483 
NS O, 012 '· 
350,0 3,063 4,99 










Method 2: Comparison of peak heights of test and controls using one 
of the peaks as an internal standard in order to attempt to reduce inter-
and intra-gel variations in peak height. Peak 3 was chosen as the inter-
nal standard because it had the smallest difference in peak height between 
test and controls. The results for this method were obtained by dividing 
the peak heights of peaks 1, 2, 4 and 5 by the peak height of peak 3. 
The ratios for all the peaks were added together as in method 1. 
Results are given in Tables 6.57c and 6.57T (pp. 402 and 403). 
Summary of results in Table 6.56. 
Results are shown graphically in Fig. 6.10. 
Method 3: Comparison of test and controls in an attempt to minimise 
inter-gel variation. The peak heights for all the peaks arising from 
control samples were added together and their mean calculated for each 
gel. The data for each gel (test and control) was then divided by the 
appropriate mean. 
Results are given in Table 6.58C and 6.58T (pp. 404 and 405). 
Summary of results in Table 6.56. 
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All the results obtained from the 3 methods of analysis were statistically 
analysed by the Tukey modification of the Willcoxon signed ranks test and 
the Mann Whitney U test. In addition, some of the peaks were analysed by 
the Kolmogorov-Smirnov two-sample test which is sensitive both to differen-
ces in means and in distribution. 
Although the medians for peak heights 1, 2, 5 and the total were greater 
for tests than controls, analysis of peak heights (Method 1) by Mann 
Whitney U test only shows a significant difference in peak 5 (median peak 
height of 78,6mm for treated fetuses compared with 64,9mm in controls, 
p<0,05), but no significant difference in any of the other peaks or in 










































































































































































Inspection of the 95% confidence range suggested the possibility of large 
differences in peak intensities between gels. Hence Method 2 was em-
ployed to try and minimise these variations. Using peak 3 as an internal 
standard (Method 2) medians for peaks l, 2 and 5 and the total were again 
greater for tests, with significant differences for peaks 5 and the total 
(Median ratio 0,935 and 3,36 respectively compared with 0,77 and 3,06 
respectively in controls, p = 0,03 and 0,01: Tukey modifications of the 
Willcoxon signed ranks test and Mann Whitney U test - see Tables 6.57c 
and 6.57T. 
It is thought, however, that the above procedure might minimise differen-
ces in distribution between test and control. Therefore, Method 3 was 
employed in an attempt to minimise inter-gel variation only. By dividing 
all the data by the mean control value for each gel, a similar trend as 
before was observed: the median ratio for band 5 and the total for 
treated fetuses of 1,18 and 5,48 respectively were higher than for con-
trols (0,95 and 4,99, p = 0,02 and 0,04 respectively), but not for any 
of the other bands. 
Results are shown in Tables 6.58C and 6.58T. 
In teratological work it is reasonable to consider that distributions 
may be bimodal, one mode corresponding to a susceptible subpopulation of 
tests. The data for peaks 2 and 5 were felt to be particularly likely 
to give such bimodal distributions and were therefore analysed by the 
Kolmogorov-Smirnov two-sample test. For peak 2 there was no significant 
difference between test and control but for peak 5 and the sum of the 
peaks, a value of p = 0,05, T>C, was obtained. (Data obtained using 
Method 3). 
Discussion and conclusion 
Peak 5 and the sum of the peak heights of the isoenzyme bands of AChE 
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were greater for tests than controls (p = 0,05, methods 2 and 3). This 
was consistent with the significantly higher AChE activity detected for 
test animals compared with controls using the Ellman technique (P<0,0005, 
section 6.4.5). 
The predominant increase in enzyme activity was in band 5 (p = or <0,05), 
although the median peak heights for bands 1 and 2 were also greater for 
tests but this was not significant. 
The absence of any difference in band 4 between tests and controls could 
simply be accounted for by the faintness of this band. 
It was felt unlikely that overcoming minor technical problems such as 
the high background scatter and inter- and intra-gel variation would sub-
stantially improve the sensitivity of the technique, and this avenue of 
investigation which appeared to be less sensitive than the spectrophoto-
metric assay (see also sections 7.5 and 8.5), was not performed in other 
experiments with vitamin A where changes in AChE activity were not demons-
trable. 
6.8. SUMMARY AND DISCUSSION OF VITAMIN A STUDY 
In this study a wide dosage range from 1 000 to So 000 IU vitamin A 
per mouse was used, which resulted in a spectrum from no detectable 
embryotoxic effect, through teratogenic to embryolethal. With the 
exception of 2 experiments a dose of 10 000 IU was the maximum dose 
used in the definitive study and was not associated with any significant 
maternal toxicity. 
In the absence of evidence of maternal toxicity obvious teratogenic 
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effects were observed in the offspring, which is in keeping with the 
concept of a direct effect of vitamin A on the embryo (see section 1.2). 
The time of administration varied from day 7 to 17 of gestation which 
enabled testing the effects of the teratogen during the embryonic phase 
of development and during fetogenesis. Most studies were performed 
during an important period of brain development. Dosing on a single day 
was found to be adequate to produce a teratogenic effect. 
The time of sacrifice chosen also varied. In many studies this was 1 
or 2 days prior to term when substantial enzyme activity was present. 
This ensured a good chance of detecting small changes in enzyme activity. 
Fetuses were also sacrificed earlier in gestation, such as on day 12, to 
limit the possibility of repair masking embryotoxic effects. This, 
however, necessitated using the whole head because of the technical 
difficulty of removing the brain, and enzyme activity was substantially 
lower. Fetuses were not studied post-natally because of the likelihood 
of dams cannibalising abnormal fetuses. 
The use of controls kept under identical conditions in each experiment 
accounted for variation in such parameters as fetal weight and AChE 
activity in different experiments. 
A possible criticism may be that larger sample sizes might have been 
used. This, however, was not possible because assays were performed 
on fresh brain homogenates where test and control animals were only 
compa=ed in the same experiment, limiting the number of brains that 
could be assayed. On reviewing the study it is improbable that larger 
sample sizes or repeat experiments would have improved precision sub-
stantially. 
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An obvious difference in severity and frequency of congenital defects 
from litter to litter as well as from offspring to offspring within the 
same litter was apparent. This phenomenon is well known in teratology 
and may depend on biochemical or morphological variations that are ge-
netically determined (Wilson, 1977 : 49). 
Resorptions 
Resorption was a useful indicator of embryotoxicity. There was an 
increase in the incidence of resorptions with an increase in dose. 
Similarly dosing earlier in gestation e.g. on days 7, 8 or 9 was asso-
ciated with a substantial increase in resorption rate. These findings 
are in agreement with those of other workers (Kalter and Warkany, 1961). 
Intra-uterine deaths 
With the range of doses and times of administration of vitamin A used 
in this study, it is interesting that embryotoxicity was manifest either 
as embryolethality resulting in resorption or early intra-uterine death, 
or malformations, without evidence of intra-uterine death arising later 
in gestation. This contrasts with the findings of the cyclophosphamide 




There was a dramatic increase in incidence of gross morphological ab-
normalities with increasing dose, jumping from 9,1% with 5 000 IU vitamin 
A on day 9 to 100% with 10 000 IU on day 9. The incidence with 10 000 IU 
administered on day 10 was lower at 42,3 to 54,5%. This indicates a very 
steep dose response curve for malformations induced by vitamin A in C3H 
mouse fetuses, which is to the left of that for embryolethality. The 
gross abnormalities are similar to those noted by others (Kalter and 
Warkany, 1961; Kalter, 1968; Geelan, 1979), although the strikingly 
high incidence of exophthalmos with the characteristic abnormal shaped 
head (38%) and the high incidence of tail abnormalities (66%) have not 
been described by other workers and probably indicate a particular sus-
ceptibility of C3H mice with dosing on day 9 or 10 of gestation. 
Fetal weight and brain weight 
There was no consistent effect on these parameters compared with controls 
except with 10 000 IU on day 9 and 3 000 IU consecutively on days 8 and 9 
when fetal weight,and in some experiments brain weight,were significantly 
reduced. This is compatible with a growth inhibitory effect of vitamin A. 
Of note is that this was only observed when teratogenic doses were used, 
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nor was this apparent when dosing later on day 10 with the exception of one 
experiment (section 6.6.5) where a high dose of 15 000 on day 10 was used. 
This contrasts with cyclophosphamide which can cause a growth retarding 
effect when doses that are not teratogenic are used and is growth inhibitory 
when administered later in gestation (see Chapter 7). A growth retarding 
effect of vitamin A has been noted by other workers (Morriss and Steele, 
1974; Morriss and Steele, 1977; Kochar, 1968). 
Acetylcholinesterase 
I have shown that vitamin A, independent of its embryotoxic effects, did 
not alter AChE activity. 
A dose of l 000 IU vitamin A administered on day 9 did not appear to be 
teratogenic: no abnormalities were noted in any of the parameters exa-
mined. A non-teratogenic dose was not associated with any change in AChE 
activity. 
Studies with 5 000 IU on day 9 or day 10 were not associated with a con-
sistent change in any of the parameters examined, although a teratogenic 
effect was grossly apparent in 2 fetuses with exophthalmos. Examination 
of fetuses 48h after dosing reduced the possibility that repair of any 
CNS damage could have accounted for an absence of altered AChE activity. 
The administration of 10 ()()() IU of vitamin A on day 10 was associated 
with a 42 - 54% incidence of gross malformations and an increase in brain 
AChE (p<0,005). The mechanism for the increase in brain AChE activity 
could be reasonably explained on the basis of relative sparing of choli-
nergic neurons from the CNS damage caused by the teratogen, i.e. that 
cholinergic neurons are relatively more resistant than other neuronal 
cells. This suggestion is in agreement with that of Adlard and Dabbing 
(1972) and Valcana and Timiras (1974) who noted increased brain AChE in 
rats exposed to X-irradiation. There is also histological evidence that 
radiation results in reduced numbers of granule, basket and stellate 
cells of the cerebellar cortex, but that cholinergic golgi cells are un-
affected (Altman and Das, 1970; Altman and Anderson, 1971; Ebels, 1970). 
The findings of Langman and Welch (1967) that Swiss-Webster mice treated 
with vitamin A had reduced numbers and abnormal differentiation of neuro-
blasts in the cerebral cortex indicates the susceptibility of this pop-
ulation of cells. It is quite conceivable that the ontogenetically older 
cholinergic neurons are relatively unaffected. 
An alternative explanation is that the increase in AChE activity could be 
a reflection of exuberant repair or growth of cholinergic neurons. The 
findings of Smith et al., (1978) of hyperplasia and overgrowth of neural 
tube tissue in rat fetuses exposed to vitamin A are consistent with this 
concept. Conceptually, however, exuberant repair is more acceptable than 
involking a teratogenic mechanism which directly stimulates cholinergic 
neurons. The latter might imply a growth stimulatory effect which is 
contrary to the reported growth inhibitory effect of vitamin A, although 
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no growth inhibition was evident with this regimen. The absence of 
an increase in fetal weight or brain total protein content argue against 
increased growth. Similarly, the absence of an increase in ChAT ac-
tivity tends to point against exuberant repair. 
The absence of an increase in brain total protein content in the face 
of higher AChE activity suggested that the greater enzyme activity was 
not merely the result of a general increase in brain total protein con-
tent. 
Examination of the isoenzymes of AChE showed that the sum of the peak 
heights of the isoenzyme bands were greater for test brains (p = 0,05) 
which was consistent with the findings above. The predominant increase 
in enzyme activity was noted in band 5 (p = 0,05), although the median 
peak heights for bands 1 and 2 were also greater for tests, although not 
demonstrably. 
Despite a higher incidence of gross morphological abnormalities with 
teratogenic doses of vitamin A, dosing earlier on days 8 and 9, when the 
fetal CNS is likely to be highly susceptible to teratogenic insults, was 
not associated with a significant change in brain AChE activity in whole 
brain, cortex or cerebellum. The explanation for this may have been a 
growth inhibitory effect of the vitamin as suggested by the lower fetal 
and brain weights. As noted in the cyclophosphamide experiments (see 
Chapter 7) this was associated with a lower AChE activity, but could have 
been offset by another teratogenic effect of vitamin A, which in previous 
experiments was associated with an increase in enzyme activity, the net 
result reflecting no significant change. 
The absence of any change in AChE activity in cortex and cerebellum 
tended to exclude the possibility that changes in specific brain regions 
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in opposite directions accounted for the absence of an alteration in 
whole brain AChE. 
As teratological effects are influenced by the time of exposure or 
developmental stage of an organ, this may explain the discrepancy in 
the above findings. (For example, even opposite effects have been ob-
served by administration of the same dose of vitamin A one day apart. 
(Seller et al., (1979) noted an increased incidence of neural tube 
defects in curly-tailed mice when vitamin A was administered on day 8, 
but a decreased incidence when given on day 9). Perhaps a different 
mechanism operates with dosing on days 8 or 9 as opposed to day 10, the 
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one associated with a change in enzyme activity and the other not. This 
exposes a definite potential weakness of a biochemical parameter such as 
AChE. Depending on the interaction of a number of factors such as growth 
inhibition, cell damage, relative sparing, repair, direct effects or 
different changes in different parts of an organ to increase or decrease 
the parameter examined, there may or may not be a net change. This is 
highlighted by the fact that when a more pronounced biochemical disturbance 
might have been anticipated with dosing on day 9 as opposed to day 10, 
none was found. This also illustrates that AChE alone is not a reliable 
marker of teratogenic injury induced by vitamin A, and emphasises the im-
portance of considering all parameters when assessing a potential embryo-
toxic effect, including growth inhibition, malformations and embryoletha-
lity. Another potential limitation of AChE as a brain marker of terato-
genic injury in the mouse fetus was revealed by the low AChE activity in 
the ontogenetically new cerebral cortex which would be expected to be the 
most susceptible to teratogenic insult. 
The likelihood that the absence of any alteration in AChE activity in the 
above experiments was due to repair was diminished by the fact that no 
change in enzyme activity could be demonstrated in fetuses examined 
72h after dosing on day 12. However, repair appears to be a rapid pro-
cess and could have been complete by this time (Langman et al., 1980). 
The absence of an increase in AChE activity in these 12 day fetuses 
suggests that the mechanism of embryotoxicity of vitamin A is not asso-
ciated with a haemorrhagic process (contrast cyclophosphamide, Chapter 7). 
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Using the same dose of 10 000 IU later in gestation during the period of 
fetogenesis was not associated with any abnormality in any of the para-
meters studied i.e. it did not appear to be teratogenic when administered 
at this time and was not associated with a change in AChE activity. Larger 
doses of a teratogen are usually needed to produce embryotoxic effects 
later in gestation but I did not pursue studies during fetogenesis because 
of the somewhat disappointing results during the more sensitive period of 
organogenesis and the fact that large doses can result in maternal toxicity, 
which could confound interpretation of results. 
Although it is conceivable that changes in post-natal brain AChE activity 
might occur after exposure to vitamin A in the absence of pre-natal changes, 
post-natal studies may be of limited value because mothers are known to 
cannibalise abnormal offspring (Palmer, 1978; Wilson, 1973). 
6.9. CONCLUSIONS 
It is concluded from this study that: 
a) A dosage regimen of 10 000 IU vitamin A or less was not associated 
with significant maternal toxicity. 
b) In vivo maternal administration of vitamin A caused a dose dependent 
increase in resorption rate. 
c) Dosing earlier in gestation resulted in a steep increase in the 
number of resorptions. 
d) There was a steep dose response curve for malformations induced by 
vitamin A which increased from 9,1% to 100% by doubling the dose from 
5 000 to 10 000 IU when administered on day 9 p.c. and from 0% to 54,5% 
when administered on day 10 p.c. 
e) The high incidence of exophthalmos/abnormally shaped head and the 
high incidence of tail abnormalities indicated a particular sensitivity 
of C3H mice to these defects after exposure to vitamin A on day 9 or 10 
of gestation. 
f) Teratogenic doses of 10 000 IU vitamin A administered on day 8 or 9 
of gestation, were associated with a small decrease in fetal weight which 
is compatible with a growth inhibitory effect. 
g) Vitamin A, independent of its embryotoxic effects, did not alter AChE 
activity. 
h) In the absence of evidence of a significant teratogenic effect of 
vitamin A, no change in brain AChE activity was demonstrable. 
i) With the administration of an obviously teratogenic dose of vitamin 
A during the period of CNS development the presence or absence of a change 
in brain AChE activity depended on the time of administration. 
j) Ten thousand IU vitamin A administrered on day 9 was associated with a 
100% incidence of malformations (p<0,001) and a decrease in fetal ~eight 
ll 160mg compared with 1 250mg in controls, p = 0,061 and a de-
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crease in brain weight (78,4mg compared with 82,7mg in controls, 
p = 0,07), but was not associated with a change in AChE in whole brain, 
cortex or cerebellum compared with controls}. 
k) The likelihood that the absence of any alteration in AChE referred 
to in (j) above could be accounted for by repair was diminished by the 
absence of any change in enzyme activity in fetuses examined 72h after 
dosing. 
1) The administration of 10 000 IU of vitamin A on day 10 was asso-
ciated with a 42% and 54% incidence of malformations (p<0,01) and a 
significant increase in brain AChE (3,20 compared with 2,99nmol/min/~g 
in controls in the first experiment, p<0,005, and 3,55 compared with 
3,19nmol/min/mg in controls in the second experiment (p<0,0005). 
m) The increase in brain AChE in (1) above was not associated with 
a demonstrable increase in fetal weight, brain total protein content or 
ChAT activity and was therefore probably not related to enhanced growth 
or exuberant repair of cholinergic neurons. 
n) The administration of 10 000 IU vitamin A on day 10 was associated 
with a significantly higher AChE activity of band 5 and the sum of the 
activities of the isoenzyme zones (p = 0,05) . 
. o) A dose of 10 000 IU administered later in gestation on day 13 p.c., 
was not associated with a significant effect on any of the parameters 
studies i.e. did not appear to be embryotoxic. 
p) Brain AChE alone is not a reliable indicator of teratogenic injury 
induced by vitamin A in C3H mice. 
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C H A P T E R 7 
A STUDY OF THE EFFECTS OF IN VIVO MATERNAL ADMINISTRATION 
OF CYCLOPHOSPHAMIDE ON THE C3H MOUSE FETUS 
7.1. INTRODUCTION 
A discussion on cyclophosphamide as a teratogen, with particular reference 
to its effects on the developing CNS, has been given in section 1.3. 
The aims of this study were: 
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i) To investigate the effects of cyclophosphamide when administered 
during embryonic development, including an important period of CNS develop-
ment, on gross fetal parameters in C3H mice,including embryolethality, 
gross morphological abnormalities, fetal weight and brain weight; 
ii) to compare these with the effects on brain AChE and its isoen-
zymes, and with brain ChAT; 
iii) to compare the effects with those observed using vitamin A in 
the previous study, and further evaluate AChE as a potential brain bio-
chemical marker of teratogenic injury; 
iv) to elucidate the teratogenic mechanisms of cyclophosphamide with 
particular reference to the central nervous system. 
7.2. MATERIALS AND METHODS 
7.2.1. Experimental mice 
Timed matings were performed with young healthy virgin female C3H mice 
aged 8 - 12 weeks weighing 19 - 23g, as described in section 2.4., and 
kept under standard experimental conditions (section 2.3}. Two-hour matings 
were performed. Pregnant females were randomly divided into test and con-
trol groups. 
7.2.2. Drug administration 
Cyclophosphamide was diluted in sterile water and administered by sub-
cutaneous (s.c.) injection. The doses used were 7,5-20mg/kg per mouse 
(see section 7.3.) 
s.c. to controls. 
An equal volume of distilled water was administered 
7.2.3. Records of maternal and fetal parameters and statistical analysis 
Maternal Parameters. The weight on the day of mating, day of dosing and 
the day of sacrifice and the physical state of each mouse after dosing 
and before sacrifice were recorded. 
Fetal Parameters. Resorptions, intra-uterine deaths, gross morphological 
abnormalities, fetal weights, brain weights, brain AChE activity, and in 
some instances AChE isoenzymes and choline acetyltransferase activity were 
investigated. 
Statistical Analysis. The incidence of resorptions, intra-uterine deaths 
and morphological abnormalities was compared with controls using the Chi-
square two-tailed test. Fetal weights, brain weights and brain AChE 
activity were compared with controls using the Mann-Whitney U two-tailed 
test. Medians and 95% confidence limits were calculated from the Walsh 
averages, after Tukey (Steinijans and Diletti, 1983). 
7.3. PRELIMINARY EXPERIMENTS 
Guided by the experimental literature, as presented in section 1.3, the 
susceptibility of C3H mice to cyclophosphamide under their experimental 
conditions was determined. A suitable dosage range was found to be 7,5-
20mg/kg which produced a spectrum of effects from growth inhibition alone 
at 7,Smg/kg to a high inc~dence of gross malformaticr.s and embryolethality 
at 20mg/kg. (These effects are evident in the experiments presented in 
section 7.4). The time of administration chosen was day 8 to 12 (single 
administration), because this falls within an important period of CNS de-
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velopment, and includes the most sensitive period of exposure for produ-
cing murine malformations (Gibson and Becker, 1968). Other preliminary 
experiments were performed 
a) to determine that the doses used were less than the minimal 
toxic dose for the mothers and 
b) to determine whether cyclophosphamide per se affects AChE. 
7.3.1. Study to determine whether the doses of cyclophosphamide used were 
below the minimal toxic dose level (M.T.D.) for the adult C3H 
females used 
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This experiment was performed as described for vitamin A in section 6.3.9. 
Cyclophsophamide, 20mg/kg s.c. was administered to 12 animals on the first 
day. The mice were observed for signs of toxicity and were reweighed nine 
days after dosing. (Large numbers of mice were not used as this was thought 
to be wasteful and unnecessary). 
Results and conclusion 
No signs of toxicity or deaths were noted. Table 7.1. gives the mouse 
weights on day O and day 9 and the difference in weight. In 8 mice the 
weight was unchanged, in 3 there was a gain in weight of 0,5 to lg and in 
2 a loss of weight of lg. 
Although the numbers are too small for adequate statistical analysis it 
is apparent there was no obvious toxic effect on adult C3H mice. (A dose 
of 20mg/kg cyclophosphamide was the maximum dose used in this study). 
7.3.2. Experiment to determine whether cyclophosphamide, independent of its 
teratogenic effects, alters brain acetylcholinesterase activity 
Cyclophosphamide, 12,Smg/kg, which was found in preliminary experiments to 
be teratogenic when administered on day 10 p.c., was administered on day 
17 p.c. and fetuses sacrificed the following day, i.e. on day 18 p.c. Day 
17 was chosen because this is late in the period of fetogenesis when 
susceptibility to teratogenic effects is unlikely. Sacrifice 24h later 
T A B L E 7,1, 
MOUSE WEIGHTS ON DAY OF ADMINISTRATION OF 20 mg/kg 
CYCLOPHOSPHAMIDE (DAY 0) AND 9 DAYS LATER 
WEIGHT IN GRAMS 
DAY 0 DAY 9 - WEIGHT 
CHANGE 
23 23 0 
23 23,5 +o.5 
22 22 0 
23 22 -1 
23 23 0 
23 24 +l 
23 23 0 
22 22,5 +o.5 
23 23 0 
23 22 -1 
23 23 0 
22 22 0 
207 
ensured adequate time for the drug to have entered the fetal CNS and 
produce any direct effects. 
Results are shown in Tables 7.2T and 7.2C (original data, pp. 406 and 407). 
A summary of results is given in Table 7.3. 
There was no significant difference in AChE activity between tests and 
controls, nor in fetal or brain weight. 
Conclusion 
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The absence of any difference in AChE between the group treated with 12,Smg/kg 
cyclophosphamide compared with controls suggests that cyclophosphamide, 
independent of its embryotoxic effects, does not alter fetal brain AChE 
activity. 
7.4. RESULTS OF CYCLOPHOSPHAMIDE STUDY 
Tables of original - data are presented at the end of the thesis. 
Summary Tables are given with the text. 
Table 7.4. shows the doses used, the day of administration, the day of 
sacrifice and the specific assay performed. 
7.4.1. Cyclophosphamide, 20mg/kg per mouse, administered on day 10 p.c. 
(sacrifice day 19 p.c.) 
See Tables 7.ST and 7.Sc for original data (pp. 408 and 409). 
Summary of results in Table 7.6. 
Note: There were no signs of maternal toxicity in this or any of the 
subsequent experiments with cyclophosphamide in this chapter. Weight gain 
appeared similar after dosing to that of controls but was not statistically 
compared because of the small numbers in each group. 
There was a 78% incidence of resorptions (43 of 55 conceptions) in the 
TABLE 7.3. 
SUMMARY OF RESULTS OF 12,5mg CYCLOPHOSPHAMIDE 
ADMINISTERED ON DAY 17 p.c. (SACRIFICE DAY 18 p.c.) 
TEST CONTROL 
Total 
Conceptions 20 22 
Resorptions 
(%) 5 9,1 
Intra-uterine 
Deaths 0 9,1 
( %) 
Abnormalities 
(%) 0 5,5 
Median Fetal 1,076 1,068 
Weight (1,028 - 1,121) (1,025 - 1,104) 
(g) 
Median Brain 
Weight 73,10 74,10 
(mg) (65 ,85 -75 ,55) (71,75 - 76,25) 
Median AChE 
2,328 Activity 2,458 
nmol/min/mg (2,196 - 2,502) (2,262 - 2,578) 
Figures in brackets are the 95 % confidence range 











CYCLOPHOSPHAMIDE STUDY : SUMMARY OF EXPERIMENTS PERFORMED 
SHOWING DOSE OF CYCLOPHOSPHAMIDE, DAY OF ADMINISTRATION, DAY OF 
SACRIFICE, AND THE SPECIFIC ASSAY PERFORMED 
' 
Dose of 
cyclophosphamide Day of Day of Assay 
mg/kg administration sacrifice 
20 10 19 Whole brain AChE 
12,5 10 19 " " " 
12,5 10 19 " " " 
12,5 10 18 " " " 
15 10 18 " " " 
7,5 10 19 " " " 
12,5 81l 18 -
12,5 10 14 Whole head AChE 
20 12 13 " " " 
20 10 12 " " II 
20 10 12 II II II 
20 10 12 Whole head haemoglobin 
20 10 14 II II II 
15 10 18 Whole brain ChAT 
20 10 12 Whole head ChAT 
12,5 10 18 Brain isoenzymes 
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TABLE 7.6. 
SUMMARY OF RESULTS OF 20mg/kg CYCLOPHOSPHAMIDE 
ADMINISTERED ON DAY 10 p.c. (SACRIFICE DAY 19 p.c.) 
TEST CONTROL 
Total 
Conceptions 55 21 
Resorptions 78 0 
(%) 
Intra-uterine 
2 4,8 Deaths 
(%) 
Abnormalities 100 0 
(%) 
Median Fetal o,89 1,285 
Weight (0,86 - 0,94) (1,19 - 1,35) 
(g) 
Median Brain 62,3 84,78 
Weight ( 60, 7 - 64 , 0) (81, 6 - 87, 5) 
(mg) . 
Median AChE 2,98 3,28 
Activity (2,89 - 3,07) (3,2 - 3,43) 
nmol/m.in/mg 
Figures in brackets are the 95% confidence range 










treated group compared with 0% in controls, and 1 intra-uterine death 
in each of the test and control groups. All of the 11 viable fetuses 
were abnormal in the treated group. (There were no gross abnormalities 
in the control group). Morphological abnormalities included prominent 
eyes, frank exophthalmos, and heads which were shortened anteroposterior-
ly with hypoplastic faces. Test fetuses were obviously smaller than 
controls. 
The median fetal weight for the test group (890mg) was significantly 
lower than for the control group (1 285mg; p<0,00006), as was the median 
brain weight of treated fetuses (62,3mg) compared with 84,8mg for the 
control group (p<0,00006). 
The median brain AChE activity of test animals, 2,98nmol/min/mg was 
significantly lower than that for controls (3,28nmol/min/mg; p = 0,0014). 
Discussion 
The 78% resorption rate demonstrated that 20mg/kg cyclophosphamide 
administered on day 10 to C3H mice was embryolethal. The fact 
that there were 44 resorptions and only l IUD in a near-term fetus 
suggested that cyclophosphamide at this dose exerted its main embryolethal 
effect in C3H mice early after administration. (The term resorption was 
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+ . used here because the - 2mm necrotic fetal remnants appeared to have large-
ly resorbed). 
The high incidence of resorptions and the 100% incidence of gross abnor-
malities demonstrated that a dose of 20mg/kg was teratogenic. 
The decrease in fetal weight and brain weight were in keeping with the 
growth inhibitory effect of cyclophosphamide (see section 1.3.) The . 
significant decrease in brain AChE was also in keeping with growth 
inhibition. (Because there is an increase in fetal weight, brain weight 
and brain AChE with increasing age, a growth inhibitory effect would be 
expected to be associated with a decrease in these parameters (see 
section 3.3). Another superimposed mechanism, such as a teratogenic one 
affecting AChE, could not be excluded, however. 
7.4.2. Cyclophosphamide, 12,Smg/kg per mouse, administered on day 10 p.c. 
(sacrifice day 18 and 19 p.c.) 
Three experiments were performed. 
See Tables 7.7., 7.9., 7.11 for original data (pp. 410-416). 
Swmnaries of results are presented in Tables 7.8., 7.10. and 7.12. 
Overall for the 3 experiments there was an 11,1% incidence of resorptions 
compared with 6,6% in controls, which was not significant, an 11,1% inci-
dence of intra-uterine deaths compared with 5,3% in controls (p<0,025) 
and an 11,3% incidence of gross morphological abnormalities compared with 
1,9% in controls (p<0,025). Treated fetuses were obviously smaller than 
controls. 
Fetal weights were lower in the test groups compared with controls in all 
3 experiments (p<0,00006). Median fetal weight for test animals in the 
first experiment was 986mg compared with 1 268mg for controls. 
Brain weights were also lower in the test groups compared with controls in 
all 3 experiments (p<0,00006). In the first experiment the median weight 
for tests was 68,15mg and for controls 84,15mg. 
Brain AChE activity was significantly lower for tests than for controls in 
all 3 experiments (p<0,00006). In the first experiment median AChE for 
tests was 2,78 and for controls 3,158nmol/min/mg. 
The lower fetal weight, brain weight and brain AChE of the treated 
group compared with controls in the first experiment is demonstrated 
graphically in Fig. 7.1. 
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TABLE 7.8. 
SUMMARY OF RESULTS OF 12,5mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 19 p.c.) (FIRST EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 33 16 
Resorptions 
21,2 0 (%) 
Intra-uterine 
Deaths 9_,o 0 
(%) 
Abnormalities 
(%) 21,7 0 
Median Fetal 
Weight 0,986 1,27 
(g) (0,94 - l,03) (l,19 - 1,33) 
Median Brain 
68 ,15 Weight 84,15 
(mg) (66,l - 70,4) (81, 6 - 86 ,O) 
Median AChE 
Activity 2,78 3,16 
nmol/mi.... . /mg (2 ,63 - 2 t 91} (3,06 - 3,26) 
Figures in brackets are the 95% confidence range 











T A B L E 7.10. 
SUMMARY OF RESULTS OF 12,5mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 19 p.c.) (SECOND EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 20 23 
Resorptions 
(%) 0 13,0 
Intra-uterine 
Deaths 10 4,3 
(%) 
Abnormalities 5,5 5,3 
(%) 
Median Fetal 1,106 1,320 
Weight Cl, 06 - 1, 15) (1,26 - 1,38) 
(g) 
Median Brain 74,45 86,78 
Weight (72,l - 76,7) (83,6 - 88,6) 
(mg) 
Median AChE 2,928 3,263 
Activity 
nmol/min/mg 
(2,84 - 3,0) (3,17 - 3,35) 
Figures in brackets are the 95% confidence range 










T A B L E 7.12. 
SUMMARY OF RESULTS OF 12,5mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 18 p.c.) (THIRD EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 28 22 
Resorptions 
(%) 7,14 4,5 
Intra-uterine 






Median Fetal 0,836 1,028 
Weight (0,8 - 0,88) (l,O - 1,05) 
(g) 
Median Brain 57,7 70, 3 
Weight (56 ,o - 59, 3} (68,9 - 71,5) 
(mg) 
Median AChE 2,627 2,937 
Activity (2,52 - 2,71) (2,87 - 3,0) 
nmol/min/mg 
Figures in brackets are the 95% confidence range 
































































































































































































































































































































A much lower incidence of rasorptions (11,1% overall in the treated group 
versus 6,6% in the controls, p<O,l) was apparent compared with 78% at a 
dose of 20mg/kg cyclophosphamide administered on day 10 p.c., confirming 
a smaller embryolethal effect with the lower dose. There was also an 
overall 11,1% incidence of IUD's compared with 5,4% in controls (p<0,025) 
which was further evidence for a significant but small embryolethal effect 
of 12,5mg cyclophosphamide administered on day 10 p.c. 
The 11,3% incidence of gross morphological abnormalities compared with 
1,9% in controls (p<0,025) was in keeping with a teratogenic effect, but 
12,5mg/kg was obviously less potent than 20mg/kg. Of note was that a 
significant incidence of gross morphological abnormalities was only 
apparent in the first experiment. Although gross abnormalities are a 
relatively crude indicator of teratogenic effects this would be in keeping 
with the probability that 12,5mg/kg is at the lower end of the tera-
togenic dose-response curve for cyclophosphamide in the C3H mice used, 
where abnormalities in only a few fetuses within a limited number of 
litters would be expected. 
Cyclophosphamide 12,5mg/kg on day 10 resulted in a 16 - 22% decrease in 
fetal weight, a 14 - 19% decrease in brain weight and a 10 - 12% decrease 
in brain AChE activity compared with controls in the 3 experiments, which 
were in keeping with the growth inhibitory effect of the drug. Of interest, 
with a larger dose of 20mg/kg cyclophosphamide administered on day 10, the 
decrease in brain AChE activity was marginally smaller at 9,15%, despite a 
greater decrease in fetal weight of 30,7% and a greater decrease in brain 
weight of 26,5%. The percentage decrease in fetal weight, brain weight 
and brain AChE with increasing doses of cyclophosphamide is shown in Table 
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T A B L E 7.13. 
THE PERCENTAGE DECREASE IN FETAL WEIGHT, BRAIN WEIGHT AND 
BRAIN ACETYLCHOLINESTERASE WITH INCREASING DOSES OF CYCLOPHOSPHAMIDE 
% 
Dose % decrease % decrease decrease 
(mg/kg) in fetal wt. in brain wt. in AChE 
7,5 8,5 6,5 0 
12,5 19,03 17,03 11,0 
20,0 30,7 26,5 9,15 
It is evident that the percentage decrease in fetal and brain weight 
was proportional to the dose of cyclophosphamide administered, but this 
was not the case with brain AChE activity. This may suggest that the 
decrease in brain AChE was not entirely explicable on the basis of the 
growth inhibitory action of cyclophosphamide, although the percentage 
decrease in AChE need not parallel the decrease in fetal and brain weight. 
An experiment was next performed with control fetuses sacrificed on days 
17 and 18 p.c., and cyclophosphamide-treated fetuses sacrificed on day 
18 p.c., in an attempt to compare brain AChE of treated with 
fetuses of similar weight. 
control 
7.4.3. Cyclophosphamide, 15mg/kg, administered on day 10 p.c. (sacrifice 
day 18 p.c.) Controls sacrificed on days 17 and 18 p.c. 
See Tables 7.14T and 7.14C for original data (pp. 417-421). 
Summary of results in Tables 7.15 and 7.16. 
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T A B L E 7. 15. 
SUMMARY OF RESULTS OF 15mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICED ON DAY 18 p.c. AND CONTROLS 
SACRIFICED ON DAY 17 p.c. 
TES'T CONTROL p 
Total 
Conceptions 46 28 -
Resorptions 
(%) 43,5 7,1 <0,01 
Intra-uterine 
Dea~hs 19,6 3,6 <0,02 
(%) 
Abnormalities 
(%) 6,0 0 NS 
Median Fetal 0,796 0,681 <0,001 
Weight (0, 77-0,83) (0,65-0, 71) 
(g) 
Median Brain 




Activity 2,382 1,882 <0,001 
runol/min/mg 
(2,28-2,48) (1,81-1,97) 
Figures in brackets are the 95% confidence range 
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TAB LE 7. 16. 
SUMMARY OF RESULTS OF 15mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 18 p.c. AND CONTROLS 
SACRIFICED DAY 18 p.c.) 
TES:' CONTROL p 
Total 
Conceptions 46 2d -
Resorptions 
(%) 43,5 10 < 0,01 
Intra-uterine 
Dea~hs 19,6 0 < 0,05 
(%) 
Abnormalities 
(%) 6,0 0 NS 
Median Fetal 0,796 o,996 <0,002 
Weight 
(g) 




67,35 < 0,002 
(56,1-59,9) (64,9-69,4) 
Median AChE 2,382 2,425 NS 
Ac-civity I 
nmol/min/mg 
(2, 28-2 ,48) (2,37-2,51) 
Figures in brackets are the 95% confidence range 
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There was a 43,5% incidence of resorptions in the treated group compared 
with 7,1% in controls (p<0,01). As expected the incidence of resorptions 
was higher than dosing with 12,Smg/kg (12,2%) and lower than dosing with 
20mg/kg (78%) (see Fig. 7.3). 
There was a 19,6% incidence of intra-uterine deaths compared with 3,6% 
in controls. This was higher than the 11,1% incidence with 12,Smg/kg 
cyclophosphamide. (The low incidence of 2% IUD's with 20mg/kg (section 
7.4.1.) was probably accounted for by the high resorption rate (with a 
small number of remaining viable fetuses) demonstrating an earlier embryo-
toxic effect with this higher dose. 
One fetus in the treated group had exophthalmos. There were no abnor-
malities in the control group. There was a lower fetal weight in the 
test group (median fetal weight 0,796g) compared with controls of the 
same age, i.e. 18 days p.c. (median weight 0,996g, p<0,002). There was 
also a significantly lower brain weight in the treated group (median 
57,95mg) compared with controls of the same age (median 67,35mg, p<0,002). 
Although the median brain AChE activity in the treated group was lower 
than in controls of the same age (2,382 compared with 2,425nmol/min/mg 
respectively) this was not significant. However, brain AChE of 18 day 
treated fetuses was highly significantly greater than 17 day controls 
(median brain AChE 2,382 and l,882nmol/min/mg respectively, (p<0,001) 
although median brain weight was only marginally higher in the 18 day 
treated group (median 57,95mg compared with 54,6mg, p = 0,01). Figure 
7.4. shows the relationship of brain AChE activity to brain weight in the 
17-day and 18-day controls and the 18-day cyclophosphamide-treated 
fetuses. The higher brain AChE activity of 18-day treated fetuses 
is apparent compared with the 17-day control fetuses of similar brain 
weight. For a given brain weight, therefore, cyclophosphamide-treated 
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fetuses have a higher AChE activity than controls, and one is tempted to 
speculate that, despite the effect of the teratogen to retard growth or 
development, and to therefore be associated with a decrease in AChE, this 
appears to have been offset by an independent effect of the teratogen to 
increase the enzyme. However, fetal weights (which would have been a more 
reliable index of growth inhibition) of the two groups were not comparable, 
the 18-day treated fetuses weighing significantly more than controls, which 
may have accounted for the difference in enzyme activity. Unfortunately 
it was apparent that to try and resolve the issue large numbers of fetuses 
would have been needed to enable comparison of adequate samples of similar 
weight. 
7.4.4. Cyclophosphamide, 7,5mg/kg per mouse, administered on day 10 p.c. 
(sacrifice day 19 p.c.) 
See Tables 7.17T and 7.17C for original data (pp. 422 and 423). 
Summary of results in Table 7.18. 
This experiment was performed to determine the effect of a lower dose of 
cyclophosphamide. 
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There were 4 resorptions in the test group (15,4%), 3 of which were in one 
animal, compared with 1 resorption in the controls. There we~e no intra-
uterine deaths in the test group but 2 in the control group (8,0%). No 
gross morphological abnormalities were observed. Fetal and brain weights 
were significantly lower in the test group (p<0,00006 and p = 0,0006, 
respectively), but there was no meaningful difference in brain AChE acti-
vity between test and controls (median AChE values 3,304 and 3,296nmol/min/mg, 
respectively). 
Discussion 
The incidence of resorptions of 15,4% was higher than that with 12,5mg 
cyclophosphamide administered on day 10. However, three of the four 
T A B L E 7.18. 
SUMMARY OF RESULTS OF 7,5mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 19 p.c.) 
TEST CONTROL 
Total 26 25 
Conceptions 
Resorptions 15,4 4,0 
(%) 
Intra-uterine 
Deaths 0 8,0 
(%) 
Abnormalities 
(%) 0 0 
Median Fetal 1,24 1,35 
Weight (1, 19 - 1,27) (1,32 - 1,39) 
(g) 
Median Brain 80,5 86,1 
Weight (78, 9 - 82, 2} (83,1 - 88,1} 
(mg) 
Median AChE 3,304 3,296 
Activity (3, 18 - 3, 39) (3,18 - 3,38) 
:-...mol/mi."'l/mg 
I 
Figures in brackets are the 95 % confidence range 










resorptions were in the same litter and probably either represent an 
unusually susceptible litter or a chance high spontaneous resorption 
rate. (The one resorption in the remaining 23 conceptions gives a re-
sorption rate of 4,7%). The two IUD's in the control group are expli-
cable on the basis of spontaneous deaths. 
The significantly lower fetal and brain weights are again in keeping . 
with the growth retarding effects of cyclophosphamide. Note, however, 
the proportionately smaller decrease in weight compared with higher 
doses (see Fig. 7.2). The lack of any significant difference in brain 
AChE may have been due to the fact that the mild growth inhibitory 
effect (there was only an 8,5% decrease in fetal weight and a 6,5% de-
crease in brain weight compared with controls) may not have been large 
enough to be associated with a decrease in brain AChE. Alternatively, al-
though 7,5mg/kg is a growth inhibitory dose, the absence of morphological 
abnormalities may suggest the absence of other embryotoxic effects. 
7.4.5. Cyclophosphamide, 12,5mg/kg per mouse, administered on day 8~ p.c. 
(sacrifice day 18) 
See Table 7.19. for original data (p. 424). 
This experiment was performed to compare the effects of the teratogen when 
administered earlier in gestation. 
Three pregnant C3H females were used. Although they appeared healthy at 
the time of sacrifice there were 18 resorptions and only l live fetus 
which appeared grossly normal. (Controls were not sacrificed). 
Discussion 
Administering 12,5mg/kg cyclophosphamide on day 8~ as opposed to day 10 
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p.c. was highly embryolethal (94,7% incidence of resorptions), demonstrating 
the considerably greater sensitivity of the embryo earlier in development. 
Finding a single live, grossly normal fetus demonstrates the variability 
in susceptibility to a teratogen within the same litter. 
Further Experiments 
Because (i) repair of any CNS damage could have been complete by the 
usual time of sacrifice of day 18 or 19 p.c. and therefore mask bio-
chemical changes, and (ii) inhibition of growth appeared to be marked 
by day 19 and was associated with a decrease in AChE activity at doses 
of 12,5 and 20mg/kg cyclophosphamide, fetuses were examined earlier (days 
11 to 14 p.c.) in the following experiments. It was anticipated that ex-
amining fetuses soon after administration of the teratogen would minimise 
growth inhibitory effects, and repair, and therefore permit assessment of 
biochemical changes independently of the above influences. 
Note: 
a) The small size of the fetuses and the early stage of development made 
assessment of gross morphological abnormalities difficult. 
b) The whole head (which comprises mainly brain at this early stage of 
gestation) was used for AChE assay. 
7.4.6. Cyclophosphamide, 12,5mg/kg per mouse, administered on day 10 p.c. 
(sacrifice day 14 p.c.) 
See Tables 7.20T and 7.20C for original data (pp. 425 and 426). 
Summary of results in Table 7.21. 
There was no difference in the incidence of resorptions or intra-
uterine deaths. As with sacrifice on day 19, the median fetal ' weight 
and brain weight of treated animals of 135mg and 51,1mg, respectively, 
were lower than for controls (169mg and 63,7mg, respectively, p<0,00006). 
However, no difference could be shown between whole head AChE activity of 
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T A B L E 7.21. 
SUMMARY OF RESULTS OF 12,5mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 14 p.c.) 
TEST CONTROL 
Total 22 21 
Conceptions 
Resorptions 9,1 4,5 
(%) 





Median Fetal 0,135 o,169 
Weight (0,125 - 0,148) (0,161 - 0,178) 
(g) 
Median Head 51,1 63,65 
Weight (44,4 - 57 ,8) (60,4 - 66,5) 
(mg) 
Median AChE 1,012 1,044 
Activity (0,96 - 1,07) (1,0 - 1,1) 
nmol/m.L""l/mg 
Figures in brackets are the 95% confidence range 










test and control animals. 
Discussion 
The significant decrease in fetal weights and head weights in the treated 
group (p<0,00006) confirm an early growth inhibitory effect of cyclophos-
phamide. The absence of a difference in AChE (when a decrease in AChE 
was found with the same dose of cyclophosphamide but sacrifice on day 19) 
is interesting. The relevance of this became ~pparent after results 
from subsequent experiments were examined and will be discussed later. 
Because of the possibility that repair could have been complete 4 days 
after dosing with cyclophosphamide (see discussion in section 1.3.), 
sacrifice was performed earlier in the ensuing experiments. 
7.4.7. Cyclophosphamide, 20mg/kg per mouse, administered on day 12 p.c. 
(Sacrifice day 13 p.c.) 
In an attempt to avoid working with fetuses that were too small, but which 
were sacrificed within a day or 2 of dosing, dosing on day 12 was used 
in this experiment. 
See Tables 7.22T and 7.22C for original data (pp. 427 and 428). 
Summary of results in Table 7.23. 
There was no significant difference in fetal weight, head weight or AChE. 
Discussion 
The fact that there was not the usual decrease in fetal and head weight 
in the treated group could be explicable on the basis that a growth in-
hibitory effect was not significantly manifested as early as 24h after 
dosing. Alternatively, dosing later in gestation on day 12 as opposed to 
day 10, might be anticipated to be less embryotoxic and to not have as 
a pronounced a growth retarding effect. 
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T A B L E 7.23. 
SUMMARY OF RESULTS OF 20mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 12 p.c. (SACRIFICE DAY 13 p.c.) 
TEST CONTROL 
Total 
Conceptions 22 20 
Resorptions 
(%) 4,5 10 
Intra-uterine 
Deaths 0 0 
(%) 
Abnormalities 
(%) 0 0 
Median Fetal 0,113 0,117 
Weight 
(0,109 - 0,118) (0,110 - 0,124) (g) 
Median Head 45,75 49,45 
Weight (43, 3 - 48, 2) (46,3 - 53,1) (mg) 
Median AChE 0,805 0,816 
Activity (0, 78 - 0,82) (O, 78 - 0,85) 
nmol/min/mg 
Figures in brackets are the 95% confidence range 










7.4.8. Cyclophosphamide, 20mg/kg per mouse, admL~istered on day 10 p.c. 
(Sacrifice day 12 p.c.) 
Because of the absence of apparent embryotoxic effects with dosing on day 
12 p.c., mice were dosed earlier on day 10 in this experiment. 
See Tables 7.24T and 7.24C for original data (pp. 429-431). 
Summary of results in Table 7.25. 
The median fetal weight and brain weight of treated animals of 418mg 
and 15,5mg, respectively, were lower than for controls (714mg and 25,6mg, 
respectively, p<0,00006). A greater head AChE activity of 
l,2nmol/min/mg in the test fetuses was apparent compared with controls 
(1,lnmol/min/mg, p = 0,02). Although 20mg/kg cyclophosphamide adminis-
tered on day 10 was shown to produce a high resorption rate in an earlier 
experiment, treated fetuses were still viable as assessed by the presence 
of a regular heartbeat. The embryolethal effect of cyclophosphamide must 
therefore be manifest after day 12 (presumably shortly after day 12 to 
account for the high resorption rate in section 7.4.1). 
Because of the unusual finding of a trend for a higher AChE activity 
in treated fetuses in the face of obvious growth retardation this ex-
periment was repeated. 
See Tables 7.26T and 7. 26C (pp. 432 and 433). 
Summary of results in Table 7.28. 
Again an obviously lower fetal and head weight was apparent in the 
treated group (p<0,00006), and were associated with a greater head 
AChE activity of l,24nmol/min/mg compared with controls (1,14nmol/min/ 
mg, p<0,001). 
Some control fetuses were sacrificed on day 11 p.c. to compare enzyme 
activity with day 12 p.c. (see Tables 7.29. and 7.30, pp. 236 and 237). 
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T A B L E 7.25. 
SUMMARY OF RESULTS OF 20mg/kg CYCLOPHOSPHAMIDE ADMINISTERED 
ON DAY 10 p.c. (SACRIFICE DAY 12 p.c.) (FIRST EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 32 2l 
Resorptions 
(%) 12,5 4,8 
L'ltra-uterine 
Deat.hs 6,3 0 
(%) 
Abnormalities 
(%) 15,4 0 -
Median Fetal 0,418 0,714 
Weight 
(0,38 - 0,45) (g) (0,66 - 0, 77) 
Median Head 15,5 25,55 
Weight (13,9 - 17 ,O) (23,2 - 27 ,8) (mg) 
Median AChE 1,175 1,11 Activity 
nmol/min/mg (1,14 - 1,24) (1,08 - 1, 16) 
Figures in brackets are the 95% confidence range 










T A B L E 7.28. 
SUMMARY OF RESULTS OF 20mg/kg CYCLOPHOSPHAMIDE ADMINISTERED ON 
DAY 10 p.c. (SACRIFICE DAY 12 p.c.) (SECOND EXPERIMENT) 
TEST CONTROL 
Total 
Conceptions 22 26. . 
Resorptions 
(%) 4,5 11,5 
Intra-uterine 
Deat.hs 4,5 3,8 
(%) 
Abnormalities 
(%) 15 0 
Median Fetal 
Weight 0,494 o,678 
(g) (45,95 - 52,3) (63,5 - 71,7) 
Median Head 
Weight 11,93 18,7 
(mg) (10,2 - 13 ,85) (16,5 - 21,0) 
Median AChE 
1 , 24 Activity 1,142 
nmol/min/mg (1,207 - 1,273) (1,109 - 1,175) 
Figures in brackets are the 95% confidence range 











FETAL WEIGHT, HEAD WEIGHT AND HEAD ACETYLCHOLINESTERASE ACTIVITY 
OF 11 DAY FETUSES 
No. Fetal wt. Head Wt. Head AChE 
(mg) (mg) (runol/min/mg) 
Cl 35,5 9,2 o,881 
C2 15,3 7,2 1,012 
CJ 28,6 9,1 0,914 
C4 28,6 10,3 0,783 
cs 36,1 8,4 0,946 
C6 44,8 8,8 0,816 
C7 23,4 7,7 1,077 
cs 36,1 14,2 0,914 
C9 33,0 7,7 0,979 
ClO 31,8 9,9 0,979 
Cll 29,6 7,9 0,979 
Cl2 34,3 7,9 0,979 
Cl3 33,0 7,6 o,914 
Cl4 26,7 6,8 0,848 
ClS 23,8 7,7 0,979 
Median 30 ,8 8,4 0,946 




FETAL WEIGHT, HEAD WEIGH.T AND HEAD AChE ACTIVITY OF 12 DAY FETUSES 
No. Fetal wei.ght Head wei..ght Head AChE 
ungI 0ng1 (nmol/mi..n/mg) 
Cl 61,9 13,9 1,109 
C2 63,2 18,3 1,109 
C3 78,7 31,1 1,109 
C4 61,6 20,5 1,044 
cs 81,5 26,3 1,109 
, 
C6 70,9 17,0 1,109 
C7 60,6 18, 3 1,175 
ca 63,1 13,9 1,240 
C9 73,0 23,0 1,109 
ClO 76,1 19,1 1,175 
Cll 60,2 13 ,9 1,207 
Cl2 56,1 14,7 1,175 
Cl3 69,7 19,1 1,175 
Cl4 77 ,o 23, 5 0,848 
ClS 65,3 12,6 1,272 
Cl6 70,4 21,2 (spoilt} 
Cl? 99,0 25,0 0,946 
Cl8 66,2 21,7 1,175 
Cl9 59,0 14,7 1,272 
C20 60,1 14,8 1,109 
C21 73,5 17,6 1,175 
C22 64,7 17,0 1,175 
Median 67,8 18,7 1,142 
± (60, 3-81, 5.) (16,5-21,0) (1,012-1,224) 
p <0,00003* <0,00003* <0,00003* 
* comparison with data in Table 7.29. 
Median head AChE activity of 11 day control fetuses of o,946nmol/min/ 
mg was lower than for 12 day control fetuses (1,142nmol/min/mg, <0,00003. 
Discussion 
The decrease in fetal and head weight was again in keeping with a 
growth inhibitory effect of cyclophosphamide. A rapid onset of growth 
depression must have occurred to explain this effect. This contrasts 
with dosing later in gestation (day 12} where no significant growth 
retardation was apparent 24h after administration. 
In the fact of a decrease in fetal and head weight the increase in 
head AChE activity appeared to add further support to the likelihood 
that cyclophosphamide had an effect on AChE which was independent of 
the growth inhibitory effect. {The increase was unlikely to be ex-
plicable on the basis of retarded development as younger fetuses had 
a lower head AChE activity). 
A possible explanation for the increased head AChE activity was sugges-
ted by the observation that the brains of some of the cyclophosphamide 
treated fetuses had small areas of haemorrhage (haemorrhagic necrosis 
has been noted in the literature - see section 1.3}. Because AChE ac-
tivity in 12 day fetal heads is low it was possible that blood AChE was 
accounting for the higher activity (median AChE activity of 18 day fetal 
blood was found to be l,7lnmol/min/mg - see section 3.12}. The haemo-
globin concentration in heads of treated fetuses was therefore compared 
with that of controls as an index of the amount of blood present (see 
section 3.12). 
7.4.9. Cyclophosphamide, 20mg/kg per mouse, administered on day 10 p.c. 
(Sacrifice day 12 p.c.) Comparison of head haemoglobin concen-
tration with that of controls 
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Haemoglobin determination was performed using the cyanmethemoglobin 
method (see section 3.12). Absorbance at 540nm of head homogenate 
(20mg/ml) from treated fetuses was compared with controls. 
Results are given in Table 7.31 (p. 240). 
Discussion 
As noted in previous experiments the fetal weight and head weight of 
cyclophosphamide-treated fetuses were significantly lower than that 
for controls (p<0,001). The median absorbance at 540nm for cyclophos-
phamide treated fetal heads was 0,012, and for untreated fetuses 0,004, 
(p<0,001) i.e. 2,86 times higher for the treated group. This was in 
keeping with a significantly greater amount of blood in treated fetal 
heads, which was therefore the likely explanation for the increased 
AChE activity. (Because of the minute size of the 12 day fetuses it was 
impossible to collect sufficient blood for AChE determination. However, 
as already mentionedr median AChE activity of 18 day fetal blood was 1,71 
nmol/min/mg which was higher than that of 12 day fetal brains). 
7.4.10. Cyclophosphamide, 20mg/kg per mouse, administered on day 10 p.c. 
(Sacrifice day 14 p.c.) Comparison of head haemoglobin concen-
tration with that of controls 
This experiment was performed in an attempt to determine whether the 
absence of an increase in AChE in the treated group compared with controls 
4 days after dosing in section 7.4.6. was related to the presence or ab-· 
sence of blood. Haemoglobin determination was performed using the cyan-
methemoglobin method (see section 3.12). Absorbance at 540nm of head 
homogenate (20mg/ml) from treated fetuses was compared with controls. 
Results are given in Table 7.32 (p. 241). 
There was no significant difference in absorbance at 540nm between tests 
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T A B L E 7.32. 
RESULTS OF CYCLOPHOSPHAMIDE 20mg/kg ON DAY 10 p.c. (SACRIFICE DAY 
14 p .c.) COMPARISON OF HEAD ABSORBANCE AT 540nm 
TEST CONTROL 
NO. 
HEAD ABSORBANCE HEAD ABSORBANCE 
(540nm) (540nm) 
20mg/ml head homogenate 20mg/ml head homogenate 
1 0,0058 0,0059 
2 0,0073 0,0082 
3 0,0087 0,0077 
4 0,0055 0,0065 
5 0,0052 0,0042 
6 0,005~ 0,0095 
7 0,0081 0,0061 
; 
8 0,006 0,0063 
9 0,0081 0,0051 
10 0,0055 0,006 
11 0,0082 0,0063 
12 0,0120 0,0045 
13 0,007 0,0053 
MEDIAN 0,00695 0,0062 
(0,0058 - 0,0084) (0,0053 - 0,0073) 
p NS 




The absence of a greater head AChE activity in the treated group 4 
days after dosing (section 7.4.6.) was therefore not associated with 
in increase in head haemoglobin. This suggested considerable repair 
with resorption of blood had occurred after 4 days, which contrasted 
with the findings 2 days post administration of the teratogen (secticn 
7.4.8. and 7.4.9). 
7.4.11. Cyclophosphamide 15mg/kg administered on day 10 p.c. (Sacrifice 
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day 18 p.c.) Determination of choline acetyltransferase activity 
This experiment was performed to compare the effect of cyclophosphamide 
on ChAT activity with that on AChE, where a decrease in activity accom-
panied a lower fetal and brain weight (see section 7.4.2). 
Results and discussion 
See Tables 7.33T and 7.33C for original data (pp. 434-436). 
Summary of results in Table 7.34. 
There was a 26,5% resorption rate in the treated group (a higher incidence 
than with 12,5mg/kg) compared with 0% in controls (p<0,02) and a 8,8% in-
cidence of IUD's compared with 0% in controls. One fetus treated with 
cyclophosphamide had exophthalmos. There were no abnormalities in the 
control group. 
There was a significantly lower fetal weight in the treated group compared 
with controls (median fetal weight= 0,8214g and 1,062g respectively, 
p<0,00006). Brain weights were also significantly lower in the test group 
compared with controls (median= 57,0mg and 68,85mg respectively, p<0,00006) 
as was the brain ChAT activity (median 568 d.p.m. and 734 d.p.m. respec-
tively, p = 0,008). A similar effect was noted with AChE (see section 
T A B L E 7.34. 
SUMMARY OF RESULTS OF CYCLOPHOSPHAMIDE 15mg/kg 
ADMINISTERED ON DAY 10 p.c. (SACRIFICE DAY 18 p.c.) 
TEST CONTROL 
Total 
Conceptions 34 21 
. 
Resorptions 
26,5 0 (%) 
' 
Intra-uterine 
Deaths 8,8 0 
(%) 
Abnormalities 
(%) 4,5 0 
Median Fetal 
Weight 0,8214 1,062 
(g) (0,7936-0,8579) (l,036-1,088) 
Median Brain 57,0 68,85 
Weight 
(55,1-59,0) (67, 1-71,0) (mg) 
Median ChAT 
Activity 568 734 
d.p.m. 
(505-668) (647-820) 
Figures in brackets are the 95% confidence range 










7.4.4.) and is consistent with the growth inhibitory effect of cyclo-
phosphamide (there is a slow continuous rise in ChAT activity in brain 
tissue during development (Bus and Gibson, 1974). Developmental retar-
dation resulting from cyclophosphamide administration would therefore 
be anticipated to be associated with a lower enzyme activity compared 
with controls). 
(As was noted with previous ChAT experiments (see section 6.6.) a wide 
variation in ChAT activity between brain samples was apparent). 
7.4.12. Cyclophosphamide 20mg/kg per mouse, administered on day 10 p.c. 
(Sacrifice day 12 p.c.) 
This experiment was performed to compare the effects of cyclophos-
phamide on ChAT activity with those on AChE activity. Maternal in vivo 
administration of cyclophosphamide 20mg/kg on day 10 resulted in an 
increased head AChE activity, thought to be on the basis of increased 
blood (see sections 7.4.8 and 7.4.9). As blood does not contain sig-
nificant quantities of ChAT this experiment was performed to assess 
the effect of cyclophosphamide on head ChAT activity independent of the 
effect of blood and to therefore further elucidate the cause for the in-
creased AChE activity. 
See Tables 7.35T and 7.35C for original data (pp. 437-439). 
A summary of results is given in Table 7.36. 
There were three resorptions in the test group and two IUD's. In the 
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one dead fetus the whole brain looked haemorrhagic. In two of the viable 
fetuses small haemorrhagic areas were apparent macroscopically in the 
brains and blood stained liquor was apparent with two others. There was 
one resorption in the control group and no abnormalities were apparent. 
A significant decrease in fetal and brain weight in the treated group 
(p<0,00006), as noted in previous experiments with this dose, was appa-
TABLE 7.36. 
SUMMARY OF RESULTS OF CYCLOPHOSPHAMIDE 
20mg/kg ADMINISTERED ON DAY 10 p.c. (SACRIFICE DAY 12 p.c.) 
TEST CONTROL 
Total 25 23 
Conceptions 
Resorptions 12 4 
(%) 
Intra-uterine 
Deaths 9,1 0 
(%) 
Abnormalities 20 0 
(%) 
Median Fetal 0,052 0,066 
Weight (0,048-0,055) (0,063-0,07) 
(g) 
Median Head 





Activity 661,8 729 
d.p.m. 
(633 - 701) (675 - 779) 
Figures in brackets are the 95% confidence range 











rent. HeadChAT activity of treated fetuses was 662 d.p.m. which was 
lower than controls (729 d.p.m.), but only at the p = 0,06 level. 
Discussion 
The low ChAT activity in 12 day fetal heads compared with 18-day fetal 
mouse brains is apparent (median blank activity was 676 d.p.m. and was 
not subtracted when analysing results because of the low total activity.) 
The lower head ChAT activity in the treated group as opposed to the 
higher AChE activity noted in the previous experiments lends further 
support to the suggestion that the higher AChE was due to the presence 
of increased blood. If another effect, independent of a haemorrhagic 
process, had caused the increased AChE activity a similar rise in ChAT 
activity might have been acticipated. (If, for example, the cause of 
the higher AChE activity was exuberant repair of cholinergic neurons, 
then the synthetic enzyme of acetylcholine, ChAT, would also be expected 
to be increased). 
Despite the absence of statistical significance the lower head ChAT 
activity in the treated group compared with controls would be in keeping 
with the growth inhibitory effect of cyclophosphamide. (The very low 
ChAT activity and wide variation in activity between samples reduced 
the likelihood of demonstrating a significant difference). 
7.5. ANALYSIS OF THE ISOENZYMES OF FETAL BRAIN ACETYLCHOLINESTERASE : 
CYCLOPHOSPHAMIDE, 12,Smg/kg PER MOUSE ADMINISTERED ON DAY 10 p.c. 
(SACRIFICE DAY 17 p.c.) 
Separation and densitometric analysis of the isoenzymes of AChE were 
performed as described in Chapter 5. The isoenzymes from 18 brain 
homogenates of treated fetuses were compared with those from 18 controls. 
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Results 
Five isoenzymes were present in all test and control samples. No 
obvious difference was apparent on visual inspection of the gels 
between tests and controls, and the isoenzyme pattern was the same 
as that observed in 18- and 19-day fetuses in previous experiments. 
Peak heights were measured from the best apparent baseline. The same 
three methods of analysis of the densitometric results as described 
for vitamin A in section 6.7 were used. Statistical analysis was per-
formed by the Tukey modification of the Willcoxon signed ranks test 
and the Mann Whitney U test. In addition, some of the peaks were 
analysed by the Kolmogorov-Smirnov two-sample test. 
A summary of the results obtained using the three methods of analysis 
is given in Table 7.37. 
Discussion 
As expected from the decreased brain AChE activity (using the Ellman 
technique, section 7.4.2) of animals treated with cyclophosphamide, 
the sum of the peak heights of the isoenzymes was apparently lower 
for tests than for controls, but this did not reach statistical sig-
nificance. The median peak height of band 4 for treated fetuses (21mm) 
was significantly lower than for control fetuses (31mm, p<0,02), as 
were the median ratios using methods 2 and 3. Also of interest was that 
for band 5 the median peak height appeared to be slightly higher than 
for controls (43,25mm and 39mm respectively), although this was not sig-
nificant. 
7.6. SUMMARY AND DISCUSSION OF CYCLOPHOSPHAMIDE STUDY 
In this study a dosage range from 7,5mg to 20mg/kg cyclophosphamide per 
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TABLE 7.37. 
SUMMARY OF DENSITOMETRIC RESULTS 
CYCLOPHOSPHAMIDE, 12,5mg/kg, ADMINISTERED ON DAY 10 p.c. 
Method 1 Method 2 Method 
median 




C 35 o,525 0,6975 
1 NS NS 
T 33,63 0,520 0,6950 
C 75 1,120 1,500 
2 NS NS 
T 73,5 1,168 1,455 
C 68,5 - 1,365 
3 NS -
T 64 - 1,280 
C 31 0,4675 0,6375 
4 <0,02 <0,02 
T 21 0, 3350 0,4250 
C 39 o,5600 o,7650 
5 NS NS 
T 43,25 0,6775 0,8725 
Sum C 250,5 3,710 5,030 
of 
/ 
1-5 NS NS 
T 235,8 3,673 4,798 











mouse was used, which resulted in a spectrum of observations from 
growth inhibition alone at lower doses to gross malformations and 
embryolethal effects at higher doses. Dosing on a single day was 
suitable for producing embryotoxic effects. The highest dose used 
of 20mg/kg appeared to be below the maternal M.T.D. and no toxicity 
was observed in the dams in any of the experiments. This lends support 
to a direct effect of the drug on the embryo. 
As was noted with vitamin A, the incidence of resorptions increased with 
an increase in dose, reaching 78% with 20mg/kg administered on day 10 
p.c. (see Fig. 7 .3). 
The embryolethal effect of cyclophosphamide must have been manifest 
after day 12 because there was no significant increase in mortality 
noted in fetuses examined on day 12, but presumably occurred shortly 
after this to account for the high incidence of resorptions, and not 
later intra-uterine deaths, when fetuses were examined on day 18 p.c. 
Dosing earlier in gestation with 12,Smg/kg on day 8~ p.c. was associated 
with a substantial increase in the incidence of resorptions of 94,7%, 
compared with 11,1% on day 10. (A similar dose-dependent increase in 
resorption rate was noted in Swiss-Webster mice when cyclophosphamide 
was administered intraperitoneally on day 10 p.c. by Gibson and Becker 
(1968), although a low dose of Smg/kg was obviously embryolethal causing 
a 20% resorption rate, which increased to 37% on doubling the dose to 
lOmg/kg. Cyclophosphamide, 20mg/kg resulted in a 67% resorption rate, 
whereas the same dose given a day earlier on day 9 caused a 97% resorp-
tion rate). 
Intra-uterine deaths 
A dose of 7,Smg/kg was not associated with a significant incidence of 
IUD's but there was a small increase from 11,1% to 15% with a change 
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in dose from 12,S to 15mg/kg (a higher dose of 20mg/kg exerted an em-
bryolethal effect earlier resulting predominantly in resorption rather 
than later intra-uterine death). The age of dead fetuses was judged 
to be about 14 days, which, taking the growth inhibitory effect of 
cyclophosphamide into account would indicate that death probably 
occurred 4 to 5 days after administration. 
Gross Morphological abnormalities 
These were less frequently observed than with vitamin A. Furthermore, 
in contrast to vitamin A, the cyclophosphamide dose-response curve for 
gross malformations with lower doses was to the right of that for 
embryolethality (although it must be emphasised that these were gross, 
and by inference not total abnormalities). Gibson and Becker (1968) 
and Gebhardt (1970) also noted that smaller doses of 5 to lOmg/kg resul-
ted in an increased incidence of resorptions with no discernible abnor-
malities. The results in this study (section 7.4.1. where there was a 
100% abnormality and 78% resorption rate) suggest that with the higher 
dose of 20mg/kg, however, the dose response curve for malformations has 
moved to the left of the mortality curve. The predominant malformations 
observed with dosing on day 10 were defects of the eye (prominent eyes 
or exophthalmos) and craniofacial deformities. Areas of cerebral 
haemorrhage were evident in some 12-day fetuses after 20mg/kg on day 10, 
which is in keeping with the described CNS effects (Kreybig and Smidt, 
1967; Wendler, 1979). 
Fetal weight and brain weight 
There was a dose-dependent decrease in fetal weight and brain weight (see 
Fig. 7.2), which was in keeping with the growth inhibitory effect of the 
teratogen. The reduction appeared to be independent of a teratogenic 
effect, with the dose response curve for growth inhibition to the left 
of that for embryolethality and malformations. A similar finding was 
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noted by Bus and Gibson (1973) with ifosfamide, a structural analogue 
of cyclophosphamide. 
Acetylcholinesterase 
In 18- and 19-day fetuses there was a decrease in AChE activity. This 
occurred in association with a decrease in fetal and brain weight, and 
with doses that were teratogenic, as judged by gross morphological 
abnormalities in some of the fetuses. A dose of 7,Smg/kg on day 10 
which did not appear to be teratogenic, but which was associated with 
a decrease in fetal weight and brain weight, did not result in any change 
in AChE compared with controls. Although the decrease in fetal weight 
and brain weight was dose dependent this was not the case with AChE (see 
Fig. 7.2). The decrease appeared to be maximal with a dose of 12,Smg/kg 
on day 10 p.c., with no further decrease at a dose of 20mg/kg. The 
possibility of an effect on AChE, perhaps teratogenic, independent of 
a growth retarding effect, was raised but not proven. 
Examination of fetuses 2 days after dosing on day 12 revealed an increase 
in head AChE despite a decrease in fetal weight and head weight. This 
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was associated with a 2,86 times greater head haemoglobin suggesting that 
blood was responsible for this increase, probably as a result of a 
haemorrhagic process. Although examining fetuses shortly after adminis-
tration of the teratogen should have reduced the influence of growth in-
hibitory effects and repair processes, the substantial amount of blood which 
resulted in an increase in AChE activity confounded the possibility of 
assessing possible changes in AChE independent of the above two parameters. 
The absence of an increase in head AChE activity in the treated group 4 
days after dosing (section 7.4.6) was not associated with an increase in 
haemoglobin (section 7.4.10) and suggested that considerable repair with 
resorption of blood had occurred by this stage. The absence of a decrease 
in head AChE in this experiment despite a significant growth inhibitory 
effect was also interesting. A possible mechanism could have been exu-
berant repair of cholinergic neurons (compare vitamin A) which masked 
a decrease in AChE associated with the growth inhibitory effect. The 
absence of increased brain haemoglobin in the treated group tended to 
exclude the possibility that some residual blood accounted for the 
absence of a decrease in AChE activity. 
The absence of an increase in head AChE on day 13, after administration 
of cyclophosphamide 20mg/kg on day 12 p.c., suggested the absence of a 
haemorrhagic process. This is consistent withe the principle that the 
fetal CNS is likely to be less susceptible to the embryotoxic effects 
of this dose later in gestation. 
Choline acetyltransferase 
As with AChE, the median brain ChAT activity of 568 d.p.m. in fetuses 
treated with 12,5mg/kg on day 10 was lower than that of controls 
(734 d.p.m., p = 0,008). This was also associated with a significant 
decrease in fetal weight and brain weight and was consistent with the 
growth inhibitory effect of the teratogen. Head ChAT activity in 12 
day fetuses was also lower than controls (section 7.4.12) which contras-
ted with the higher AChE activity and was further indirect evidence that 
the higher AChE was due to the presence of blood. 
The only significant finding on examination of the isoenzymes of AChE 
was a lower peak height for band 4 for treated fetuses (21mm) compared 
with 31mm for controls (p<0,02). This is clearly different to the 
findings of a greater peak 5 and sum of the peak heights after vitamin A 
administration on day 10 (section 6.7) and demonstrates different effects 
of the two teratogens on the isoenzymes. 
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7.7. CONCLUSIONS 
It is concluded from this study that: 
a) A dosage regimen of 20mg/kg cyclophosphamide or less was not 
associated with significant maternal toxicity. 
b) In vivo maternal administration of cyclophosphamide resulted in 
a dose-related increase in the incidence of resorptions and 
intra-uterine deaths, although a high dose of 20mg/kg resulted 
predominantly in resorptions rather than later intra-uterine deaths. 
c) Administration of cyclophosphamide on day 8~ of gestation resulted 
in a steep increase in resorption rate. 
d) There appeared to be a dose dependent decrease in fetal weight 
and brain weight (Fig. 7.2), which was in keeping with the growth 
inhibitory effect of cyclophosphamide. 
e) The dose-response curve for growth inhibition was to the left of 
that for malformations and embryolethality and appeared to be in-
dependent of a teratogenic effect. 
f) Cyclophosphamide, independent of its embryotoxic effects, did not 
influence fetal brain AChE activity. 
g) Cyclophosphamide administration of 12,Smg/kg or more on day 10 
resulted in a decrease in brain AChE and ChAT activity in 18- or 
19-day fetuses and was associated with a decrease in fetal weight 
and brain weight. 
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h) The increase in head AChE activity in fetuses examined 2 days 
after dosing in the face of an increased haemoglobin but decreased 
ChAT activity suggest that the increase was due to blood, which is 
compatible with a haemorrhagic process. 
i) Repair processes appear to have been completed by 4 days after 
administration as judged by an absence of an increase in head 
haemoglobin or AChE compared with controls. 
j) The administration of 12,Smg/kg cyclophosphamide was associated 
with a significantly lower peak height for isoenzyme band 4 (21mm), 
compared with controls (31mm, p<0,02). 
k) Fetal brain or head AChE activity was influenced by growth inhibi-
tion and the amount of blood present and does not appear to offer 
any particular advantage over standard teratological parameters as 
a marker of teratogenicity. 
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C H A P T E R 8 
A STUDY OF THE EFFECTS OF IN VIVO MATERNAL ADMINISTRATION 
OF SODIUM VALPROATE ON THE C3H MOUSE FETUS 
8.1. INTRODUCTION 
A discussion on sodium valproate as a teratogen, with particular 
reference to its effects on the developing CNS, has been given in 
section 1. 4 . 
The aims of this study were: 
i) To investigate the effects of sodium valproate when administered 
during embryonic development, including an important period of CNS 
development, on gross fetal parameters in C3H mice, including embryo-
lethality, gross morphological abnormalities, fetal weight and brain 
weight; and 
ii) to compare these with the effects on brain AChE and its iso-
enzymes; 
iii) to compare the effects with those observed using vitamin A 
and cyclophosphamide in the previous studies, and further evaluate 
AChE as a potential brain biochemical marker of teratogenic injury; 
iv) to elucidate the teratogenic mechanisms of sodium valproate 
with particular reference to the central nervous system. 
8.2 MATERIALS AND METHODS 
8.2.1. Experimental mice 
Timed matings were performed with young healthy virgin female C3H mice 
aged 8 - 12 weeks weighing 19 - 23g, as described in section 2.4, 
and kept under standard experimental conditions (section 2 . 3). Two-hour 
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matings were performed. Pregnant females were randomly divided into 
test and control groups. 
8.2.2. Drug administration 
Sodium valproate was dissolved in sterile water and administered by 
subcutaneous (s.c.) injection. The doses used were 400 - 800mg/kg/day 
on 2 or more days from day 8 - 12 p.c. A s.c. injection of an equal 
volume of distilled water was administered to controls. 
8.2.3. Records of maternal and fetal parameters and statistical 
analysis 
Maternal Parameters 
The weight on the day of mating, day of dosing and the day of sac-
rifice and the physical state of each mouse after dosing and before 
sacrifice were recorded. 
Fetal Parameters 
Resorptions, intra-uterine deaths, gross morphological abnormalities, 
fetal weights, brain weights, brain AChE activity, and in some instances 
AChE isoenzymes were investigated. 
Statistical analysis 
The incidence (not percentages) of resorptions, intra-uterine deaths 
and morphological abnormalities was compared with controls using the 
Chi-square two-tailed test. Fetal weights, brain weights and brain 
AChE activity were compared with controls using the Mann-Whitney U two-
tailed test. Medians and 95% confidence limits were calculated 
from the Walsh averages, after Tukey (Steinijans and Diletti, 1983). 
8 . 3 . PRELIMINARY- EXPERIMENTS 
The aims of these experiments were: 
i) To determine the susceptibility of C3H mice to sodium valproate; 
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ii1 to find a suitable dosage range and times of administration of 
the teratogen for subsequent experiments with brain A(:hE; 
iii) to determine whether the doses used were less than the M.T.D. 
for the mothers, and; 
iv) to determine whether sodium valproate per se affects brain AChE 
activity. 
Guided by doses used in NMRl mice (Nau et al., 1981b), where a dose 
dependent increase in exencephaly and resorption rate was demonstra-
ted with s.c. administration of sodium valproate, 4 dosage regimens 
were tried: 
i) 400mg/kg/day s.c. on days 8 and 9 p.c. 
ii) 400mg/kg/day s.c. on days 10, 11 and 12 p.c. 
iii) 800mg/400/400/kg/day s .c. on days 10, 11 and 12 p.c. 
iv) 520mg/kg/day s.c. on days 8 and 9 p.c. 
No controls were used for this preliminary study as this was felt to 
be wasteful and unnecessary. 
Results are presented under each experiment and details given in 
Tables 8.1, 8.2, 8.3 and 8.4. 
end of the thesis, pp. 440-444). 
(Tables of original data are at the 
8.3.1. Sodium valproate, 400mg/kg, administered on days 8 and 9 p.c. 
(Sacrifice day 18 p.c.) 
See Table 8.1 (pp. 440 and 441). 
There were 2 resorptions and 5 intra-uterine deaths (18%) out of 28 
conceptions in the 4 mice treated. Six of 21 live fetuses (28,5%) were 
grossly abnormal with exencephaly, 5 of whom also had exophthalmos. 
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8.3.2. Sodium valproate, 400mg/kg, administered on days 10, 11 and 12 p.c. 
See Table 8.2 (p.442). 
There were no resorptions, one IUD, and no gross abnormalities in the 20 
live fetuses. 
8.3.3. Sodium valproate, 800mg/kg, administered on day 10, and 400mg/kg 
on days 11 ~d 12 p.c. 
See Table 8. 3 (p_. 443) . 
Of the 6 mice treated, 2 died and the remainder demonstrated transient 
drowsiness and ataxia after the first dose of 800mg. Subsequent doses 
were therefore reduced. Two of the dams were not pregnant. Inane of the 2 
remaining mice all 7 fetuses had resorbed, and in the other, there were 
6 resorptions and only 1 live fetus which was grossly normal. 
8.3.4. Sodium valproate, 520mg/kg on days 8 and 9 p.c. 
See Table 8.4 (p. 444). 
There were 2 resorptions (11%), 6 intra-uterine deaths (33%) and 8 of the 
10 live fetuses (80%) were grossly abnormal with exencephaly and exophthal-
mos. 
8.3.5. Study to determine whether sodium valproate, at a dose of 400mg/kg 
on 2 consecutive days, was below the minimal toxic dose level for 
adult C3H females used 
This experiment was performed as described for vitamin A in section 6.3.9. 
Twelve non-pregnant C3H mice weighing 22 - 25g were numbered and observed 
for signs of toxicity after treatment with sodium valproate 400mg/kg on 
2 consecutive days. They were re-weighed 9 days after dosing and the 
weights compared with the pre-treatment weights (see Table 8 .5). 
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T A B L E 8. 5. 
MOUSE WEIGHTS ON FIRST DAY OF ADMINISTRATION OF SODIUM VALPROATE 
(DAY 0) AND 9 DAYS LATER 
WEIGHT IN GRAMS 
Day 0 Day 9 Weight 
Change 
23 23 0 
23 23,5 +o.5 
23 23,5 +o.5 
23 24 +l.O 
24 24,5 +o.s 
25 25 0 
24 23,5 -0.5 
25 24,5 -0.5 
22 22 0 
24,5 24 -0.5 
24 24,S +0.5 
24 25 +l 
Results 
There was no mortality and no signs of toxicity were observed. 
Table 8.5 gives the mouse wights on day O and day 9 and the difference 
in weight. Six of the mice gained weight, in 3 the weight remained the 
same and with 3 there was a reduction of 0,5g. These results suggest 
that a dose of 400mg/kg sodium valproate on 2 consecutive days was below 
the M.T.D. for adult C3H mice. 
8.3.6. Experiment to determine whether sodium valproate, independent 
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of teratogenic effects, alters brain acetylcholinesterase activity 
Sodium valproate (400mg/kg) on 2 consecutive days, which was the dose 
chosen for further studies, was administered on days 16 and 17 p.c. (when 
susceptibility to teratogenic effects is less likely) and fetuses sacrificed 
on day 18 p.c., to determine whether sodium valproate, independent of 
teratogenic effects, alters AChE activity. 
Results are shown in Tables 8. 6T and 8. 6C (pp. 445 and 446) • 
Summary of results in Table 8. 7 . 
There were no gross abnormalities in the treated group and no significant 
difference in brain AChE activity between test and controls. 
Conclusion 
The absence of any difference in AChE activity between the treated group 
and controls suggests that sodium valproate, independent of embryotoxic 
effects, does not affect brain AChE activity. 
8.3.7. Discussion and Conclusions of Preliminary Experiments 
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Sodium valproate, 400mg/kg on days 8 and 9 p.c. was obviously teratogenic 
with an 18% incidence of intra-uterine deaths and 28,5% of the live fetuse~ 
demonstrating exencephaly (71,5% of live fetuses were macroscopically 
normal). This dosing regime therefore appeared to be suitable for studies 
on the effects of sodium valproate on fetal brain AChE activity, and was 
chosen for subsequent experiments. 
With treatment later in gestation at the same dose of 400mg/kg on days 10, 
11 and 12 p.c. there were no resorptions or morphological abnormalities 
and only one intra~uterine death, suggesting no embryotoxic effect. Dosing 
later in gestation was therefore felt to be unsuitable. 
With a dose of 520mg/kg sodium valproate on days 8 and 9 p.c. the high per-
centage of morphological abnormalities (80%) and the 33,3% incidence of 
intra-uterine deaths suggested this dose was too high for a study of brain 
AChE activity. The ~aternal toxicity and 93% resorption rate with 800mg/kg 
on day 10, and 400mg/kg on days 11 and 12 p.c. also indicated this was an 
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T A B L E 8. 7. 
SODIUM VALPROATE, 400mg/kg, ADMINISTERED ON DAYS 16 AND 17 p.c. 
TESl' CONTROL p 
Total 
Conc-:ptions 21 23· -
Resorptions s 8,7 NS 
(%) 
Intra-uterine s 4,3 NS 
Deat:hs 
( %) 
Abnormalities 0 0 NS 
(%) 
Median Fetal 1,004 1,01 NS 
Weight 
(0,98-1,03) (0,99-1,03) (g) 
Median Brain 67,9 67,6 NS 
Weight (66,7-69,3) (66,0-69, 7) 
(mg) 
Median AChE 2,94 2,89 
Activity NS 
nmol/min/mg (2,89-3,00) (2,82-2,96) 
Figures in brackets are the 95% confidence range 
unsuitable dosage regimen (in NMRI mice, Nau et al., (1981b) noted a 100% 
resorption rate at a dose of 800mg/kg). 
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As expected, the above results suggested a dose-related increa~e in embryo-
lethality and gross morphological abnormalities. In contrast to the fin-
dings with vitamin A and cyclophosphamide the commonest gross abnormality 
was exencephaly (associated in most instances with exophthalmos), although 
this probably reflects the earlier administration of valproate on days 8 and 
9. ,Closur~ of the anterior neuropore occurs in mice on days 8-9. These 
findings are in agreement with those of others (Nau et al., 1981b; Bruckner 
et al., 1983). 
A dose of 400mg/kg sodium valproate on 2 consecutive days did not appear to 
be toxic to adult C3H mice. 
Sodium valproate, independent of embryotoxic effects, did not alter fetal 
brain AChE activity. 
8.4. RESULTS AND DISCUSSION 
Two experiments were performed with sodium valproate 400mg/kg on days 8 
and 9 p.c., and 2 experiments with 440mg/kg on days 8 and 9 p.c. Tables 
of original data are presented at the end of the thesis (see Tables 8.8T 
and 8.8C; 8.lOT and 8.lOC; 8.12T and 8.12C and 8.14T and 8.14C (pp. 447-456). 
A summary of results of each experiment is given with the text (Tables 
8.9, 8.11, 8.13 and 8~15. 
A summary of the effects of sodium valproate on fetal outcome in all 
experiments is given in Table 8.16. 
Overall there was a 20,7% incidence of resorptions in the sodium valproate 
treated group compared with 4,7% for controls (p<0,0005). 
Alti.~o~gh the incidence of intra-uterine deaths of 5,1% was low in these 
experiments, this was significantly greater than the 1,2% for controls 
(p<0,005). 
T A B L E 8. 9. 
SUMMARY OF .RESULTS OF SODIUM VALPROATE, 400mg/kg ADMINISTERED . 
ON DAYS 8 AND 9 p.c. (SACRIFICE DAY 19 p.c.) FIRST EXPERIMENT 
TES1' CONTROL p 
Total 
Conceptions 32 2.3 -
Resorptions 
(%) 34 9 <0,001 
Intra-uterine 
Dea~hs 3 0 NS 
(%) 
Abnormalities 10 5 NS (%) 
Median Fetal 1,27 1,37 <0,001 
Weight 
(g) (1,22 - 1,30) (1,33 - 1,39) 
Median Brain 85,4 90,5 <0,001 
Weight (83,2 - 86,8) (87,6 - 93,2) (mg) 
Median AChE 3,16 3,lo NS Activity 
nm.cl/min/mg (3,05 - 3,26) (2,99 - 3,15) 
Figures in brackets are the 95% confidence range 
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TAB LE 8. 11. 
SUMMARY OF RESULTS OF SODIUM VALPROATE 400mg/kg, ADMINISTERED 
ON DAYS 8 AND 9 p.c. (SACRIFICE DAY 19 p.c.) SECOND EXPERIMENT 
TEST CONTROL p 
Total 
Conceptions 30 18· -
Resorptions 
17 0 <0,001 (%) 
Intra-uterine 
Deat.hs 10 5 NS 
(%) 
Abnormalities 
(%) 18 5 0,001 
Median Fetal 1,23 1,32 0,02 
Weight 
(g) (l,16 - 1,29) (l,29 - 1,38 ): 
Median Brain 76,8 82,5 <0,05 
Weight 
(mg) 
(71,3 - 82 ,O) (78, 7 - 85,5) 
Median AChE 3,21 3,35 <0,05 
Activ-ity I 
nmol/min/mg (3,14 - 3,28) (3,25 - 3,44) 
Figures in brackets are the 95% confide.~ce range 
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T A B L E 8.13. 
SUMMARY OF RESULTS OF SODIUM VALPROATE, 440mg/k~ ADMINISTERED 
ON DAYS 8 AND 9 p.c. (SACRIFICE DAY 19 p.c.)- FIRST EXPERIMENT 
TEST CONTROL p 
Total 
Conceptions 26 20 -
Resorptions 8 0 NS 
(%) 
Intra-uterine 8 0 NS 
Deat.hs 
(%) 
Abnormalities 23 0 <0,001 
(%) 
Median Fetal 1,21 1,29 0,003 
Weight 
(g) (1, 17-1, 25) (1,25-1,33) 
Median Brain 76,2 82,9 0,02 
Weight 
(mg) (56,1-82,4) (81,0-85,2) 
Median AChE 3,34 3,46 0,09 
Activity 
nmol/min/mg (3,25-3,46) (3,32-3,59) 
Figures in brackets are the 95% confidence range 
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TAB LE 8. 15. 
SUMMARY OF RESULTS OF SODIUM VALPROATE, 440mg/kg, ADMINISTERED 
ON DAYS 8 AND 9 p.c. (SACRIFICE DAY 19 p.c.) SECOND EXPERIMENT 






21 9 <0,001 
Intra-uterine 0 0 NS 
Deat.hs 
(%) 
Abnormalities 18 0 0,001 
(%) 
Median Fetal 
Weight 1,21 1,31 0,009 
(g) 
(1,17 - 1,25) (1,24 - 1,36) 
Median Brain 79,5 84,9 < 0,001 
Weight 
(mg) (53,6 - 82,4) (83 ,4 - 87 ,O) 
Median AChE 3,34 3,37 NS 
Activity I nmol/min/mg ( 3, 24 - 3,46) (3,29 - 3,44) 
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There was a 17,4% incidence of gross morphological abnormalities in the 
treated group, compared with 2,4% for controls (p<0,0005). The commonest 
abnormality was exencephaly which occurred in 13% of fetuses. Exophthal-
mos was noted in 7% and exomphalos in 5% of fetuses. 
The apparent dose-related increase in embryolethality and morphological 
abnormalities has been referred to in section 8.3.7. and is shown gra-
phically in Fig. 8.1. Fetal weights were slightly, although significant-
ly, lower in all 4 experiments for the treated groups. For example, in 
the first experiment, median weight of sodium valproate treated fetuses 
was 1,27g compared with 1,37g for controls {p<0,001). 
Brain weights were also lower for the treated groups. For example, in the 
first experiment median brain weight was 85,5mg compared with 90,5mg for 
controls (p<0,001). 
The lower fetal and brain weights are consistent with a growth inhibitory 
effect of sodium valproate. These findings are similar to those with 
cyclophosphamide (Chapter 7) although the growth inhibitory effect of cy-
clophosphamide was more pronounced. 
A trend for lower brain AChE activity in the treated groups was only 
demonstrated in 2 experiments. In the second experiment, with 400mg/kg, 
median AChE activity was 3,21 compared with 3,36 for controls (p<0,05), 
and in the first experiment with 440mg/kg median AChE activity was 3,34 
compared with 3,46 for controls (p=0,09. If exencephalic brains were ex-
cluded in the latter experiment, median brain AChE for the treated group 
was 3,27runol/min/mg, p<0,05). The effect of 400mg/kg sodium valproate 
in the second experiment on fetal weight, brain weight and brain AChE 

















THE RELATIONSHIP BETWEEN: THE TOTAL DOSE OF SODIUM VALPROATE -ADMINISTERED AND THE. INCIDENCE Of RESOR.PTIONS, INTRA UTERINE DEATRs AND GROSS MALFORMATIONS. 
~ resorptions 
• intra-uterine deaths 













































































































































































































































































































The decrease in brain AChE activity was associated with a lower fetal 
and brain weight in the sodium valproate treated fetuses and could merely 
have been compatible with a growth retarding effect of the drug (compare 
cyclophosphamide, Chapter 7). 
Exencephalic fetuses were also analysed separately. An analysis of 
fetal weight, brain weight and brain AChE of exencephalic fetuses from 
2 experiments is compared with the relevant median values for Tests and 
Controls in Table 8.17. Although numbers were too small to demonstrate 
statistical significance, fetal weights and particularly brain weights of 
exencephalic fetuses were generally lower than those of non-exencephalic 
test or control fetuses. However, brain AChE activity was generally 
higher in exencephalic fetuses (particularly high values are evident in 
4 of the 6 fetuses). In only 1 fetus (with the largest exencephalic brain) 
was the brain AChE activity lower than that of non-exencephalic fetuses. 
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The elevated AChE activity in the small necrotic looking exencephalic brains 
may suggest that cholinergic neurons are relatively spared in the degenera-
tive process accompanying exencephaly, resulting in a relative preponderance 
of cholinergic cells. The degeneration and necrosis of brain tissue occurs 
secondary to the exencephaly, whatever the cause of the exencephaly, and is 
therefore presumably independent of the teratogenic effect of the agent 
used. 
Although brain hemoglobin values were not determined, the higher AChE 
activity in exencephalic brains cannot be reasonably explained on the basis 
of increased blood (for example if the degenerative process was one of 
hemorrhagic necrosis) because the AChE activity of blood is considerably 
lower than that of 19-day fetal brain (see section 3.5). 
In the thi:cd experiment the normal brain weight of the exencephalic fetus 
T A B L E 8. 17. 
ANALYSIS OF FETAL WEIGHT , BRAIN WEIGHT ANO ACETY LCHOLINESTERASE 
OF EXENCEPHALIC FETUSES FROM THREE EXPERIMENTS AN O COMPARISON 
WITH MEDIAN VALUES OF NON-EX ENCEPHALIC TESTS (T) AN O 
CONTROLS (C) IN EACH EXPERIMENT 
' Fetus Fetal Median Brain Median .~ChE Median 
Wt. (mg_.) wt. ( mg) 
No . mg_ T C mg T C nrnol/ T C 
min/mg 
272 
1 980 1200 1310 27,8 81, 6- 84,7 3, 59 3,33 3,29 
2 1080 (n=21) (n=21) 
21 1080 
22 1260 
15 1110 1200 1285 
16 1050 ( n= 21) (n=20) 
17 1200 
21 1 020 
22 1160 
12 1190 I 1250 1360 
13 10 01 (n=20) (n=l7) 
* Too small for analysis 




59, 3 81,3 82,55 3,34 3,27 3,40 5 
27,0 4,73 
23,0 * 
22 ,7 * 
39,1 6,07 
74,l 77,2 82,5 2,15 3,205 3,36 
16., 6 * 
suggests an absence of degeneration and necrosis. Acetylcholinesterase 
would therefore not be expected to be increased and in fact is considerab-
ly lower than that of non-exencephalic fetuses. This is in keeping with 
the lower AChE in fetuses exposed to sodium valproate. Further study is 
envisaged to confirm these findings in exencephalic brains and to eluci-
date the mechanisms involved. 
With the timing of administration and doses of sodium valproate used an 
obvious teratogenic effect was demonstrated. It was therefore felt that 
further experimentation with different doses and times of administation 
was not warranted. In the absence of promising AChE changes in whole 
brains I did not endeavour to examine AChE changes in specific brain areas. 
8.5. ANALYSIS OF THE ISOENZYMES OF FETAL BRAIN ACETYLCHOLINESTERASE 
SODIUM VALPROATE, 400mg/kg, ADMINISTERED ON DAYS 8 AND 9 p.c. 
Separation and densitometric analysis of the isoenzymes of AChE were per-
formed as described in Chapter 5. The isoenzymes from 18 brain homoge-
nates of treated fetuses were compared with those from 20 controls. 
Results and discussion 
Five isoenzymes of AChE were present in all Test and Control samples. 
No obvious difference was apparent on visual inspection between the treated 
and untreated groups. 
Peak heights were measured from the best apparent baseline. The same 3 
methods of analysis of the densitometric results as described for vitamin A 
in section 6.7 were used. Statistical analysis was by the Tukey modifica-
tion of the Willcoxon signed ranks test and the Mann-Whitney U test. In 
addition some of the peaks were analysed by the Kolmogorov-Smirnov two-
sample test. A summary of the results obtained using the 3 methods is 
given in Table 8.18 and shown graphically in Fig. 8.3. 
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T A B L E 8. 18. 
SUMMARY OF DENSITOMETRIC RESULTS 
SODIUM VALPROATE, 400mg/kg, ADMINISTERED ON DAYS 8 AND 9 p.c. 
Method 1 Method 2 Method 3 
Median 
Median Median Peaks peak hts p I p p ratio ratio 
mm 
T 32,88 0,62 0,615 
1 (n=20) NS NS NS 
C 35,o 
(n=20) 0,67 o,66 
T 77 ,88 1,465 1,43 
2 NS NS NS 
C 79,25 1,51 1,47 
T 52,38 - 0,96 
" 3 NS - NS 
C 52,5 - 0,99 
T 19,0 0,34 0,34 
4 
<0,002 <0,02 <0,002 
C 27,75 0,54 0,52 
T 67,38 1,265 1,24 
5 NS NS NS 
C 72,63 1,48 1,36 
Sum T 247,6 3, 71 4,55 
of <0,02 NS <0,02 
1-5 C 268,0 4,21 5,00 










































































































































































































Although the medians for the test peaks were apparently lower than for 
controls, this was only statistically significant for peak 4 (19mm compared 
with 27,75mm, p<0,002) and the sum of peaks 1 - 5 (247,6mm compared with 
268mm, p<0,02). Using method 1 the level of significance for peak 4 was 
p<0,002, and for the sum of the peaks, p<0,02. Using peak 3 as internal 
standard (method 2) did not improve the level of significance. Division of 
all the data by the mean control value for each gel (method 3) gave similar 
results to method 1. 
The significantly lower sum of peak heights 1 - 5 for tests is consistent 
with the lower brain AChE activity for tests compared with controls noted 
in 2 of the experiments (section 8.4) using the Ellman technique. 
A lower peak height for isoenzyme band 4 was also found after administration 
of cyclophosphamide (section 7.5). Because both drugs have a growth inhibi-
tory effect on the fetus it is conceivable that this may be the reason for 
the common finding. Alternatively, the particular susceptibility of iso-
enzyme 4 may be the expression of some other embryotoxic effect. Whether 




It is concluded from this study that: 
a) A dosage regimen of 520mg/kg sodium valproate or less on 2 con-
secutive days was not associated with any apparent maternal toxicity, 
and 400mg/kg on 2 consecutive days was below the M.T.D. 
b) There was an apparent dose-related increase in the incidence of 
resorptions and intra-uterine deaths. 
c) There was an apparent dose-related increase in the incidence of 
gross morphological abnormalities. 
d) The commonest gross abnormality was exencephaly. 
e) At doses of sodium valproate from 400mg/kg - 520mg/kg there was 
a decrease in fetal weight and brain weight, which was in keeping 
with a growth inhibitory effect. 
f) Sodium valproate, independent of its embryotoxic effects, did not 
influence fetal brain AChE activity. 
g) Despite a decrease in fetal weight and brain weight sodium valproate 
400 - 440mg/kg on days 8 and 9 p.c. was only associated with a de-
crease in AChE in 2 of 4 experiments. 
h) Exencephalic fetuses appeared to have a higher AChE activity than 
non-exencephalic fetuses. 
i) The administration of 400mg/kg sodium valproate on days 8 and 9 
p.c. was associated with a significantly lower peak height for 
band 4, and the sum of the peaks 1 - 5. 
j) Fetal brain AChE activity does not appear to offer any particular 
advantage over standard teratological parameters as a marker of 
teratogenicity induced by sodium valproate. 
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C H A P T E R 9 
A STUDY OF THE EFFECTS OF IN VIVO MATERNAL ADMINISTRATION OF LARGE DOSES 
OF VITAMIN A DURING THE PREIMPLANTATION PERIOD 
9.1. INTRODUCTION 
In contrast to the susceptibility to teratogenesis of embryos after im-
plantation during the phase of organogenesis, preimplantation embryos 
are remarkably resistant (Tuchmann du Plessis, 1975 : 40; Austin, 1973). 
There are very few studies in the literature on the administration of 
vitamin A during the preimplantation period. Adams et al., (1961) found 
no evidence of any deleterious effect of excess vitamin A on the blasto-
cyst or on subsequent development in the rabbit when administered during 
the preimplantation period. However, Morriss (1972) found malformations 
of the central nervous system in 8 out of 144 young rats after maternal 
administration of large doses of vitamin A before the time of implanta-
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tion. The abnormalities were postulated to be due to changes in the maternal 
organism. 
The aim of this study was firstly to determine the effects of large 
doses of vitamin A on C3H mouse embryos when administered during the 
preimplantation period. Secondly, to compare the findings with those 
resulting from administration of vitamin A later in gestation, and 
thirdly, to help elucidate the teratogenic mechanisms of vitamin A. 
The first objective of the study was to determine the susceptibility 
of C3H mice to different doses of vitamin A administered during the pre-
implantation period by examining fetuses for gross morphological changes 
towards the end of gestation. The second objective was to determine 
whether embryotoxic effects were apparent in the preimplantation embryo 
by (i) determining viability using the fluorescein diacetate test, which 
is dependent on esterase enzyme activity, and (ii) noting cell number, 
mitotic index and chromosome structure. 
The principle of the fuorescein diacetate (FDA) test is that normal 
embryos are impermeable to fluorescein but permeable to the non-
fluorescent derivative, FDA. The acetate groups of FDA are cleaved by 
cellular esterases releasing free fluorescein intracellularly and cells 
will maintain fluorescence when the plasma membranes are intact. 
Jackowski (1977) used a fluorescent dye technique to assay the viability 
of mouse ova, demonstrating a high correlation (0,96) between the ability 
of embryos to retain fluorescein and their ability to develop in culture. 
Damaged or dying cells quickly lose fluorescence and dead cells show none 
at all (Whittingham, 1981). Mohr and Trounson (1980) and Kola and Folb 
(1986) have used the test as an assay of blastocyst viability. 
Vitamin A has been shown to interfere with mitosis in epithelial cells 
in vitro (Aydelotte, 1963 a, b) and in neuroepithelial cells of fetal 
mouse cerebral cortex after maternal treatment (Langman and Welch, 1967). 
Also, vitamin A and other retinoids have been shown to induce sister-
chromatid exchange in fibroblast cultures (Tetzner et al., 1980). In 
this study the effect of vitamin A on cell number, mitotic index and 
chromosome structure of C3H mouse blastocysts was investigated, with a 
view further to elucidate the molecular mechanisms whereby vitamin A 
perturbs the pre- and post-implantation development of embryos. 
9.2. MATERIALS AND METHODS 
9.2.1. Experimental mice 
The housing of mice and method of mating have been described in Chapter 2. 
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9.2.2. Drug administration 
Vitamin A was administered by gastric intubation to the experimental 
animals on the third day of gestation, 60h after copulation. The 
following doses of the drug were used: O (controls}, 5 000, 
10 000, 15 000, 30 000 I.U. per mouse. 
9.2.3. Assessment of embryotoxicity at 18 days post conception 
The incidence of resorptions, intra-uterine deaths, gross morphologica~ 
abnormalities and fetal weights was noted. 
9.2.4. Retrieval of preimplantation embryos and assessment of viability 
Twenty-one hours after treatment, i.e. 81h after copulation the mice 
were sacrificed by cervical dislocation. The uterine horns were ex-
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posed and the blastocysts flushed from the uteri using a modified 
Dulbecco's phosphate-buffered saline (PBS: Whittingham, 1971). Embryos 
were examined under a dissecting microscope and the number of blastocysts 
and morulae recorded. The fluorescein diacetate test used was that used by 
Kola and Folb (1986), based on the technique of Mohr and Trounson (1980). 
Embryos were incubated for lmin at room temperature in a solution of 
FDA (Sigma, USA) in PBS (final concentration 2,5µg FDA/ml PBS). The 
embryos were then washed in plain PBS solution for 3-5min. Each embryo 
was examined at a magnification of x240 under a fluorescence microscope 
(Wild and Leitz, Germany), using a combination of filters which contained 
an excitor filter PB 450-490, chromatic beam splitter FT 510 and a 
barrier filter LP 520. Fluorescence was measured using a centre field 
light sample which was fed into a photomultiplier tube. The camera 
mechanism was triggered when a predetermined amount of light was received, 
and the time taken to this point was determined using a digital timer. 
Fluorescence that was just visible was sufficient to trigger the camera 
mechanism. A normal viable embryo took 2, 8 to 3, 1sec to trigger the 
mechanism, whereas an embryo was regarded as non-viable if it took 13 sec 
or longer (Kola and Folb, 1986). 
9.2.5. Cell number, mitotic index and chromosome structure 
The technique used was based on that of Tarkowski (1966) and Kola (1985). 
Mice were injected intra-peritoneally with 2mg/kg colchicine (Lennon, Port 
Elizabeth, South Africa) 2h prior to sacrifice by cervical dislocation. 
Uterine horns were exposed and blastocysts flushed from the uteri with 
PBI. Viewed under a dissecting microscope the blastocysts were trans-
ferred with a Gibson P20 micropipette to a hypotonic solution of 1% triso-
dium citrate at room temperature and allowed to incubate for 10 - 20 min. 
The embryos were then transferred onto clean glass slides in a minimum 
amount of hypotonic solution and the preparation fixed by the drop-wise 
addition of a mixture of 3:1 methanol : glacial acetic acid. The 
optimal number of fixative drops in the case of blastocysts is 5 - 6. 
The air-dried preparations were then stained with 10% Giemsa (Merck, 
Darmstadt, Germany) solution for 7 min. Preparations were then examined 
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by phase microscopy. The blastocyst cell number was determined by counting 
the nuclei. The mitotic index (number of cells in mitosis/total number of 
cells) was determined and metaphases were scored for chromosomal aberra-
tions such as breaks, gaps, and translocations or rearrangements. 
9.2.6. Statistical analysis 
The number of resorptions, intra-uterine deaths and malformations in the 
treated and control groups was compared using the Chi-squared test. 
Fetal weights were compared using the Mann-Whitney U two-tailed test. 
The Mann-Whitney U two-tailed test was used to compare the time taken 
to trigger the camera mechanism by viable treated and control embryos. 
Cell numbers in the treated group were compared with controls using 
the Mann-Whitney U two-tailed test. The number of cells in mitosis in 
treated and control groups were compared using the chi-squared test. 
9.3. RESULTS 
9.3.1. The effects of vitamin A administered 60h after copulation on 
fetuses at 18 days p.c. 
Tables of original data are presented at the end of the thesis (see 
Tables 9.2. - 9.7; pp. 457-468). Summary of results in Table 9.1. 
Resorptions/Intrauterine deaths 
The effects of increasing doses of vitamin A on embryo resorption/IUD's 
is shown in Table 9.1. There was no significant embryolethal effect 
with a dose of 15 000 IU per mouse or less. However, with 30 000 IU 
there was a 65% incidence of resorptions (38 out of 59 conceptions, 
p<0,001). 
Malformations 
Vitamin A administered 60h post copulation at a dose of 10 000 IU or 
greater was associated with a significantly higher incidence of gross 
abnormalities compared with controls (see Table 9.1). Malformations 
included exophthalmos, anophthalmia, microphthalmia, exencephaly, 
exomphalos and limb defects (see Tables 9.2 - 9.5, pp. 457-465). The 
highest incidence of malformations, 59%, was observed after treatment with 
15 000 IU vitamin A (in 16 of 27 live fetuses, p<0,001). 
Fetal Weight 
There was no difference in fetal weight compared with controls after 
treatment with 5 000 and 10 000 IU vitamin A (see Table 9.1), The 






























































































































































































































































































































































































































































A was 0,94g and 0,825g, respectively, compared with 1,057g for controls 
(p<0,0003 in each case). 
9.3.2. The effect of vitamin A on viability of 81h blastocysts 
Viability was assessed in 53 control and 68 treated blastocysts. Vitamin 
A, at a dose of 30 000 IU, which in the previous experiment was shown to 
be obviously embryotoxic, was not associated with any alteration in 
embryo viability (see Fig. 9.1). The median time taken to trigger the 
camera was 2,9sec for untreated and 2,8sec for treated embryos. There 
were 3 non-viable blastocysts in each group. 
9.3.3. The effects of vitamin A on cell number, mitotic index and 
chromosome structure 
Vitamin A, 30 000 IU per mouse, did not significantly alter cell number, 
mitotic index or chromosome structure (see Table 92 and Figs. 9.2, 9.3 
and 9.4). 
TABLE 9.8. 
THE EFFECTS OF 30 000 IU VITAMIN A ADMINISTERED TO C3H MICE 60h AFTER 
COPULATION ON THE CELL NUMBER, MITOTIC INDEX AND CHROMOSOME STRUCTURE 
OF 81h BLASTOCYSTS 
No. of Cell number Mitotic Chromosome 
blastocysts per blastocyst index abnormalities 
(Median) 
CONTROL 19 34 6 0 
I (29-41) (4-9,5 ) 
TEST 34 30 * 5 * 1 break* 
(27-34) (4-6,5) 






























THE EFFECT OF VITAMIN A ADMINISTERED 60h POST COPULATION ON 














DOSE OF VITAMIN A 
p value determined by Mann-Whitney u Test. Error bars are 95% 
confidence limits. Time taken to trigger the camera mechanism 
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is inversely proportional to the intensity of embryo fluorescence 
and esterase enzyme activity. 
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Fig. 9.2. 
THE EFFECT OF 30 000 IU VITAMIN A ADMINISTERED TO C3H 
MICE 60h AFTER COPULATION ON THE CELL NUMBER OF 81h BLASTOCYSTS 
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DOSE OF VITAMIN A 
p value determined by Mann-Whitney U test. 
Error bars are 95 % confidence limits. 
Fig.9.3 
Magnification x 1 000 
Photomicrograph of a set of chromosomes from an untreated 81h blastocyst. 
No aberrant chromosomes are seen. 
Fig. 9.4 
Magnification x 1 000 
Photomicrograph of a set of chromosomes from an 81h blastocyst after 
maternal treatment with 30 000 IU vitamin A. 
No aberrant chromosomes are seen. 
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9.4. DISCUSSION 
The findings that administration of vitamin A during the preimplantation 
or pre-differentiation period is associated with an obvious embryolethal 
effect with a dose of 30 000 IU, a decrease in fetal weight with doses 
of 15 000 and 30 000 IU vitamin A and gross morphological abnormalities 
after treatment with 10 000, 15 000 and 30 000 IU vitamin A are very 
interesting and to my knowledge have not been previously recorded in the 
mouse. The observations contrast with findings after excess vitamin A 
administration during the preimplantation period in the rabbit where no 
embryotoxic effect was demonstrated (Adams et al., 1961), and appear to 
be more pronounced than in the rat, where only 8 of 144 offspring were 
noted to have abnormalities (Morriss, 1972). The high incidence of 
embryotoxic effects in this study is striking. Although the reasons for 
this have not been investigated, a possible explanation may be on the 
basis of different kinetics of the vitamin in the mouse. Further study 
is needed to elucidate this. 
Perhaps more intriguing is the apparent absence of any embryotoxic effect 
in blastocysts examined 22h after administration of the vitamin A accor-
ding to the criteria applied in this study. 
The lack of any demonstrable effect of vitamin A on blastocyst viability, 
cell number, mitotic index and chromosome structure is in keeping with 
th.e remarkable resistance of the preimplantation embryo to teratogenic in-
sults and suggest that the morphological abnormalities noted in 18-day 
fetuses were not due to embryotoxic effects during the predifferentiation 
period. Although vitamin A has been shown to decrease cell proliferation 
(Kochar, 1968) and to inhibit mitosis in epithelial and neuroepithelial 
cells (Aydelotte, 1963a, b; Langman and Welch, 19671 there was no de-
288 
monstrable evidence of this in these experiments. It is apparent the 
developmental aberrations were due to effects operating after the pre-
implantation period. Vitamin A is known to have a long elimination half 
life (t~) in the human (Rosa et al., 1984). The malformations observed, 
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such as eye defects, limb defects, exencephaly and exomphalos were 
characteristic of teratogenic insults operating during the period of 
organogenesis (see section 1.2 and Chapter 6). This study suggests that 
timing was not as important in determining susceptibility as the t~ of the 
teratogen, and highlights the danger of simplistically assuming resistance to 
teratogenesis during the predifferentiation period as the only criterion. 
With the retinoic acid derivitive, Etretinate, because of its long t~ patients 
are advised not to fall pregnant for~ to 2 years after discontinuing 
treatment (Grote et al., 1985). Similarly, Rosa et al., 1984 warn against 
excessive exposure to vitamin A for several months before pregnancy occurs 
because vitamin A is extensively stored and has a prolonged t~. Despite 
this knowledge, as far as I can ascertain, this is the first animal study 
demonstrating the importance of this warning. The findings should also be 
extended to caution against the use of any potentially teratogenic drug with 
a long t~. 
Although the induction of chromosomal aberrations is considered an important 
mechanism whereby teratogens induce abnormal development (section 1.11), no 
serious consideration has been given in the literature to the possibility 
that the mechanisms by which vitamin A produces teratogenic effects may 
involve chromosomal defects (see section 1.2). The absence of any effects 
on chromosome structure in these experiments suggests that the production 
of chromosomal abnormalities is not an underlying mechanism in the mouse. 
The absence of demonstrable embryotoxicity in the preimplantation embryos 
as opposed to the postimplantation fetuses may be a further pointer to 
the teratogenic mecr..anism of vitamin A. If the mechanism was secondary 
to a toxic effect on cell membranes or DNA synthesis, this would have 
been expected to also be apparent in the preimplantation blastocysts. 
Although it can be argued that the resistance of the early embryo is due 
to the fact that the cells of the early embryo are totipotent and can 
"replace" damaged cells, the observation that vitamin A continues to 
exert its embryotoxic ~ffects for many days may be anticipated to preclude 
adequate repair. 
9.5. CONCLUSIONS 
It is concluded from this study that: 
(i) Vitamin A, 30 000 IU, administered 60h after copulation had 
no demonstrable effect on the viability, cell number, mitotic 
index or chromosome structure of 81h embryos. 
(ii) Vitamin A, 30 000 IU, administered 60h post copulation was 
obviously embryolethal. 
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(iii) Vitamin A, 15 000 and 30 000 IU administered 60h post copulation 
was associated with a lower fetal weight compared with controls 
(p<0,0003), which is in keeping with the growth-inhibitory effect 
of the teratogen. 
(iv) Vitamin A administered 60h post copulation at a dose of 10 000, 
15 000 or 30 000 IU produced characteristic gross malformations. 
(v) The above embryotoxic effects are explicable on the basis of the 
long t~ of elimination of vitamin A. 
CH APTER 10 
A STUDY OF THE EFFECTS OF IN VIVO ADMINISTRATION OF LARGE DOSES OF 
VITAMIN A ON C3H FETAL MOUSE BRAIN PROTEIN PATTERNS USING HIGH 
RESOLUTION TWO-DIMENSIONAL ELECTROPHORESIS 
10.l. INTRODUCTION 
The detection of many proteins requires methods that are independent of 
functional activity. Traditional methods fall far short of revealing 
the full complexity that is present. Two-dimensional (2D) gel electro-
phoresis, owing to its resolution and sensitivity, is the emerging tech-
nique that holds the greatest promise for the analysis and detection of 
proteins from complex biological sources (Garrels, 1980; 
Two recent full supplements to Clinical Chemistry (1982; 
O'Farrell, 1975). 
1984) have been 
devoted to the technique. The method is based on two steps of electro-
phoresis of proteins in polyacrylamide gels. Isoelectric focusing is 
used in the first dimension to separate the proteins by charge, and sodium 
dodecyl sulphate (SDS) electrophoresis is used in the second dimension to 
separate the proteins by molecular weight. Since there is poor correlation 
between the charge of a protein and its molecular weight it is possible 
to obtain an almost uniform distribution of protein spots across the gel 
and the number of proteins that can be detected is in theory equal to the 
product of the numbers of proteins resolved by each method used above. In 
practice, distributions of up to several thousand well resolved proteins 
can be obtained from cell homogenates (Garrels, 1980). The technique is 
sufficiently sensitive to detect very small quantities of protein and the 
reproducibility permits each spot on one separation to be matched with a 
spot on a different separation. In most comparisons of two samples, visual 
inspection alone allows detection of the alteration or disappearance of 
a single protein in a field of up to 2 000 spots. This accounts for the 
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widespread usefulness of the technique without computerised data analysis 
(Anderson, et al., 1984). 
There are a number of reasons why this technique was considered to have 
potential as a method for investigating the teratogenic effects and me-
chanisms of drugs. Firstly, the system can resolve proteins differing 
in a single charge and consequently can be used in the analysis of in 
vivo modifications resulting in a change in charge (O'Farrell, 1975). 
(Indeed, . the system has been used for detecting point mutations in mammals 
(Klose, 1975; 1979) and in man (Comings, 1979). Secondly, proteins re-
present a class of molecules which should be particularly suitable for 
studying teratogenic effects in mammals at the level of macromolecules, 
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and the proteins affected may indicate a specific teratogenic mechanism 
(Klose et al., 1977). There is some evidence that alkylation of proteins 
may constitute one of the primary targets of cyclophosphamide teratogeni-
city (Gurtoo et al., 1978). Thirdly, considerable qualitative differences 
in the composition of protein patterns occurs at different developmental 
stages in the embryo (Klose and von Wallenberg-Pachaly, 1976), whilst both 
qualitative and quantitative differences in protein spots have been shown 
between different strains of mice (Klose, 1979). It is therefore reasonable 
to expect that a teratogenic insult resulting in changes during development 
might produce changes in protein patterns. Finally, 2D analysis has been 
successfully used to detect heat-shock-induced proteins in human cells 
(Anderson et al., 1982), and in rat embryo fibroblasts (Welch, 1985). 
In a recent embryonic stress hypothesis of teratogenesis it was proposed 
that the induction of a heat-shock response provides a common pathway by 
which diverse teratogenic agents result in developmental abnormalities 
(German, 1984). 
From the foregoing it is apparent that prote~n-mapping with 2D electro-
phoresis may enable detection of alterations in protein patterns when 
embryos bearing a teratogenically induced defect are investigated. 
Changes in abundance, modifications or alterations in the rate of synthe-
sis of proteins never before observed can potentially be detected. 
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The following preliminary study was performed with a view to future research. 
10.2. MATERIALS AND METHODS 
10.2.1. Experimental mice 
The housing and mating of mice have been described in Chapter 2. 
10.2.2. Drug administration and sacrifice 
Maternal administration of 10 000 IU or 12 500 IU vitamin A was by oral 
gavage on day 9 p.c. _As shown in Chapter 6 these doses and the time of 
administration were associated with obvious teratogenic effects in this 
mouse model. 
Sacrifice was by cervical dislocation on day 11 or day 18 p.c. 
10.2.3. High resolution two-dimensional electrophoresis of proteins 
The technique used was based on that of O'Farrell (1975). 
Sample preparation 
This was. adapted from Wilson et al., (1977). (The following technique 
was used so that autoradiography could also be performed). 
10mg brain was sonicated in 22µ1 homogenising fluid (BM urea, o,5% SDS, 
8,71mg phenylmethylsulphonyl fluoride, 5 % mercaptoethanol) and 88µ1 of 









To 75µ1 of homogenate were added 15µ1 of o,6% sodium cyanoborohydride 
(NaBH
3
CN) in sodium phosphate buffer and 7,5µ1 of a formaldehyde solution 
(0,37ml formaldehyde made up to 50ml with sodium phosphate buffer). The 
mixture was shaken for at least 4h and then made up to 750µ1 with sodium 
phosphate buffer. This was dialysed against deionised water for 24h with 
a minimum of 4 changes of water. The sample was quickly frozen in dry 
ice and acetone, and then resolubilised in 60µ1 of lysis buffer. To this 
was added 7,5µ1 of 10% Triton X-100 and ampholines (40µ1 pH5-7, 10µ1 
pH3,5-lO,O). 
Isoelectric focusing of gels (first dimension) 
The proteins were separated in the first dimension by isoelectric focusing 
on polyacrylamide rod gels over an approximate pH range of 4,0-7,0. Gels 
were made in glass tubing, sealed at the bottom with Parafilm. To a 
125ml side arm flask were added 5,5g urea, 1,33ml 30% acrylamide solution, 
2ml 10% Triton X-100, 1,97ml water and 0,4ml ampholines (0,4ml, pH 5-7; 
0,1ml pH 3-10). The contents were mixed until the urea had completely 
dissolved. Ten microlitres of 10% ammonium persulphate were added and the 
solution degassed for 1 to 2 min. Seven microlitres of Terned were added 
and the mixture immediately poureq_into gel tubes, care being taken not to 
trap any air bubbles. This was carefully overlayed with a solution of SM 
urea and allowed to polymerise for l~h. The overlay solution was then 
poured off and replaced with 20µ1 of lysis. buffer (9,5 M urea; 2% (w/v) 
Triton X-100; 2% (w/v) ampholines (1,6%. pH 5-7; 0,4%, pH 3-10); 5% w/v 
S - mercaptoethanol). This was overlayed with a small amount of water. 
The gels were allowed to set for a further l~h. The lysis buffer, water 
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and Parafilm were removed, 20µlof fresh lysis buffer added and overlayed 
with 0,02 M NaOH. The lower reservoir of a Hoefer GT3 gel electrophoresis 




and the upper reservoir with 
0,02M NaOH. The gels were then pre-electrophoresed at 200 volts for 15 min, 
300 volts for 30 min and 400 volts for 30 min. The power was turned off, 
the upper reservoir emptied, lysis buffer and NaOH removed from the surface 
of the gels, and the samples loaded and overlayed with 10µ1 of sample over-
lay solution ( 9 M urea; 1% ampholines (0,8%. pH 5-7; 0,2%, pH 3-10). Gels 
were rWl at 400 volts for 16h, followed by 800 volts for lh (total volt-
hours = 6 200). Gels were forced out of the tubes using the pressure of 
a syringe with distilled water. Gels were either prepared for loading in 
the second dimension immediately or stored frozen in 5ml SDS sample 
buffer. 
Molecular weight separation - 2nd dimension 
In this dimension the proteins were separated on a 5-15% polyacrylamide 
gradient gel (molecular weight range 30-110 x 10-3 dalton). 
Materials and Methods 
TABLE 10.1. 
INGREDIENTS OF 5% - 15% GRADIENT GEL 
REAGENT 5% 15% 
Acrylogel 2,7ml 8ml 
1,5M Tris, pHS,8 with 5% glycerol 4ml -
1,5M Tris, pHS,8 with 60% glycerol - 4ml 
10% SDS 0,2ml 0,2ml 
Water up to: 16ml 16ml 
Ammonium persulphate 66µ1 53µ1 
Terned 6µ1 6µ1 
A 5-15% gradient gel (see Table 10.l) was poured from a gradient mixer 
between glass plates (Hoefer). The gel was overlayed with water and 
allowed to polymerise for 40 min. The water was then poured off and 
the gel first overlayed with stacking gel (1,5ml acrylogel, 2,5ml stacking 
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gel buffer comprising 0,5M Tris, pH6,8 with 5% glycerol, 0,1ml 10% SDS, 
40µ1 ammonium persulphate (lOOmg/ml), 5µ1 Terned, made up to 10ml with 
waterj and then overlayed with water. The gel was allowed to polymerise 
for approximately 20 min, the water removed and the glass sandwiches 
assembled into the upper tank. The rod gels were briefly immersed in 
10ml heated SDS sample buffer (10% w/v glycerol, 2,3% SDS, 0,0625M 
Tris/pH 6,8, 5% S mercaptoethanol). Excess buffer was removed and the 
rod gels embedded on top of the sandwiches with 0,1% agarose preheated 
0 
to 80 c. The agarose was allowed to set, the lower and upper tanks 
filled with tank buffer (12g Tris, 57,6g glycine and 40ml 10% SDS in 4 1 
of water) and the gels electrophoresed at 20mA per gel for lOh. 
Staining 
The gel plates were prised apart and the gel stained withCoomassie blue 
(5gCoomassie blue stain, 1,5ml methanol, 3,1ml water and 500g trichloro-
acetic acid) for 6h and then destained for up to 72h. Silver staining 
was performed according to the technique of Guevara et al., 1982. 
Standardisation 
Standardisation of the gels was initially obtained by co-electrophoresing 
the proteins with a set of standards of known molecular mass and iso-
electric point. 
Analysis of gels 
The intensity, size, position and number of protein spots were assessed by 
visual inspection. With the use of grid lines each gel was divided into 
25 squares as shown in Fig. 10.l which ensured systematic analysis. Re-
ference to specific spots is possible by employing a notation system based 
on that of Bravo and Celis (1982). This was not applied in this case, but 
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From gels stained with Coomassie blue approximately 450 discrete 
spots were identified (Figs. 10.2 and 10.3). Silver staining 
increased the number of spots by :20% (Figs. 10.4 and 10.5). 
Definition and discrimination were good and there was more than 
95% reproducibility of gel patterns. Table 10.2 gives the number 
of gels analysed after maternal administration of 10 000 and 12 500 
IU vitamin A on day 9 p.c. in 11-day and 18-day fetuses. Thirty-
four gels were stained with Coomassie blue and 6 were silver stained. 
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T A B L E 10. 2 . 
THE NUMBER OF 2-D GELS ANALYSED IN 11-DAY AND 18-DAY FETUSES 
DOSE OF NUMBER OF GELS 
VITAMIN A (IU) (Sacrifice (Sacrifice 
day 11 p.c.) day 18 p.c.) 
0 (control) 12 10 
10 000 6 4 
12 500 4 6 
There was no obvious difference in the cephalic protein patterns 
of untreated 11-day and 18-day fetuses. 
A broad spectrum of deletion of 10 - 15% of protein spots was noted and 
a limited number of new protein spots appeared in the B2, C2 and D3 sec-
tors of vitamin A treated fetuses compared with controls. 
10.4. DISCUSSION 
The broad spectrum deletion of protein spots in this study suggests that 
teratogenic doses of vitamin A modify the brain protein pattern of the 
fetal C3H mouse in a non-specific way. The new protein spots observed 
may suggest induction of proteins. Heat-shock-induced proteins have been 
detected in human cells (Anderson et al., 1982, and in rat embryo fibro-
blasts (Welch, 1985). However, further experience with and refinement 
of this technique is needed before meaningful conclusions can be drawn. 
The number of protein spots which were visualised is relatively small 
for brain tissue. Celis and Bravo (1981) were able to identify approxi-
mately 1 200 spots from as few as 50-100 He La cells by using 35 S 


















COOMASSIE BLUE STAIN GEL ELECTROPHORETIC PROTEIN PATTERN 
OF 11-DAY FETAL MOUSE BRAIN (CONTROL) 
Fig. 10.3 
COOMAS-SIE BLUE STAIN GEL ELECTROPHORETIC PROTEIN PATTERN 
OF 18-DAY FETAL MOUSE BRAIN (CONTROL) 
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SILVER STAIN GEL ELECTROPEORETIC PROTEIN PATTERN OF 11-DAY FETAL 
MOUSE BRAIN (CONTROL) 





















SILVER STAIN GEL ELETROPHORETIC PROTEIN PATTERN OF 11-DAY FETAL MOUSE 
BRAIN AFTER MATERNAL TREATMENT WITH 10 000 IU VITAMIN A ON DAY 9 p.c. 
i ) The broad spectrum deletion of protein spots (compare Fig. 10. 4) . 
ii) Major spots are unchanged. 
iii) New protein spots (arrowed) in sectors B2, C2 and D3. 
iv) The number of spots counted in this gel was 465. 
of proteins and subsequent radiography will augment the sensitivity of 
this method. Another technique for increasing the number of spots is 
the use of larger gels (Klose et al., 1977). More spots become visible 
because the resolving power is improved and the intensity of weak spots 
is increased due to the larger amounts of protein samples used. The 
use of different pH ranges will also enable the visualisation of proteins 
which do not run only in the range 4 - 7. 
A further limitation of the present system is that visual inspection is 
only semiquantitative making subtle quantitative changes impossible to 
detect by eye (Ridder et al., 1984). Also, information overload is 
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quickly experienced with a large number of spots and when more than 2 gels 
must be compared. Ridder et al., (1984) have described an image-analysis 
technique to determine spot intensities and to match spot patterns among 
gels. An alternative approach is a computer-assisted densitometry technique 
for quantifying individual protein spots (Goldman et al., 1982; Narayan 
et al., 1984). Anderson et al., (1984) have used multivariate stati:stical 
analysis of computer-generated quantitative data from 2D gels. Computer 
programs also facilitate comparison between the pattern of spots seen on 
different gels (Alexander et al., 1980; Skolnick et al., 1982). In fact 
it has been suggested that 2D electrophoretic separation of complex mix-
tures of proteins can only be exploited to its fullest potential using 
sophisticated computerised spot detection, quantification, pattern recog-
nition, pattern normalisation, data reduction and data storage ( Gersten 
et al., 1983) 
After appropriate attention to the foregoing further experiments with 
vitamin A are envisaged, including exposure on other days of gestation. 
10.5. CONCLUSIONS 
1. The non-specific deletion of protein spots and the apparent induction 
of new proteins in this study suggest that teratogenic doses of vitamin 
A modify the brain protein pattern of the fetal C3H mouse. 
2. This technique has the potential to develop a test system aimed at 
detection of newly induced point mutations in fetuses exposed to 
teratogenic agents and it might give an indication of underlying 
mechanisms. This potential was not realised in the study reported 
here, for the reasons that are likely to include those that have been 
provided. 
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CH APTER 11 
AN IN VIVO STUDY OF THE EFFECTS OF CYCLOPHOSPHAMIDE, AND LARGE DOSES 
OF VITAMIN A ON CEPHALIC DNA DAMAGE IN THE FETAL MOUSE USING 
A DNA UNWINDING ASSAY TO DETEcr DNA STRAND BREAKS 
11.1. INTRODUcrION 
The critical target in terms of the antineoplastic, carcinogenic and 
mutagenic properties of cyclophosphamide is DNA. As discussed in section 
1.2, although the mechanism of cyclophosphamide teratogenicity is un-
known, available evidence supports the hypothisis that DNA is the primary 
target (Mirkes, 1985). Cyclophosphamide metabolites have been shown to 
alkylate embryonic DNA (Murthy et al., 1973), to inhibit DNA synthesis 
(Short et al., 1972), and monofunctional phosphoramide mustard has been 
found to induce fetal DNA strand breaks (Mirkes et al., 1984). 
It appears less likely that DNA damage plays an important part in vitamin 
A teratogenicity. Although the vitamin has been noted by some workers to 
decrease fetal DNA synthesis (Dingle, Lucy and Fell, 1961; Langman and 
Welch, 1967; Nanda, 1971; Morriss, 1972; and Kochar, 1975), Kochar 
(1975) was unable to show an effect on DNA synthesis with concentrations 
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of vitamin A ten times that which cause malformations in culture. Similar-
ly, Eckhert and Hurley (1979) could not demonstrate an effect on DNA syn-
thesis in rat fetuses exoposed to doses of vitamin A which had induced a 
61% incidence of malformations. 
The aim of the present study was: 
i) To compare the effects of cyclophosphamide and vitamin A 
on cephalic DNA damage in the C3H mouse fetus; 
ii) To utilise an in vivo technique which is rapid and simple, 
without the necessity of the usual requirements of culturing 
or radiolabelling; 
iii) To elucidate the teratogenic mechanisms of cyclophos-
phamide and vitamin A with particular reference to the 
CNS. 
A fluorometric method for rapid detection of DNA strand breaks was used 
(Birnboim and Jevcak, 1981). DNA strand breaks can be detected with 
great sensitivity by methods which utilize the observation that the rate 
of unwinding of the 2 DNA strands in alkali is related to the covalent 
length of strands (Kohn and Ewig, 1973; Rydberg, 1975). DNA strand 
breaks are associated with increased unwinding which was monitored with 
the fluorescent dye, ethidium bromide. 
11 • 2 • MATERIALS AND METHODS 
11.2.1. Experimental mice 
The housing of mice and method of mating have been described in Chapter 2. 
11.2.2. Drug administration 
Vitamin A, 30 000 or 60 000 IU, was administered by gastric intubation on 
day 11 p.c. to pregnant C3H mice. An equal volume of arachis oil was 
administered at the same time to controls. 
Cyclophosphamide, 15, 30 or 60mg/kg, was administered s.c. on day 11 p.c. 
to pregnant C3H mice. An equal volume of distilled water was administered 
at the same time to controls. 
11.2.3. Sacrifice, fetal decapitation and head storage 
Treated and control mice were sacrificed by cervical dislocation from 6 -
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40h after drug administration. The abdominal cavity was opened and 
uterine horns externalised. The number of fetuses was noted, and 
fetuses removed and decapitated by a horizontal incision in line with 




11.2.4. DNA unwinding assay for detection of DNA damage 
The principle of the procedure is as follows: 
The fluorescent dye, ethidium bromide, binds selectively to double-
stranded DNA in the presence of single-stranded DNA when short duplex 
regions in single-stranded DNA molecules are destablized by alkali 
(Morgan and Pullyblank, 1974). Conditions were used under which the 
dye fluoresces preferentially with double-stranded DNA. The cephalic 
cell lysate was divided equally among 3 sets of tubes. The contribu-
tion to fluorescence by components other than double-stranded DNA 
(including free dye) was estimated from a blank sample (B) treated 
under conditions which caused complete unwinding of DNA. A second 
sample was used for estimating total fluorescence CT) i.e. fluorescence 
due to the presence of double-stranded DNA plus contaminants. The diff-
erence (T-B) provided an estimate of the amount of double-stranded DNA 
in the extracts. A third sample (P) was used to estimate the degree of 
unwinding of the DNA. The cephalic lysate was exposed to alkaline con-
ditions sufficient to permit partial unwinding of the DNA. The fluores-
cence of this sample less the fluorescence of the blank (P-B) provided 
an estimate of the amount of double-stranded DNA remaining. 
Heads were placed individually in microfuge tubes at 4°c and 300µ1 of 
phosphate buffered saline (PBS) added. Disruption of cells was gently 
initiated using a pipette. Nine hundred microlitres of solution A, 
(0,87% NH4Cl, lOmM Tris-HCl, pH7,2) was added and the suspension left 
until cell lysis was complete (20 - 30min). The suspension was centri-
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fuged at 12 OOOg for lmin, the supernatant discarded and the pellet 
resuspended in 1ml of solution A, then centrifuged at 12 OOOg for a 
further lmin. This pellet was resuspended in 0,8ml of solution B 
(0,25M mesa-inositol, lOmM sodium phosphate, lmM MgC12 , pH7,2) to give 
6 a cell count of 5 - 10 x 10 /ml). Two hundred microlitre aliquots 
of this suspension were dispensed into glass tubes designated T, P and 
B. To each was added 200µ1 of solution C (9M urea, lOmM NaOH, 2,SmM 
cyclohexanediamine-tetraacetate, 0,1% sodium dodecyl sulphate), and 
incubated at 4°c for lOmin (during this time chromatin disruption occurs). 
To the P and B tubes, 100µ1 of solution D (0,45 volume solution C in 
200mM NaOH) and 100µ1 of solution E (0,4 volume solution C in 200mM 
NaOH) were gently added without mixing at 4°c for 30min. The contents 
of the B tube were sonicated for 2sec to ensure rapid denaturation of the 
DNA in alkaline solution. 0 P and B tubes were incubated at 15 C for 60 
min. Denaturation was stopped by addition of 400µ1 of a solution con-
taining lM glucose and 14mM mercaptoethanol (solution F) at o0 c, which 
+ lowered the pH to - 11. One hundred microlitres of solution~D and E 
0 were added to the tube Tat O C. All 3 tubes were sonicated briefly to 
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give a homogeneous suspension and diluted with 1,5ml of ethidium bromide 
(6,7µg/ml, 13,3mM NaOH). Fluorescence was read at room temperature in a 
Perkin-Elmer luminescence spectrometer (excitation 520nM; emission 590nM). 
The T tubes differed from the P tubes in that the neutralising solution, 
solution F, was added before the alkaline solutions D and E so that the 
DNA was never exposed to a denaturing pH. 
The extent of DNA unwinding after a given time of exposure of cephalic 
cell lysates to alkali was calculated from the fluorescent values of the 
T, P and B samples. The percent of double-stranded DNA remaining after 
partial alkali treatment was given by (P-B)/(T-B) x 100. Subtracting this 
value from that obtained for controls gave the percentage conversion 
of double-stranded DNA to the single-stranded form. For example, if 
the percentage of double-stranded DNA for controls was 75 % and that 
of the treated fetuses 52%, then 23% of the DNA in the treated fetuses 
was converted to the single-stranded form. 
The reagents described give a final pH value which is high enough to 
destablilize single-stranded DNA and RNA (to give low B fluorescence 
values) yet still below the denaturing pH for double-stranded DNA 
(Birnboim and Jevcak, 1981). 
11.2.5. Statistical analysis 
The Mann-Whitney U two-tailed test was used to compare data from treated 
fetuses with control data. Medians and 95% confidence limits were 
calculated from the Walsh averages, after Tukey (Steinijans and Diletti, 
1983) . 
11.3. RESULTS 
11.3.1. The effects of cyclophosphamide on cephalic DNA damage 
The effect of the dose of cyclophosphamide and the time of assay after 
administration an murine fetal cephalic DNA damage is shown in Table 11.1 , 
where DNA damage is expressed as the percentage of double stranded DNA. 
The time course of cephalic DNA damage is shown in Fig. 11.l , where DNA 
damage is expressed as the percentage conversion of DNA to the single-
stranded form. 
The effect of incremental doses of cyclophosphamide on cephalic DNA damage 








T A B L E 11.1. 
THE EFFECT OF THE DOSE OF CYCLOPHOSPHAMIDE AND THE TIME OF 
~.SSAY AFTER ADMINISTRATION ON MURINE CEPHALIC DNA DAMAGE 
TIME (h) AFTER ADMINISTRATION OF ASSAY 
-
3 6 9 16 22 
78% 80% 86% 75% 71% 
(66-91) (74-87) (75-95) (72-80) ( 63-89) 
n=6 n=l3 n=6 n=47 n=l2 
72% t 45% * 37% * 52% * 83%t 
(68-76) (38-50) ( 33-40) (4 7-57) ( 73-89) 
n=7 n=ll n=5 n=33 n=l4 
75% 
t 
24% * 30% * 45% * 78% t 
(55-87) (20-29) (25-30) (40-50) (65-90) 
n=6 n=l2 n=6 n=42 n=ll 
31% * 
- - - (25-40) -
n=34 
DNA DAMAGE EXPRESSED AS THE PERCENTAGE OF DOUBLE STRANDED DNA. 
n = no of assays (= no of fetal heads) 
* p<0,0003 













p value determined by comparison with control data using Mann-Whitney U test. 









PERCENTAGE OF 50 
DOUBLE STRANDED 
DNA CONVERTED TO 
THE SINGLE 
STRANDED FORM 40 
30 
20 
TIME COURSE OF CEPHALIC DNA DAMAGE INDUCED 
BY CYCLOPHOSPHAMIDE. 







6 9 12 18 24 30-40 
T I M E < H O U R S) 
DNA DAMAGE EXPRESSED AS % CONVERSTION OF DNA TO THE 
SINGLE STRANDED FORM 
* p<0,0003 
p value determined by cooparison with control data us i ng 
Mann-Whitney U test. 







THE EFFECT OF INCREMENTAL DOSES OF CYCLOPHOSPHAMIDE 
ON MORINE FETAL CEPHALIC DNA DAMAGE 16h AFTER 
ADMINISTRATION EXPRESSED AS THE PERCENTAGE CONVER-
























DOSE OF CYCLOPHOSPHAMIDE (mg/kg) 
p value determined by comparison with control 
data using Mann-Whitney U test. 
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conversion of DNA to the single-stranded form). 
There was no evidence of cephalic DNA damage in 12-day fetal mice at 3h 
after administration (the median percentage of double-stranded DNA of un-
treated mice was 78% compared with 72% and 75% in fetuses exposed to 
cyclophosphamide lSmg/kg and 30mg/kg respectively). However, at 6h after 
cyclophosphamide administration there was obvious evidence of DNA damage. 
The percentage conversion of DNA to the single-stranded form was 35% and 
56% for fetuses exposed to lSmg/kg and 30mg/kg respectively, p<0,003. 
Similarly, evidence of DNA strand breaks was present and still maximal at 
9h (49% and 56% conversion in fetuses exposed to lSmg/mg and 30mg/kg cy-
clophosphamide respectively, p<0,003). At 16h, although there was signi-
ficant DNA damage, as can be seen in Fig. 11.1, it appeared to be less than 
at 6h and 9h (23% and 30% conversion in fetuses exposed to lSmg/kg and 
30mg/kg, respectively). 
At 22h and 30-40h after cyclophosphamide there was no evidence of DNA 
strand breaks. 
An increase in DNA damage was evident in fetal heads examined 
6, 9 and 16h after cyclophosphamide administration (see Fig. 11.1). Fig. 
11.2 further illustrates the effect of incremental doses (15, 30 and 60mg/ 
kg) 16h after cyclophosphamide administration, suggesting a dose-related 
increase in cephalic DNA damage. 
11.3.2. The effect of vitamin A on murine fetal cephalic DNA 
Teratogenic doses of 30 000 and 60 000 IU vitamin A administered on the 
11th day post conception were not associated with any evidence of DNA 
strand breaks. The percentage of double-stranded DNA in untreated fetuses 
was 76% compared with 67% and 73% in fetuses exposed to 30 000 and 60 000 




















Fig. 11. 3. 
THE EFFECT OF VITAMIN A ON MURINE FETAL 
CEPHALIC DNA DAMAGE 16H AFTER ADMIN·ISTRATION 
EXPRESSED AS THE PERCENTAGE OF DOUBLE-STRANDED DNA 
* N=16 





0 30000 60000 
DOSE OF VITAMIN A (IU) 
* p = NS 
p value determined by compariso~ ~th control data 
·using Mann-Whitney U test. 
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on day 11 p.c. were obviously teratogenic as shown in the results of 
an experiment where fetuses were examined on day 18 p.c. (Tables 11.2 
and 11.3 ) . There was a 93% incidence of early intra-uterine deaths 
and one live abnormal fetus after administration of 30 000 IU, and 100% 
embryolethality with 60 000 IU. (At the time of sacrifice on day 12 
in the DNA experiments, fetuses exposed to vitamin A were still viable 
with normal heartbeats). 
11.4. DISCUSSION 
314 
The absence of evidence of fetal cephalic DNA damage 3h after cyclophos-
phamide administration is explicable on the basis of the time needed for 
maternal absorption, metabolism to active metabolites (Greenaway et al., 
1982; Hales, 1983), and distribution via the placenta to the fetus. How-
ever, evidence of maximal DNA damage was apparent 3h later at 6h after 
administration, indicating the rapidity with which marked DNA damage occurs 
in this in vivo model. 
In histological studies cell necrosis was only noted in the fetal rat 
brain 24h after administration of cyclophosphamide (Wendler, 1978), where-
as in embryonic limb buds evidence of excess necrosis was apparent Sh 
after exposure (Manson et al., 1982). The rapid onset in the latter in 
vitro study is not strictly comparable because the exclusion of maternal 
factors would ensure almost immediate access of the teratogen to the fetal 
tissues. 
Although there was significant DNA damage at 16h, it was less than at 
6h and 9h (30% conversion of the single-stranded form of DNA at 16h com-
pared with 56% at 6 and 9h after a dose of 30mg of cyclophosphamide). 
This was in keeping with the onset of DNA repair and i.~dicates how rapidly 





























































































































































































































































































































































































































































































































































































































































































demonstrating repair was complete by this stage. In published histological 
studies of the embryotoxic effects of cyclophosphamide such rapid onset 
of repair has not been described. Von Kreybig and Schmidt (1967) recorded 
repair in the course of the second 24h after administration in the fetal 
rat brain, whereas Wendler noted evidence of repair after 72h (Wendler, 
1979). In experiments with 5-fluorodeoxyuridine which blocks DNA replica-
tion, repair was evident 24h after application (Langman et al., 1980) ·. 
It would therefore appear that DNA damage and repair antedate evidence of 
histological necrosis and repair. The entity of DNA repair is well known 
(Manson, 1981b), but the rapidity with which it occurs is an interesting 
finding. 
Manson et al., (1982) also attempted to correlate cell death with DNA 
damage. A trend towards increasing DNA damage with time was observed, 
the greatest damage occurring during the postnecrotic period at 48 and 
72h. These in vitro observations are clearly different from the present 
study and are not readily explicable, because a decrease in DNA damage 
would be anticipated during the postnecrotic repair period, such as was 
found in these experiments. 
Because the technique used detected DNA strand breaks this study demonstrates 
that this primary lesion of DNA is probably important in producing embryo-
toxic effects, as was reported by Mirkes et al., (1984) where the defects 
produced by monofunctional phosphoramide mustard were associated with the 
induction of DNA strand breaks. 
The findings in this study are in agreement with the hypothesis that the 
underlying mechanism of cyclophosphamide induced teratogenicity is DNA 
damage. Thereafter the pathogenesis of developmental defects could follow 
the pathway outlined in Fig. 1.2 (section 1.1). Mirkes (1985) suggests 
that DNA lesions lead to cell death or mutations ultimately resulting 
in the final defect. 
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The absence of any evidence of DNA strand breaks induced by embryotoxic 
doses of vitamin A in the present study is further support that DNA damage 
does not play an important part in vitamin A induced teratogenicity. '!'he 
fetuses in this experiment were examined 16h after administration of vitamin 
A and it is possible that DNA damage may occur after this period. However, 
considering the teratogenic dose administered and lack of evidence to the 
contrary this was considered unlikely and was not pursued. 
Although, as outlined in section 11.1, conflicting results have been found 
by different workers as regards the effect of the vitamin on DNA synthesis, 
this to my knowledge, is the first study investigating DNA damage. 
11.5. CONCLUSIONS 
1) The administration of teratogenic doses of cyclophosphamide on the 
11th day post conception was associated with an increase in DNA 
damage in fetal heads examined 16h after dosing, which appeared to 
be dose-related. 
2) There was no evidence of DNA damage 3h after administration, but 
damage was apparent at 6h and was still present at 16h. However, 
the absence of DNA damage in fetuses examined at 22, 30 and 40h 
suggest that DNA repair had occurred. 
3) Teratogenic doses of vitamin A administered on the 11th day post 
conception we:::-e not associated with any evidence of DNA strand 
breaks. 
4) The technique is a sensitive and simple one for the in vivo deter-
mination of DNA damage induced by teratogens. 
C H A P T E R 1 2 
CONCLUDING CHAPTER 
I have documented substantial AChE activity in 17-day to 19-day C3H 
fetal mouse brains, and a lower activity of approximately one third 
in 11- and 12-day fetal heads. However, fetal brain cholinesterase 
activity was very low, contributing only 3,0 - 6,7% to the total en-
zyme activity (AChE and ChE), and was not demonstrable on polyacryla-
mide gel electrophoresis. Five distinct isoenzyme zones of AChE were 
demonstrated and the band pattern was similar in 17-, 18- and 19-day 
fetuses. 
An observation well known in teratology was the substantial difference 
in severity and frequency of congenital defects from litter to litter 
as well as from offspring to offspring within the same litter after ad-
ministration of all 3 teratogens used in this thesis. No maternal 
toxicity was observed with the doses of the drugs used in the definitive 
experiments which lends support to the concept that the fetal abnormalities 
observed were due to direct effects of the teratogens on the embryo. 
Other similarities were the rise in incidence of malformations and 
embryolethality with increase in dose as well as a steep rise in resorp-
tion rate after administration earlier in gestation. A steep dose-
response curve for malformations was apparent. A striking abnormality 
was exophthalmos which was most frequently observed after vitamin A 
administration and appeared to be due to the reduction in size of the 
orbit. Although a growth-inhibitory effect was demonstrable with all 
3 teratogens, it was most pronounced after cyclophosphamide administra-
tion and appeared to be dose-related with the dose-response curve to 
the left of that for malformations and embryolethality. In contrast, the 
vitamin A-induced growth inhibitory dose-effect curve appeared to be to 
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the right of the malformations curve. 
Because embryotoxic mechanisms vary with the teratogen used and the time 
of exposure it is not surprising that differences were found in fetal 
brain AChE activity. The increase in brain AChE activity observed after 
vitamin A administration was most reasonably explained on the basis of 
relative sparing of cholinergic neurons from the embryotoxic effects of 
the teratogen. The absence of an increase in brain total protein content 
suggested that the greater enzyme activity was not secondary to a general 
increase in brain protein, and the absence of an increase in ChAT activity 
pointed against exuberant repair. The decrease in fetal brain AChE (and 
ChAT) activity after cyclophosphamide and sodium valproate administration 
was explicable on the basis of a growth-inhibitory effect. In fetuses 
examined two days after cyclophosphamide administration the greater head 
AChE activity a.long with an increased haemoglobin and decreased ChAT 
activity suggested that the increase was due to blood. This was compatible 
with a haemorrhagic process and was not a feature of teratogenic injury 
with vitamin A. The differential effect of the teratogens used on the 
isoenzyme zones provide evidence that these are indeed isoenzymes and not 
aggregates, and furthermore suggest distinct embryotoxic mechanisms. 
Further inv~stigation might have been of interest but because AChE offered 
no particular advantage as a marker of teratogenic injury this was not 
pursued. 
Numerous points emerge regarding the potential of AChE (and ChAT) as a 
biochemical marker of teratogenic injury in the fetal CNS. It does not 
appear to be more sensitive than standard teratogenicity tests because 
changes in activity were not apparent in the absence of evidence of gross 
effects such as growth retardation, morphological abnormalities or embryo-
lethality. Furthermore, a change in brain enzyme activity was not always 
observed when there was other evidence of teratogenic effects. It would 
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appear that a number of factors such as growth inhibition, haemorrhagic 
processes, repair, relative sparing of neurons, time of administration 
and oppositve changes in different parts of the brain can all influence 
whether there is ultimately a detectable overall change in brain AChE 
activity. Also, the finding that the ontogenetically new cerebral cortex, 
which would be expected to be the most susceptible part of the brain to 
teratogenic insults, has a low AChE activity is another potential limita-
tion of this enzyme as a brain marker of teratogenic injury. Perhaps a 
better choice, rather than an enzyme which is merely a component of the 
cholinergic nervous system, might have been an enzyme involved in one of 
the more fundamental functions of embryonic cell physiology. However, 
although AChE alone is not a reliable indicator of embryotoxicity, when 
viewed together with other parameters such as growth inhibition, repair, 
malformations and embryolethality the information is useful and the fin-
dings have pointed to some of the underlying processes such as haemorrha-
gic necrosis, relative sparing of cholinergic neurons, growth inhibition 
and repair. 
The potential of other biochemical markers merits further investigation. 
Detection of metabolic lesions, such as quantifiable deviations in enzymes, 
particularly in the absence of gross morphological abnormalities would 
greatly extend the sensitivity of standard teratological procedures. 
Another enzyme, ornithine decarboxylase, a regulator of macromolecule 
synthesis, has recently proven useful as a brain biochemical marker for 
teratologic events (Slotkin et al., 1985). 
Other findings in this thesis have contributed to a better understanding 
of the pathophysiology of vitamin A-induced embryotoxic effects. Although 
vitamin A has been reported to decrease fetal cell proliferation and 
inhibit mitosis, no demonstrable effect was observed in blastocyst cell 
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number or mitotic index, which tends to exclude these as important mecha-
nisms in this model. Furthermore, viability/esterase enzyme activity of 
the preimplantation embryo was unaffected, suggesting that the striking 
incidence of abnormalities noted in fetuses near term was not due to em-
bryotoxic effects operative during the predifferentiation period. It is 
apparent the developmental aberrations were due to effects operating 
during the post-implantation period, which is consistent with the long 
half-life of elimination of vitamin A. Despite the apparent resistance 
to teratogenesis of the pre-differentiation embryo these findings caution 
against the use of any potentially embryotoxic drug with a long half-life 
during this period. 
The findings in this study also suggest that the production of chromosomal 
abnormalities is not an underlying mechanism of vitamin A teratogenicity in 
the mouse. Similarly, the absence of any evidence of DNA strand breaks in-
duced by embryotoxic doses of vitamin A is further support that DNA damage 
does not play an important part in vitamin A induced teratogenicity. How-
ever, the finding that vitamin A altered brain protein patterns in the fetal 
mouse may be a pointer to an important mechanism whereby vitamin A causes 
abnormal embryogenisis. High resolution 2D electrophoresis of protein 
requires further investigation as a potential tool for determining the 
teratogenic effects and mechanisms of drugs. 
The evidence in this thesis for the apparently dose-related fetal cephalic 
DNA damage induced by cyclophosphamide provide further support for the im-
portance of this mechanism in cyclophosphamide induced teratogenicity. Of 
particular interest was the rapidity with which this DNA damage occurred 
in vivo, and likewise the rapidity with which repair occurred. The findings 
also demonstrate that the induction of DNA strand breaks is important in 
producing the emrbyotoxic effects of cyclophosphamide. In addition, the 
t echnique described is a sensitive and simple one for the in vivo deter-
322 
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mination of DNA damage induced by teratogens. Following the teratogenic 
insult of DNA damage, impaired biosynthesis or mutations may result leading 
to decreased cellular proliferation and increased cell death, and ultimately 
abnormal differentiation and morphogenesis causing the final defect such as 
malformation. 
In conclusion, progress has been made towards the accomplishment of the two 
major objectives of this thesis, namely the definition of the mechanism of 
action of teratogens, and the development of test methodologies. There is 
still much work to be done before more sensitive markers of teratogenic 
injury are found and until there is a thorough understanding of the patho-
genie mechanisms of drug injury to the fetus. I feel research directed at 
defining abnormalities at a biochemical or subcellular level is of primary 
importance. It is hoped that the findings in this study will stimulate 
further investigation and will ultimately play a role in decreasing the 
incidence of drug-related birth defects. 
A P P E N D I X 1 
STATISTICAL TESTS USED 
Because of the bimodal nature of teratological results non-parametric 
statistics were used. Similarly, medians and 95% confidence limits 
were employed rather than means, since the former reflects central ten-
dency of a skewed distribution better than the mean. The difficulty 
arises in establishing the confidence limits of the median. A useful 
approach is to use the Tukey modification of Wilcoxon's signed rank 
matched pairs test, as described by Steinijans and Diletti (1983). Me-
dians and confidence limits are calculated using Walsh averages and the 
+ Wilcoxon Sum T of positive ranks. This method of establishing central 
tendency and scatter for a group of data compares well with parametric 
equivalents for data where either nonparametric or parametric tests may 
be used. 
324 
The Mann-Whitney U Test (Segal, 1956a), one of-the most powerful of the 
nonparametric tests and a useful alternative to the parametric t test 
without the t test's assumptions, was used to compare test and control data. 
The Chi-square test (Segal, 1956b) was used to determine the significance 
of the differences among independent groups. 
The Kolmogorov-Smirnov two sample test (Segal, 1956c) which is sensitive 
both to differences in means and in distribution, was used in certain si-
tuations where a bimodal population was suspected. 
All p values quoted were for 2 tailed tests and a p value of less than 
0,05 was regarded as statistically significant. 
326 
A P P E N D I X 2 
TABLES OF ORIGINAL DATA 
Note: Tables are printed on both sides of the page. 
For parametric data calculations of means, standard derivations and 
linear regressions were performed as required. Reference was made to 
standard texts for derivations. 
Calculations were carried out using a Hewlett-Packard desk top calcu-
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400 
T A B L E 6 .SST 
METHOD l : ANALYSIS OF ISOENZYMES. PEAK HEIGHTS (mm) 
OF PEAKS 1-5 AND THE SUM OF PEAKS 1-5 ( 11 TOTAL 11 ) 
Sample TEST 
No. Peak heights (mm) 
1 2 3 
l 69,5 121,0 .102, D 
2 53,D 108,D 89,D 
3 62,D 114,5 109,0 
4 73,5 126,0 91,0 
5 50,5 108,5 83,5 
6 38,5 87,0 59,0 
7 43,5 79,0 56,0 
8 53,D 92,5 72,0 
9 50,5 87,D 68,0 
10 32,D 73,5 58,5 
11 48,5 102,0 90,D 
12 43,5 102,5 99,5 
13 63,5 123,0 105,5 
14 70,5 124,5 112,5 
15 45,0 71,D 64,5 
16 52,D 86,0 80,0 
17 49; s 89,5 79,D 
18 43,5 82,5 76,0 
19 56,0 96,5 97,5 
20 57,5 98,0 95,0 
Median 52,75 98, 13 84,5 
95% Con- 47,75 89,5 75,5 
fidence to to to 
limits 58,5 106, 8 94,0 
p * N.S. N.S. 1\1. s. 
* Comparison with data in Table 6.SSC. 

















































7U,7'::J 336, ::i 
to to 
87,75 397, 3 
0,05 N.S. 
401 
T A 8 L E 6 .SSC 
METHOD 1 : ANALYSIS OF ISOENZYMES. PEAK HEIGHTS (mm) 
OF PEAKS 1-5 AND THE SUM OF PEAKS 1-5 ("TOTAL") 
Sample CONTROL 
No. Peak heioht.c; mm) 
1 2 3 4 5 TOTAL 
1 70,5 114,0 106,0 66,0 45,D 401,5 
2 61,0 103,5 100,0 55,5 38,5 358,5 
3 57,0 115,5 99,5 51, 5 89,0 412,5 
4 57,5 101,0 84,0 45,5 68,0 356,0 
5 61,5 99,5 75,5 52,0 43,0 331,5 
6 57,5 96,5 84,0 47,5 41,0 326,5 
7 35,0 76,0 68,5 30,0 78,0 287,5 
8 35,5 72,5 59,0 40, 5 88,0 295,5 
9 40,0 82,0 76,5 32,5 80,5 311,5 
10 41,0 72,5 54,4 28,0 70,5 266,5 
11 68,0 112,5 108,5 77,0 90,5 456,5 
12 50,5 97,0 89,0 43,0 62,0 341,5 
13 39,5 89,5 81,0 56,0 89,0 355,0 
14 53,0 106,0 98,0 50,5 59,0 366,5 
15 62,0 116,0 108, 5 65,0 61,5 413,0 
16 56,5 107,0 103,0 65,5 45,5 377,5 
17 51,0 81,5 79,0 49,0 48,o · 308,5 
18 28,5 57,0 55, 5 .... 36,5 46,0 223,5 
19 55,5 100,5 95,5 69,5 72,5 39 3, 5 
20 50,0 99,5 92,0 69,5 77,0 388,0 
Median 51.88 96.5 87.0 51,13 64,88 350,0 
95% Con- 45,75 86,5 77,5 44,25 55,00 321,5 
rfidence to to to to to to 
il imi ts 57,5 104,0 95,00 58,75 74,75 377,3 
402 
T A B L E 6 57T 
METHOD 2 : COMPARISON OF TEST AND CONTROL PEAK HEIGHTS 
USING PEAK THREE AS AN INTERNAL STANDARD 
T E S T 
PEAK NUMBER 
Sample ' 
No. 1 2 4 5 
1 0,68 1,19 0,54 0,78 
2 0,6 1,21 0,48 0,95 
3 0,57 1,05 0,56 0,84 
4 0,81 1,38 0,68 o, 71 
5 0,68 1,3 0,57 0,99 
6 0,65 1,47 0,37 1,68 
7 0,78 1,41 0,61 1,53 
8 0,74 1,28 0,68 0,97 
9 0,74 1,28 0,5 1,15 
10 0,55 1,26 0,45 1,18 
11 0,54 1,13 0,66 0,98 
12 0,44 1,03 0,57 1,04 
13 0,6 1,17 0,45 1,07 
14 0,63 1,11 0,56 0,88 
15 0, 7 1,1 0,74 0,88 
16 0,65 1,08 0,76 0,87 
17 0,63 1,13 0,87 0,97 
18 0,57 1,08 o,53 o,69 
19 o,57 0,99 0,71 o,59 
20 0,61 1,03 o,68 0,71 
1 Med.tan 0,637 1,184 o,595 o,935 
ratio 
LL 0,59 1,105 o,535 0,84 
UL 0,68 1,250 0,66 1,065 
p * N.S. 0,099 N.S. 0,032 
* Comparison.. with data in. Table 6.57C. 



























T A B L E 6 .57C 
METHOD 2 : COMPARISON ·op ·TEsT ·AND CONTROL .PEAK .HEIGHTS 
USING .PEAK ·THREE ·As ·AN ·INTERNAL ·STANDARD 
C O N T R O L 
PEAK NUMBER 
Sample 
No. 1 2 4 5 TOTAL 
1 0,67 1,08 o,62 0,42 2,79 
2 0,61 1,04 o,56 0,39 2,6 
3 0,57 1,16 0,52 0,89 3,14 
4 0,68 1,20 0,54 0,81 3,23 
5 0,81 1,32 0,69 o,57 3,39 
6 o,68 1,15 0,57 o,49 2,89 
7 0,51 1,11 0,44 1,14 3,2 
8 0,60 1,23 0,69 1,49 4,01 
9 0,52 1,07 0,42 1,05 3,06 
10 0,75 1,33 0,51 1,29 3,88 
11 0,63 1,05 0,71 0,83 3,22 
12 o,57 1,09 0,48 o, 7 2,84 
13 0,49 1,1 0,69 1,10 3,38 
14 o,54 1,08 0,52 0,6 2,74 
15 0,57 1,07 0,6 0,57 2,81 
16 0,55 1,04 0,64 o,44 2,67 
17 o,65 1,03 0,62 0,61 2,9.1 
18 0,51 1,03 0,66 0,83 3 ,03 
19 0,58 1,05 0,73 o,76 3,12 
20 o,54 1,08 0,76 0,84 3,22 
!Median 0,595 1,095 0,6 0,77 3,063 
ratio 
LL 0,555 1,065 o,55 0,625 2,92 
UL 0,64 1,155 0,65 0,94 3,255 
403 
404 
T A 8 L E 6.58T 
MET HC D 3 : CC~PA RIS CN J F TEST AND CONTROL PE AK HEIGHTS 
BY DIVI DI NG ALL DA TA BY MEAN FOR CONTR OLS FOR EACH GEL 
TEST 
1 2 3 4 5 
1 0,95 1,66 1,40 0,75 1, 09 
2 0, 7.3 1,48 1,22 0,58 1,17 
3 0,85 1,57 1,49 0,83 1,26 
4 1,01 1,73 1,25 0,84 0,89 
5 0,97 1,86 1,44 0,82 1,42 
6 0,66 1,50 1,02 0, 38 1,71 
7 0,75 1,36 D,96 0,59 1,47 
8 0,91 1,59 1,24 0,84 1,21 
9 0,87 1,50 1,17 0,59 1,34 
10 0,55 1,27 1,01 0,46 1,19 
11 0,63 1,32 1,17 0,77 1,14 
12 0 ,56 1,33 1, 29 0,73 1,34 
13 0,82 1,60 1,37 0,62 1,46 
14 0,92 1,62 1,46 0,82 1,28 
15 0, 69 1,08 0,98 0,72 0,86 
16 0,79 1, 31 1, 21 o, 93 1,06 
17 0,75 1,36 1,20 1,04 1,17 
18 0,66 1,26 1,16 0,62 0,80 
19 0,85 1,47 1,48 1,06 o,8a 
20 0,88 1,49 1,45 0,99 1,02 
Median 0,79 1,47 1,243 0,75 1,18 
Ratio 
- 0,72 1, 38 1,17 0,66 1,07 
+ 0,86 1,56 1,34 0,83 1,3 
p * NS 0 ,077 NS NS 0 ,0188 
* Comparison with data in Table 6.58C. 



















































T A B L E 6 .SSC 
METHOD 3 : COMPARISON OF TEST AND CONTROL PEAK HEIGHTS 
BY DIVIDING ALL DATA BY MEAN FOR CONTROLS FOR EACH GEL 
CONTROL 
1 2 3 4 5 TOTAL 
0,97 1,56 1,45 0,91 0,62 5,51 
0,_84 1,42 1,37 0,76 0,53 4,92 
0,78 1,58 1,36 0,71 1,22 5,66 · 
0,79 1,38 1,15 0,62 0,93 3,88 
0,84 1,36 1,03 0,71 o,59 4,55 
0,79 1,32 1,15 0,65 0,56 4,47 
0,61 1,31 1,18 0,52 1,34 4,96 
0,61 1,25 1,02 0,70 1,52 5,10 
0,69 1,41 1,32 0,56 I 1,39 5,37 
0,71 1,25 0,94 0,48 1,21 4,59 
0,88 1,46 1,41 1,00 1,18 5,93 
o,~6 1,26 1,16 0,56 o,81 4,45 
o,51 1,16 1,05 0,73 1,16 4,61 
0,69 1,38 1,27 0,66 0,77 4, 77 
0,81 1,51 1,41 0,84 0,80 5,37 
0,'73 1,39 1,34 0,85 0,59 4,90 
o,78 1,24 1,20 0,75 o, 73 4,70 
0,43 o,87 0,85 0,56 0,70 3,41 
0,85 1,53 1,45 1,06 1,10 5,99 
0,76 1,51 1,40 1,06 1,17 5,90 
o,745 1,375 1,235 o, 722.5 0,95 4, 9.9 
o,68 1,3 1,145 o,635 0,765 4,7 
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